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SUMMARY 
 
Background 
South Africa is the country with the largest number of HIV infections in the world. As 
behaviour change initiatives have been suboptimal in curbing the spread of the pandemic, an 
HIV vaccine is likely to be an important development as a biological agent may circumvent 
some of the challenges of initiating widespread behaviour change. The development of an 
HIV vaccine will require several thousands of HIV negative participants who are at high risk 
of HIV infection to participate in HIV vaccine clinical trials. Before recruitment for such trials 
may begin, various scientific, ethical, and sociobehavioural issues need to be considered. One 
of the key sociobehavioural issues concerns the willingness of individuals at high risk of HIV 
infection to participate in HIV vaccine trials. However, a psychometric measure of 
willingness to participate (WTP) has not been constructed, and there is a paucity of theory to 
guide studies of WTP. 
Objectives 
The first objective of this study was to construct a psychometric measure of WTP in an HIV 
vaccine trial, and to derive the exploratory factor structure of the measure. The second 
objective was to examine the extent to which the Theory of Planned Behavior (TPB) could 
predict variance in WTP, and to determine whether the TPB was strengthened by the 
inclusion of mistrust of researchers, knowledge of HIV vaccines and HIV vaccine trials, 
altruism, and perceived risk of HIV infection as additional predictor variables. 
Methodology 
This study was a research survey with a cross-sectional design. A convenience sample of 399 
participants was recruited from an urban-informal settlement near Cape Town. As 79 of the 
questionnaires were poorly completed, the final sample size was 320. To develop a measure 
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of WTP in an HIV vaccine trial, an item pool was developed whereby items directly 
reflected inhibitors and facilitators of WTP. After an iterative process of refinement, the final 
scale consisted of 35 items and was named the Willingness to Participate Scale (WTPS). A 
principal component Kaiser normalised exploratory factor analysis (EFA) was conducted on 
the items that constituted the WTPS. This procedure was performed to identify latent factors 
which were informed by the items of the scale. To test the predictive capacity of the TPB and 
the additional predictor variables, a two-step linear hierarchical multiple regression analysis 
was performed. At step 1, the TPB variables were entered simultaneously. At step 2, the TPB 
variables along with the additional predictor variables were entered simultaneously.  
Results 
The WTPS demonstrated excellent internal consistency (α = 0.90) and initial construct 
validity, as evidenced by the presence of seven latent factors. The factors accounted for 
53.15% of the variance in WTP and were: (i) Social approval and trust; (ii) Stigmatisation; 
(iii) Personal costs; (iv) Personal gains; (v) Personal risks; (vi) Convenience; and (vii) Safety. 
The TPB significantly accounted for 6.4% (R² = 0.06) of the variance in WTP [F(3, 316) = 
7.16, p < 0.001], yielding a small effect size (ƒ2 = 0.06). The TPB, together with mistrust, 
knowledge of HIV vaccines and HIV vaccine trials, altruism, and perceived risk of HIV 
infection as additional predictor variables significantly accounted for 10.2% (R² = 0.10) of the 
variance in WTP [F(7, 312) = 5.06, p < 0.001], yielding a small to medium effect size (ƒ2 = 
0.11). Subjective norms, mistrust of researchers, altruism, and perceived risk of HIV infection 
were significant independent predictors of WTP. 
Conclusion 
Against the backdrop of the study limitations, the results of this study provide initial support 
for the reliability and construct validity of the WTPS among the most eligible trial 
participants in the Western Cape of South Africa. The findings also suggest that the TPB may 
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not be an appropriate theoretical framework for predicting WTP in an HIV vaccine trial in 
this context. Nonetheless, normative pressure by others, mistrust of researchers, altruism, and 
perceived risk of HIV infection may influence WTP in this population. Implications for future 
research are discussed. 
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OPSOMMING 
 
Agtergrond 
Suid afrika is die land met die hoogste getal HIV infeksies in die wêreld. Vir die ontwikkeling 
van 'n HIV entstof, sal daar vereis word dat duisende HIV negatiewe deelnemers, wat 'n hoë 
risko kans staan om HIV infeksie op te doen, moet deelneem aan 'n kliniese HIV vaksine 
proeftog. Verskeie, wetenskaplike, etiese en sosiale gedrags punte moet oorweeg word, voor 
die werwing van sulke proefnemings. Een van die hoof aspekte van sosiale gedrags punte is 
die bereidwillgheid van 'n individu om blootgestel te word aan die HIV infeksie tydens die 
proeftog. 'n Psigometriese skatting van bereidwiligheid om deel te neem (BODTN) is egter 
nog nie gekonstruktureer nie en daar is 'n skaarste/geringheid in studies om as gids te dien vir 
die BODTN. 
Doel 
Die eerste doel van hierdie studie was om 'n psigometriese skatting van BODTN in ’n HIV 
vaksiene proefneming te konstruktureer, en om die ondersoekings oorsaak/faktor struktuur 
daarvan te meet en af te lei. Die tweede doel was om ondersoek in te stel of die omvang van 
die Teorie van Beplande Gedrag (TBG) verskille kan voorspel in die BODTN, en om vas te 
stel of die TBG versterk word deur die insluiting van wantroue in navorsers, kennis van HIV 
vaksienes en HIV vaksiene proefnemings, altruïsme, en die begrypbare risko van HIV 
infeksie as adisionele voorspellers.   
Metode 
Hierdie studie is 'n navorsings ondersoek met 'n deursneeproef ontwerp. ’n Grieflike aantal 
van 399 deelnemers was gewerf van 'n informele nedersetting naby Kaapstad. Die finale getal 
was 320 omdat 79 nie die vraelys korrek on volledig ingevul het nie. Na 'n interaktiewe 
proses van suiwering/verfyning, het die finale skaal uit 35 items bestaan en word die skaal 
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benoem na die Willingness to Participate Scale (WTPS). Die prinsipale komponent Kaiser 
normaliseer EFA wat gedoen was op die items wat die WTPS konstitueer. Hierdie prosedure 
was gedoen om die latente faktore te identifiseer wat beskikbaar gestel was deur die items van 
die skaal. Om die voorspelbare kapasiteit van die TBG en die adisionele voorspelbare 
verskille te toets, het ons 'n twee stap hiërargiese veelvoudige agteruitgaan analise gebruik. 
By stap 1 was die TBG veranderlikes gelyktydig ingedruk. By stap 2 is die TBG 
veranderlikes tesame met die adisionele voorspellers in gedruk. 
Resultate 
Die WTPS het uitstekende interne konsistensie en 'n aanvanklike geldigheid gedemonstreer, 
soos bewys deur die teenwoordigheid van die 7 latente faktore. Die faktore verantwoord 
53.15% van die verskil in WTP en was: (i) Sosiale aanvaarding en vertroue; (ii) Stigma; (iii) 
Persoonlike koste; (iv) Persoonlike wins/profyt; (v) Persoonlike risiko's; (vi) Gerieflikheid; en 
(vii) Veiligheid. Die TBG verantwoord 6.4% (R²=0.06) van die verskil in BODTN [F(3.316) 
= 7.16, p<0.001] met 'n toegewende klein groote uitwerking/uitslag. Die TBG tesame met 
wantroue, kennis van HIV vaksienes en HIV vaksiene proefnemings, altruïsme, en 
begrypbare risko van HIV infeksie as adisionele voorspellers, verwantwoord 10.2% (R²=0.10) 
van die verskil in BODTN [F(7.312 = 5.06, p<0.001], met 'n toegewende klein tot medium 
groote uitwerking/uitslag (f²=0.11). Subjektiewe norme, wantroue in navorsers, altruïsme, en 
'n beprypbare risko van HIV infeksie was betekenisvolle, onafhanklike voorspellers van die 
BODTN.  
Gevolgtrekking 
Teen die agtergrond van die studie beperkinge, het die resultate van hierdie studie 
ondersteuning voorsien aan die vertroubaarheid en konstruktiewe geldigheid van die WTPS 
onder die mees geskikste proef deelnemers in die Wes Kaap van Suid Afrika. Die bevinding 
stel ook voor dat die TBG nie altyd 'n geskikte teoretiese raamwerk is vir die voorspelling van 
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die BODTN in 'n HIV vaksiene proefneming  in hierdie konteks is nie. Des nie teen 
staande, normale druk van ander, wanrtroue in navorsers, altruïsme en die begrypbare infeksie 
van HIV kan die populasie deur die BODTN beinvloed word. Implikasies vir toekomstige 
navorsing is bespreek. 
Stellenbosch University http://scholar.sun.ac.za
 ix 
ACKNOWLEDGEMENTS 
 
 First and foremost, I thank Professors Ashraf Kagee and Leslie Swartz for their 
outstanding guidance and support.  
 I thank the National Research Fund (NRF) for the funding that made this study 
possible.  
 Thanks to my mother Angie, father Greg, brother Ryan, and sister Tamsyn for their 
encouragement and support.  
 Thanks to my employer and mentor, Professor Soraya Seedat, for allowing me the 
flexibility to meet with my promoters and to complete the thesis.  
 Finally, thanks to Berna Bekker for translating the summary. 
 
 
Oh, and very special thanks to Nonny, Tiger, and Evel Knievel… 
Stellenbosch University http://scholar.sun.ac.za
 x 
DEDICATION 
 
This thesis is dedicated to the people of Masiphumelele. 
 
Stellenbosch University http://scholar.sun.ac.za
 xi 
TABLE OF CONTENTS 
 
Declaration           ii 
Summary           iii 
Opsomming           vi 
Acknowledgements          ix 
Dedication           x 
List of Tables           xvii 
List of Figures                     xviii 
List of Abbreviations          xix 
Chapter 1: Introduction         1 
 1.1 The HIV/AIDS pandemic       1 
 1.2 HIV/AIDS prevention       3 
 1.3 The South African AIDS Vaccine Initiative (SAAVI)   3 
 1.4  The development of an HIV vaccine      4 
 1.5 The importance of studying willingness to participate (WTP) in an HIV  
vaccine trial         5 
 1.6 The Sociobehavioural Working Group of SAAVI (SAAVI-SB)   7 
 1.7 Research problems        8 
 1.8 A theoretical framework for studying WTP in an HIV vaccine trial  9 
 1.9 Extending the TPB in the context of WTP in an HIV vaccine trial   10 
 1.10 Goals of the study        11 
 1.11 Importance of this study       12 
 1.12 Definition of concepts       12 
  1.12.1 Facilitator        12 
Stellenbosch University http://scholar.sun.ac.za
 xii 
  1.12.2 Inhibitor                 13 
  1.12.3 Altruism        13 
 1.13 Overview of chapters         13 
Chapter 2: Literature review and theoretical framework     15 
2.1 Introduction         15 
2.2 Retention and attrition       15 
2.3 Sexual disinhibition        16 
2.4 Social harms         17 
2.5 Willingness to participate (WTP) in an HIV vaccine trial   18 
2.5.1 Inhibitors of WTP in an HIV vaccine trial     18 
2.5.1.1 Mistrust       18 
2.5.1.2 Knowledge of HIV vaccines and HIV vaccine trials  23 
  2.5.2 Facilitators of WTP in an HIV vaccine trial    26 
   2.5.2.1 Altruism       26 
   2.5.2.2 Perceived risk of HIV infection    29 
  2.5.3 Health concerns and WTP in an HIV vaccine trial   31 
  2.5.4 Gender and WTP in an HIV vaccine trial    32 
  2.5.5 Age and WTP in an HIV vaccine trial    34 
  2.5.6 Educational level and WTP in an HIV vaccine trial   35 
2.6 Part I of this study        35 
2.7 Measuring WTP in an HIV vaccine trial     37 
2.8 A theoretical framework for studying WTP in an HIV vaccine trial  39 
 2.8.1 The Health Belief Model      40 
 2.8.2 The Protection Motivation Theory     41 
 2.8.3 The Theory of Planned Behavior     43 
Stellenbosch University http://scholar.sun.ac.za
 xiii 
2.8.4 The Theory of Planned Behavior and WTP in an HIV vaccine 
trial         47 
2.9 Overview of the chapter       50 
Chapter 3: Research methodology        51 
3.1  Introduction         51 
3.2 Participants         52 
3.3 Research design        53 
3.4 Measuring instruments       53 
 3.4.1 The Willingness to Participate Scale (WTPS)   53 
  3.4.1.1 Item development      53 
  3.4.1.2 Item refinement      54 
 3.4.2 Measuring the TPB variables      54 
  3.4.2.1 Attitudes       55 
   3.4.2.2 Subjective norms      56 
3.4.2.3 Perceived behavioural control     57 
  3.4.3 Scales for the additional variables     58 
3.4.3.1 Mistrust of researchers     58 
3.4.3.2 Knowledge of HIV vaccines and HIV vaccine trials  58 
3.4.3.3 Altruism       59 
3.4.3.4 Perceived risk of HIV infection    59 
 3.4.3.5 Demographic variables     59 
 3.5 Translation of measuring instruments     60 
3.6 Procedure         61 
3.7 Data analysis         62 
3.7.1 Data screening       62 
Stellenbosch University http://scholar.sun.ac.za
 xiv 
3.7.2 Exploratory factor analysis               63 
   3.7.2.1 Sample size for exploratory factor analysis   64 
3.7.3 Two-step linear hierarchical multiple regression analysis  64 
3.7.3.1 Model specification      65 
3.7.3.2 Sample size for multiple linear regression analysis  65 
Chapter 4: Results          66 
 4.1 Demographic characteristics of the sample     66 
4.2 Internal reliability of the measures      68 
4.2.1 Attitudes        68 
4.2.2 Subjective norms       68 
4.2.3 Perceived behavioural control     68 
4.2.4 Mistrust        68 
4.2.5 Knowledge of HIV vaccines and HIV vaccine trials   69 
4.2.6 Altruism        69 
 4.3 Bivariate correlations between variables     70 
4.4 Between-groups effects       72 
4.5 The Willingness to Participate Scale (WTPS)    74 
 4.5.1 Factor structure of the WTPS      78 
4.5.2 Exploratory factor analysis diagnostics    81 
 4.6 Application and extension of the Theory of Planned Behavior  81 
  4.6.1 Two-step linear hierarchical multiple regression analysis  81 
  4.6.2 Regression diagnostics      84 
 4.7 Summary of findings        85 
Chapter 5: Discussion and conclusion        87 
5.1 Introduction         87 
Stellenbosch University http://scholar.sun.ac.za
 xv 
5.2 Limitations of the study                 89 
5.3 The representativeness of the sample      91 
5.4 Factor structure of the WTPS       94 
 5.4.1 Social approval and trust      94 
 5.4.2 Stigmatisation        96 
 5.4.3 Personal costs        97 
 5.4.4 Personal gains        99 
 5.4.5 Personal risks        100 
5.4.6 Convenience        102 
  5.4.7 Safety         103 
5.5 Application of the Theory of Planned Behavior    104 
 5.5.1 Attitudes        104 
 5.5.2 Subjective norms       105 
 5.5.3 Perceived behavioural control     106 
5.6 Extension of the Theory of Planned Behavior    107 
 5.6.1 Mistrust of researchers      108 
 5.6.2 Knowledge of HIV vaccines and HIV vaccine trials   109 
 5.6.3 Altruism        110 
 5.6.4 Perceived risk of HIV infection     110 
 5.7 Conclusions         112 
Reference list           114 
Appendices 
Appendix A          141 
 Appendix B          159 
 Appendix C          161 
Stellenbosch University http://scholar.sun.ac.za
 xvi 
 Appendix D                 164 
Appendix E          167 
Appendix F          171 
Appendix G          179 
Appendix H          183 
Appendix I           189 
Stellenbosch University http://scholar.sun.ac.za
 xvii 
LIST OF TABLES 
 
Table 1: Demographic Characteristics of the Sample     66 
Table 2: Internal Consistency of Measures Before and After Deleting Poorly 
Performing Items        70 
Table 3: Bivariate Pearson Product-moment Correlations between Continuous  
Variables         71 
Table 4: Tests of Between-groups Effects      73 
Table 5: Item-by-item Descriptive Analyses for the WTPS    75 
Table 6: Principal Components Exploratory Factor Analysis of the WTPS  80 
Table 7: Summary of Two-step Linear Hierarchical Multiple Regression Analysis  
for Variables Predicting WTP      83 
 
Stellenbosch University http://scholar.sun.ac.za
 xviii 
LIST OF FIGURES 
 
Figure 1: Enabler-Inhibitor quadrant model (Swartz et al., 2006)   36 
Figure 2: The Theory of Reasoned Action      44 
Figure 3: The Theory of Planned Behavior      45 
Figure 4: Application and extension of the Theory of Planned Behavior in this  
study          49 
Figure 5: Scree plot of factors to be extracted (Eigenvalues ≥ 1)   79 
Figure 6: Histogram and normal probability plot of the standardised residuals 84 
Figure 7: Standardised residuals/standardised predicted values plot   85 
 
 
Stellenbosch University http://scholar.sun.ac.za
 xix 
LIST OF ABBREVIATIONS 
 
AAVI:  African AIDS Vaccine Initiative 
AIDS:  Acquired Immunodeficiency Syndrome 
BHAI:  Botswana Harvard AIDS Institute 
CAB:  Community Advisory Board 
CSW:  Casual Sex Worker 
DoH:  Department of Health 
DPMSA: Detroit Primary Metropolitan Statistical Area  
DST:  Department of Science and Technology 
EAVI:  Ethiopian AIDS Vaccine Initiative  
EFA:  Exploratory Factor Analysis 
EU:  European Union 
HAART: Highly active anti-retroviral therapy 
HBM:  Health Belief Model 
HIV:  Human Immunodeficiency Virus 
HVTN: HIV Vaccine Trials Network 
IAVI:  International AIDS Vaccine Initiative 
IDU:  Injection Drug User 
IRB:  Internal Review Board 
KOSH: The Klerksdorp, Orkney, Stilfontein and Hartbeesfontein district  
LSD: Lysergic acid diethylamide 
MSM: Men who have sex with men 
MVA: Missing Value Analysis 
NAVP: Nigerian AIDS Vaccine Programme 
Stellenbosch University http://scholar.sun.ac.za
 xx 
NIH: The US National Institute of Health 
PMT: Protection Motivation Theory 
SAAVI: South African AIDS Vaccine Initiative 
SEM:  Structural Equation Modelling  
SPSS:  Statistical Package for the Social Sciences 
STD:  Sexually Transmitted Disease 
TPB:  Theory of Planned Behavior 
TRA:  Theory of Reasoned Action 
UAI:  Unprotected Anal Intercourse  
UNAIDS: The joint United Nations program on HIV/AIDS 
US:  United States 
VIF:  Variance Inflation Factor 
WTP:  Willingness to Participate 
WTPS: Willingness to Participate Scale
 
 
 
Stellenbosch University http://scholar.sun.ac.za
 1 
CHAPTER 1 
INTRODUCTION 
 
1.1. The HIV/AIDS pandemic 
 
The most recent report by the joint United Nations program on HIV/AIDS (UNAIDS, 2007) 
estimates that by December of 2007, 33.2 million people (95% CI: 30.6 million - 36.1 
million) were infected with HIV worldwide. In 2007 alone, 2.5 million people (95% CI: 1.8 
million - 4.1 million) became newly infected with HIV and 2.1 million people (95% CI: 1.9 
million - 2.4 million) died from AIDS related causes. Sub-Saharan Africa remains the most 
seriously affected region in the world, with 22.5 million people (95% CI: 20.9 million - 24.3 
million) infected with HIV by December of 2007.  
 
South Africa is the country with the largest number of HIV infections in the world (UNAIDS, 
2007). A national HIV prevalence and incidence study by Shisana et al. (2005) showed that 
the prevalence rate of HIV among persons aged 15 to 49 years in 2005 was 16.2% (95% CI: 
14.9% - 17.7%). The prevalence of HIV among females (20.2%) was nearly twice that of 
males (11.7%), and the prevalence rate among Blacks1 (19.9%) was substantially greater than 
in any other racial group (Whites: 0.5%; Coloureds: 3.2%; and Indians: 1.0%). Persons living 
in urban informal settlements demonstrated a substantially higher HIV prevalence rate 
(25.8%) than those in urban formal (13.9%), rural formal (13.9%), or rural informal 
settlements (17.3%). In sum, it seems that Black individuals (especially Black women) 
                                                 
1 Given South Africa’s history of political oppression and racial segregation, the terms ‘Black’, ‘White’, and 
‘Coloured’ may be considered offensive. This study, however, used the terms for the exclusive purpose of 
describing differences between members of different groups which occur in the context of the consequences of a 
history of discrimination on the basis of politically used categories.  No inherent “racial”differences are implied 
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between the ages of 15 and 49 years who reside in urban informal settlements are at highest 
risk of HIV infection in South Africa.  
 
Black women are also the poorest individuals in South Africa. According to the most recent 
South African census data (Statistics South Africa [SSA], 2001), 31.4% of Black females 
between the ages of 15 and 65 years had no formal source of income compared to 23.5% of 
both sexes from all population groups. Furthermore, 55.6% of employed Black females 
between the ages of 15 and 65 years were in elementary occupations, compared to 2.6% of 
both sexes from all population groups. The disproportionate burden of disease among the poor 
is a global trend (Gilbert & Walker, 2002) and suggests that socioeconomic risk factors may 
predict HIV seropositivity in developing and developed country settings alike.   
 
Given the high levels of economic, gender, and health inequality in South Africa, it seems that 
social risk factors play an exceedingly important role in the transmission of HIV in this 
context. It may even be the case that “social inequality is the greatest transmitter of 
HIV/AIDS” (Gilbert & Walker, 2002, p. 1094). Unless both biological and social risk factors 
are addressed, it is likely that there will be an exacerbation of the very inequalities that 
contributed to the spread of the epidemic in the first place (Campbell, 2003). Also, the loss of 
human capital associated with the unchecked spread of HIV will seriously impede economic 
growth and inhibit social development (Arndt & Lewis, 2000; Bachmann & Booysen, 2003; 
Piot, Bartos, Ghys, Walker, & Schwartlander, 2001). Various efforts have therefore been 
made to prevent the transmission of HIV. 
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1.2 HIV/AIDS prevention 
 
Multilateral efforts have been made to ameliorate structural risk factors such as 
unemployment, poverty, gender inequality, inadequate healthcare facilities, high costs of 
antiretroviral drugs, and low levels of education (Myer, Morroni, & Susser, 2003; Smit et al., 
2005). In sub-Saharan Africa however, most intervention strategies have focused on 
sociobehavioural risk factors. For example, behaviour change initiatives such as the 
promotion of barrier contraceptives, abstinence, a reduction in number of sexual partners, and 
delayed sexual debut have been widely implemented, with some success in Kenya and 
Zimbabwe (UNAIDS, 2007).  
 
In South Africa however, as elsewhere, the effectiveness of such interventions has been 
suboptimal as the pandemic shows no sign of abating (Sahay et al., 2005). An HIV vaccine 
may therefore be an important development as a biological agent may circumvent some of the 
challenges of initiating widespread behaviour change (McCluskey, Alexander, Larkin, 
Murguia, & Wakefield, 2005). To this end, the South African AIDS Vaccine Initiative 
(SAAVI) was formed. 
 
1.3 The South African AIDS Vaccine Initiative (SAAVI) 
 
SAAVI, established in 1999 by the Medical Research Council (MRC) of South Africa, is a 
collaborative partner in the broader international effort to develop an efficacious HIV vaccine 
(South African AIDS Vaccine Initiative [SAAVI], 2008). African partners include the African 
AIDS Vaccine Programme (AAVP), the Ethiopian AIDS Vaccine Initiative (EAVI), the 
Nigerian AIDS Vaccine Programme (NAVP) and the Botswana Harvard AIDS Institute 
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(BHAI). Further abroad, SAAVI collaborate with the International AIDS Vaccine Initiative 
(IAVI), the US National Institutes of Health (NIH), the NIH-funded HIV Vaccine Trials 
Network (HVTN), and the European Union (EU). SAAVI receives funding from both the 
public and the private sectors of South Africa, as well as funding from abroad. Public funders 
include the Department of Health (DoH) and the Department of Science and Technology 
(DST). The majority of private sector funding comes from Eskom (the national energy 
supplier) and Impala Platinum (the leading producer of platinum in the world). 
Internationally, SAAVI receives funding from the European Union (EU) and several 
biotechnology companies.  
 
Despite being highly connected with global players, the foremost goal of SAAVI is to address 
the needs of South Africa and the southern African region as a whole (SAAVI, 2008). There 
were five research sites in South Africa at the time of this study. These sites were located in 
Soweto, Cape Town, Durban, and the Klerksdorp, Orkney, Stilfontein and Hartbeesfontein 
(KOSH) district. The site in the Durban has since been closed. 
 
1.4 The development of an HIV vaccine 
 
The development of an HIV vaccine - indeed, of any pharmaceutical agent of this kind - 
involves three Phases (Slack et al., 2005). Phase I tests vaccine safety, vaccination schedule, 
and immune responses in small numbers of HIV negative participants. If the candidate 
vaccine is determined to be safe and stimulates an immune response, immunologists proceed 
to Phase II which tests the candidate vaccine’s safety and immunogenicity in larger numbers 
of HIV negative participants. If successful, immunologists proceed to Phase III which tests 
vaccine efficacy in several thousands of HIV negative participants who are at high risk of 
Stellenbosch University http://scholar.sun.ac.za
 5 
HIV infection. Considering that such a large number of individuals will be required to risk 
exposure to an experimental vaccine that has not been widely tested on human subjects, 
various scientific (Slack et al., 2005), ethical (Kerns, 1997; Lindegger & Richter, 2000; 
Lindegger, Slack, & Vardas, 2000), and sociobehavioural (Smit et al., 2005) issues need to be 
considered. One of the key sociobehavioural issues concerns the willingness of individuals at 
high risk of HIV infection to participate in HIV vaccine trials. 
 
1.5 The importance of studying willingness to participate (WTP) in an HIV vaccine 
trial 
 
Understanding the psychosocial factors that may that inhibit or facilitate WTP is important to 
ensure that a sufficiently large number of eligible individuals enrol in an HIV vaccine trial, 
and to promote the ethical treatment of trial participants. A large sample size is crucial to 
yield sufficient power to detect significant differences in rates of HIV seroconversion between 
the experimental group that receives the candidate vaccine, and the placebo control group. 
While recruiting a sample large enough to ensure adequate statistical power is a common 
hurdle in clinical trials (DerSimonian, Charette, McPeek, & Mosteller, 1982), there are unique 
challenges in the case of HIV vaccine trials. These include the existence of different HIV 
clades, variability in viral susceptibility between individuals, and a poor understanding of the 
mode of action of an HIV vaccine before the start of a clinical trial (Boily, Masse, Desai, 
Alary, & Anderson, 1999). These unusual confounds bias statistical power calculations which 
aim to estimate appropriate sample size.  
 
In addition to unusual confounds, trial participants willingly accept the burden of receiving a 
potentially harmful candidate vaccine with the belief that their participation will result in a 
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greater social good (Jenkins et al., 2000; Swartz et al., 2006). Exposing trial participants to 
an experimental vaccine in an underpowered trial which is likely to yield invalid results is 
therefore unethical (Halpern, Karlawish, & Berlin, 2002). Participants may also experience 
stigma and discrimination by participating in an HIV vaccine trial (Jenkins et al., 2000; 
McCluskey et al., 2005), adding to the unethical nature of poorly-powered clinical trials. It is 
therefore also an ethical imperative that the psychosocial factors that inhibit or facilitate WTP 
be understood.   
 
Aside from concerns over sample size and power, knowledge of inhibitors and facilitators of 
WTP that are unique to each population group may reduce disproportionate enrolment of 
subgroups of the eligible population (Moodley, 2005). Inequitable enrolment is likely to limit 
the external validity of the trial results, and will violate justice: the fourth principle of ethical 
research according to the Belmont Report of 1979 (Loue, Okello, & Kawuma, 1996). 
According to the principle of justice, the risks and rewards of research should be evenly 
distributed, whereby no single group carries a disproportionate share of the burden or the 
benefits (Moodley, 2005).  
 
In sum, recruitment difficulties are likely to hinder the development of an efficacious HIV 
vaccine. It is therefore both scientifically and ethically important that researchers understand 
the psychosocial factors that may inhibit or facilitate WTP among potential trial participants. 
Despite this need however, there was no sociobehavioural research agenda in the larger 
SAAVI group until 2003 (SAAVI, 2008). In that year, SAAVI asked Stellenbosch University 
to form a sociobehavioural working group with the goal of developing social science research 
capacity for the four national SAAVI sites mentioned above.  
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1.6 The Sociobehavioural Working Group of SAAVI (SAAVI-SB) 
 
Five objectives were set for SAAVI-SB. These objectives, taken directly from the SAAVI 
website (SAAVI, 2008), were: 
 
 National co-ordination of all SAAVI-funded sociobehavioural activities.  
 To provide a methodologically sound framework for sociobehavioural research as part 
of HIV vaccine trials in South Africa.  
 To become a national resource for SAAVI-funded sites: strengthening capacity 
building; providing input into staff needs and recruitment; providing assistance with 
protocol development, funding requirements and training of staff; facilitating co-
ordination between existing research; and, managing data among sites.  
 To facilitate communication among national and regional SB researchers, trial-site PIs 
and CAB members on sociobehavioural issues.  
 To liaise, inform and educate researchers, CAB members and fieldworkers on 
sociobehavioural research. 
 
In 2006, the SAAVI-SB group began a two-part mixed-method investigation that aimed to 
determine the factors associated with WTP in a South African sample. Part I was a qualitative 
study that aimed to elicit thick descriptions of the psychological, behavioural, and social 
concerns of South Africans who will be eligible to participate in a future HIV vaccine trial 
(Swartz et al., 2006). The results of that study are reported in Chapter 2. The research 
problems that Part II of the investigation aimed to address constituted the basis of this thesis 
and are stated below.  
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1.7 Research problems 
 
Based on the results of Part I of the two-part investigation and a review of the literature, the 
following research problems were identified: 
 
1. A psychometric measure of WTP in an HIV vaccine trial has not been developed.  
 
As a reliable and valid measure of WTP has not yet been developed, researchers have had to 
rely on visual analogue scales (Giocos, Kagee, & Swartz, 2007) and single-item scales 
(Bartholow et al., 1997; Jenkins et al., 2000; O’Connell et al., 2002; Vieira de Souza, 
Lowndes, Szwarcwald, Sutmöller, & Bastos, 2003; Yang et al., 2004) to measure WTP. There 
are at least two shortcomings to such approaches. Firstly, an assortment of response options 
used by different researchers makes comparisons across studies problematic. Secondly, the 
use of a single item to measure a potentially multidimensional construct such as WTP is likely 
to yield a shallow, one-dimensional measurement leading to high levels of measurement error 
(Neuman, 2000). It is therefore important that a psychometrically sound measure of WTP be 
developed. 
 
2. There is a paucity of theory to guide studies of WTP in an HIV vaccine trial.  
 
Studies that have examined inhibitors and facilitators of WTP have not commonly been 
informed by behavioural theory (Giocos et al., 2007; Priddy, Cheng, Salazar, & Frew, 2006). 
The result has been a lack of synthesis of research findings. The development of an 
appropriate theoretical framework may organize knowledge and guide future research by 
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specifying the types of facts to be observed, as well as how the facts relate to each other 
(Bless, Higson-Smith, & Kagee, 2006). 
 
1.8 A theoretical framework for studying WTP in an HIV vaccine trial. 
 
While searching for an appropriate theoretical framework for studying WTP, an important 
question arose: “to what extent is participating in an HIV vaccine trial a health-promoting 
behaviour?” Kafaar, Kagee, Lesch, and Swartz (2007) argue that from the perspective of the 
researcher, WTP in an HIV vaccine trial may not be regarded as a health-promoting behaviour 
since the primary aim of developing an effective HIV vaccine is to improve public health, and 
not necessarily the health of the research participants. From the perspective of a participant 
however, participating in an HIV vaccine might offer increased protection from HIV and, as a 
result, may be regarded as a health-promoting behaviour. In addition, participation in such 
trials and regular visits to trial site clinics remind individuals repeatedly of their risk for HIV 
infection (Kafaar et al., 2007). Such reminders may discourage behaviours that increase the 
likelihood of HIV infection. In this sense, participating in an HIV vaccine trial can be 
considered to be a health-promoting behaviour. 
 
Three theories of health-promoting behaviour were reviewed. These were the Health Belief 
Model (HBM) (Rosenstock, 1966), the Protection Motivation Theory (PMT) (Rogers, 1975, 
1983, 1985), and the Theory of Planned Behavior2 (TPB) (Ajzen, 1985, 1988, 1991). Meta-
analyses of studies that used the HBM (Harrison, Mullen, & Green, 1992; Janz & Becker, 
1984) and the PMT (Floyd, Prentice-Dunn, & Rogers, 2000) showed that these theories have 
been only partially successful in predicting health behaviours. Ogden (2004) argues that a 
                                                 
2 While ‘behavior’ is the American style of spelling ‘behaviour’, the TPB was developed in the US and therefore 
I refer to the original spelling throughout.     
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major reason for the limited success of the PMT and HBM has been their failure to 
incorporate social and environmental factors. A further problem with the HBM in the context 
of WTP in an HIV vaccine trial is that the theory examines the relationship between cognitive 
predictors and actual behaviour. As no Phase III HIV vaccine trials were yet underway in 
South Africa at the time of this study, actual enrolment could not be measured.   
 
Unlike the PMT and the HBM, meta-analyses of studies that have employed the TPB 
recurrently show that the theory predicts significant amounts of variance in a wide range of 
health-promoting behaviours (Armitage & Conner, 1999b, 2001; Albarracín, Johnson, 
Fishbein, & Muellerleile, 2001). In addition to the fact that the TPB is well researched, a 
benefit to using the theory in the context of WTP is that it makes provision for the role of 
social and environmental factors. Given the important role that social factors play in the 
transmission of HIV, an assessment of these factors is paramount. Another benefit to using 
the TPB in this context is the theory’s inclusion of behavioural intention, a robust predictor of 
actual behaviour (Ajzen, 1985, 1988). It follows that in the absence of actual enrolling 
behaviour, measuring an individual’s intention or willingness to participate may be the most 
appropriate proxy for future participation in an HIV vaccine trial. 
 
1.9 Extending the TPB in the context of WTP in an HIV vaccine trial 
 
While it seems that the TPB may account for variance in WTP, it might nonetheless be useful 
to include additional predictor variables shown to be robustly associated with WTP. We 
hypothesised that extending the TPB with such variables would tailor the theory to the unique 
context of WTP in an HIV vaccine trial, as evidence by incremental change in variance 
explained by the additional predictor variables over the TPB variables. The TPB has been 
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successfully adapted for various behaviours previously, including exercise (Bozionelos & 
Bennett, 1999), healthy eating (Povey, Conner, Sparks, James, & Shepherd, 2000), elicit drug 
use (McMillan & Conner, 2003), condom use (Conner, Graham, & Moore, 1999), and dietary 
and fluid adherence among a sample of haemodialysis patients (Fincham, Moosa, & Kagee, 
2008).  
 
To identify robust correlates of WTP in an HIV vaccine trial that would be added to the TPB 
variables, a comprehensive literature review was conducted and is discussed in Chapter 2. 
Briefly, mistrust of researchers, drug companies, and governmental organisations (Hays, & 
Kegeles, 1999; Parker, 2005; Sengupta et al., 2000), and poor knowledge of HIV vaccines and 
HIV vaccine trials (Hennessy et al., 1996; Nyamathi, et al., 2004) have been commonly 
reported to be inhibitors of WTP. Perceived risk of HIV infection (Jenkins et al., 2000; 
Parker, 2005) and altruism (Jenkins et al., 1998; Swartz et al., 2006) have been commonly 
reported to be facilitators of WTP. Therefore, these four variables were included as additional 
predictor variables with the aim of improving the predictive power of the TPB in the context 
of WTP.   
 
1.10 Goals of this study 
 
A consideration of the two research problems outlined above led to the development of four 
goals for this study. These were: 
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1. Construct a psychometric measure of WTP in an HIV vaccine trial. 
2. Derive, in an exploratory fashion, the factor structure of the new instrument. 
3. Examine the extent to which the TPB predicts variance in WTP in an HIV vaccine 
trial. 
4. Determine whether the TPB is strengthened by the inclusion of mistrust of 
researchers, knowledge of HIV vaccines and HIV vaccine trials, altruism, and 
perceived risk of HIV infection as additional predictor variables. 
 
1.11 Importance of this study 
 
Addressing the objectives of this study may result in two significant contributions to the field 
of WTP in an HIV vaccine trial. Firstly, this study may provide a psychometrically sound 
measure of WTP that will enable researchers to make reliable and valid measurements of 
WTP. Secondly, the development of an appropriate theoretical framework may serve to 
organize and structure future research. 
 
1.12 Definition of concepts 
 
1.12.1 Facilitator 
 
A facilitator was defined as any factor that enhances the likelihood that community members 
would participate in an HIV vaccine trial (Swartz et al., 2006). 
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1.12.2 Inhibitor 
 
An inhibitor was defined as any factor which reduces the likelihood that community members 
would participate in an HIV vaccine trial (Swartz et al., 2006). 
 
1.12.3 Altruism 
 
Despite general agreement that the notion of ‘altruism’ refers to the unselfish concern for the 
welfare of others (Baron & Byrne, 2000), there are subtle variations in the conceptualisation 
and operationalisation of this construct among researchers. Variations in definitions of 
altruism seem to be, in part, a function of differing opinions regarding the motivation behind 
altruistic behaviour (Batson, 1991), the amount of benefits or costs to the altruist (Krebs, 
1987), and the extent to which altruistic behaviour is a conscious decision (Hill, 1984). 
Within the context of WTP in an HIV vaccine trial, this study defined altruism as “behavior 
[sic] intended to benefit another, even when doing so may risk or entail some sacrifice to the 
welfare of the actor” (Monroe, 1994, p. 862). 
 
1.13 Overview of chapters 
 
Chapter 2 provides a critical review of both international and South African literature 
pertaining to the variables identified for inclusion in this study. In addition, the results of Part 
I of the study are reported, and methods employed by researchers to measure WTP are 
evaluated. Finally, the application and extension of the TPB in this study is described in 
detail. Chapter 3 describes the methodology used in this study, and includes a description of 
the participants, the development of an instrument to measure WTP in an HIV vaccine trial 
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and other measures, the research design, and the statistical procedures used to analyse the 
data. Chapter 4 presents the demographic characteristics of the sample and the results of the 
statistical analyses. Chapter 5 attempts to interpret the results within the context of the study 
population and sample, and against the backdrop of the limitations of the study. Conclusions 
and implications for future research are also discussed.   
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CHAPTER 2 
LITERATURE REVIEW AND THEORETICAL FRAMEWORK 
 
2.1 Introduction 
 
This chapter begins with an overview of four key sociobehavioural issues relating to HIV 
vaccine trials. These are retention and attrition, sexual disinhibition, social harms, and 
willingness to participate (WTP). Thereafter, international and South African literature 
pertaining to inhibitors and facilitators of WTP identified for inclusion in this study are 
critically reviewed. Inhibitors include mistrust of researchers and poor knowledge of HIV 
vaccines and HIV vaccine trials. Facilitators include altruism and a high perceived risk of 
HIV infection. Each will be discussed in turn. The results of Swartz et al. (2006) (Part I of this 
study) are then discussed, and methods employed by researchers to measure WTP are 
evaluated. Finally, the application and extension of the Theory of Planned Behavior (TPB) in 
this study is described detail.   
 
2.2 Retention and attrition 
 
A major sociobehavioural concern in HIV vaccine trials is the recruitment and retention of 
large numbers of trial participants (Grinstead, 1995; Smit et al., 2005). While some studies 
have shown that levels of retention may be high among certain populations (e.g.: Seage et al., 
2001), other studies report that attrition may be a serious concern. For example, a study that 
examined the retention of 4979 trial participants in New York found that only 36% of 
participants were retained after 12 months (Des Jarlais et al., 2000). Poor levels of retention 
were also reported by Baeten et al. (2000) in a study that examined HIV incidence in a cohort 
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of casual sex workers (CSW) in Kenya. Among the many possible reasons for attrition, 
migration of trial participants away from trial sites poses a considerable problem (Smit et al., 
2005; Suligoi, Wagner, Ciccozzi, & Rezza, 2005). Migration may be especially problematic 
in the South African context as many thousands of labourers travel between their homes in 
rural parts of the country, and urban and mining areas of the country where they work (Bank, 
2001; Lurie et al., 2003). Migration therefore inhibits the retention of HIV vaccine trial 
participants as many participants may move away from HIV vaccine trial sites (Smit et al., 
2005). In sum, retention and attrition of HIV vaccine trial participants is a major 
sociobehavioural challenge.  
 
2.3 Sexual disinhibition 
 
There is evidence to suggest that HIV vaccine trial participants may increase their sexual risk 
behaviour due to the belief that a candidate HIV vaccine will protect them against HIV 
infection. For example, Chesney, Chambers, and Kahn (1997) examined changes in sexual 
risk behaviour among 48 participants enrolled in Phase I and II HIV vaccine trials conducted 
in San Francisco. The researchers found a significant increase in insertive unprotected anal 
intercourse (UAI) among men who have sex with men (MSM) over time. At baseline, 9% 
reported UAI. The proportion increased to 13% at the sixth month assessment, and to 20% at 
the twelfth month assessment. Similar results were reported by Van de Ven, Kippax, Knox, 
Prestage, and Crawford (1999), who examined associations between optimism of new 
treatments for HIV and sexual behaviour among 4091 Australian MSM. Considering that a 
candidate HIV vaccine may not necessarily demonstrate efficacy (Slack et al., 2000, 2005), 
sexual disinhibition among HIV vaccine trial participants may lead to a perverse outcome 
where HIV vaccine trials result, paradoxically, in more HIV infections rather than less. The 
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possibility of sexual disinhibition, or increased sexual risk behaviour, is therefore a major 
challenge for researchers.  
 
2.4 Social harms 
 
Another sociobehavioural concern associated with HIV vaccine trials is the possibility that 
trial participants may experience stigma and discrimination from friends, family members, 
and the community at large as a result of their participation (Allen et al., 2001). A major 
source of negative social reactions is reported to stem from the perception that HIV vaccine 
trial participants are infected with HIV, or may at least be at high risk of HIV infection 
(Lesch, Kafaar, & Kagee, 2006). In addition, research suggests that many people are unaware 
that testing positive for HIV antibodies during an HIV vaccine trial is a result of the body’s 
response to the candidate HIV vaccine and not necessarily to HIV (Jenkins et al., 2000; Sahay 
et al., 2005; Sheon, Wagner, McElrath, Keefer, & Zimmerman, 1998). Problems experienced 
in this regard relate to difficulty obtaining health or life insurance, restrictions on trial 
participants’ ability to travel abroad, being refused to donate blood, being overlooked by 
potential employers, and being disallowed to serve in the military (McCluskey et al., 2005). In 
contexts such as South Africa where there are high levels of gender inequality, social harms 
may even manifest in domestic violence (Milford, Barsdorf, & Kafaar, 2007). Possible social 
harms associated with participation in South African HIV vaccine trials therefore represent a 
unique challenge to vaccine researchers. 
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2.5 Willingness to participate (WTP) in an HIV vaccine trial 
 
A further sociobehavioural concern in HIV vaccine trials is the willingness of many thousands 
of HIV negative participants at high risk of HIV infection to participate in HIV vaccine trials. 
Understanding the psychosocial factors that may that inhibit or facilitate WTP is important to 
ensure that sufficient numbers of eligible individuals enrol, and that the participants are 
treated in an ethical manner (DerSimonian et al., 1982; Halpern et al., 2002). Previous 
research suggests that the factors associated with WTP in HIV vaccine trials may be 
understood in terms of inhibitors and facilitators of WTP (Bartholow et al., 1997; Buchbinder 
et al., 2004; Golub et al., 2005; Hennessy et al., 1996; Jenkins et al., 1998, 2000; McCluskey 
et al., 2005; Moodley, Barnes, van Rensburg, & Myer, 2002; Nyamathi, et al., 2004). The 
results of these studies show that mistrust of researchers (Hays, & Kegeles, 1999; Parker, 
2005; Sengupta et al., 2000) and poor knowledge of HIV vaccines and HIV vaccine trials 
(Hennessy et al., 1996; Nyamathi, et al., 2004) may be robust inhibitors of WTP. In addition, 
perceived risk of HIV infection (Jenkins et al., 2000; Parker, 2005) and altruism (Jenkins et 
al., 1998; Swartz et al., 2006) may be robust facilitators of WTP. Each is discussed in turn. 
 
2.5.1 Inhibitors of WTP in an HIV vaccine trial 
 
2.5.1.1 Mistrust  
 
Mistrust of medical researchers, drug companies, and governmental organisations has been 
frequently reported to be an inhibitor of WTP in an HIV vaccine trial among both Whites and 
Blacks from developing and developed countries alike. However, levels of mistrust seem to 
be higher among Blacks, regardless of geographical, sociopolitical, and economic differences.  
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In the US, Sengupta et al. (2000) examined mistrust and other correlates of WTP in AIDS 
research among 301 Black Americans aged 18 years or older residing in Durham, North 
Carolina. Structural equation modelling (SEM) was used to test models of relationships 
between factors that inform WTP. Analyses revealed that mistrust of research and research 
institutions was the strongest inverse predictor of WTP. It is important to note, however, that 
the overall fit indices were only just acceptable. As such, the model needs to be tested again in 
future research. 
 
Notwithstanding the limitations of the study by Sengupta et al. (2000), similar results were 
reported by Braunstein, Sherber, Schulman, Ding, and Powe (2008). The researchers assessed 
WTP in clinical trials in a sample of 717 participants from 13 cardiology and general medical 
clinics in Maryland. Compared to the 460 White participants, the 257 Black participants more 
frequently reported that: (i) researchers would not adequately explain what participating in a 
clinical trial will entail (24% vs. 13%); (ii) researchers use participants as ‘guinea pigs’ 
without their consent (72% vs. 49%); (iii) researchers prescribe drugs as a way of 
experimenting on people without their knowledge (35% vs. 16%); and (iv) researchers as 
individuals to participate in clinical trials knowing that the drug under investigation may be 
unsafe (24% vs. 15%). While levels of mistrust were high for both Whites and Blacks, Blacks 
demonstrated significantly higher levels of mistrust, and lower levels of WTP. These 
differences remained significant even after controlling for racial variability in gender, age, 
cardiovascular risk profiles, and socioeconomic status. 
 
A study that explored racial differences in inhibitors of WTP in medical research studies 
among 198 residents of the Detroit Primary Metropolitan Statistical Area (DPMSA) yielded 
comparable results (Shavers, Lynch, & Burmeister, 2002). The researchers found that 
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compared to White participants, Black participants believed that minority groups bear most 
of the risks in medical research (25.2% vs. 5.2%). While both Blacks and Whites believed that 
the poor bear more of the risks in medical research than the rich, Black participants endorsed 
this belief more often than Whites (65.6% vs. 42.2%). The researchers note that a limitation of 
the study was that the census data, which constituted the sampling frame, were10 years old at 
the time of the study. In the previous decade, the population of richer people living in 
suburban areas (predominantly White individuals) of Detroit had increased by 20%, and the 
population of poorer people living in housing units within the city (predominantly Black 
individuals) had decreased by 5.7%. Although the researchers weighted the data to account 
for possible non-coverage bias, it is possible that the Black participants in the study were 
overrepresented, perhaps overstating the reported racial differential.   
 
In another US study, Buchbinder et al. (2004) compared hypothetical and actual WTP in a 
preventive HIV vaccine trial among 2531 participants previously enrolled in an HIV vaccine 
preparedness study (VPS). The researchers found that among participants who expressed low 
levels of WTP, 55% of Black participants cited mistrust of government as an inhibitor of 
WTP compared to 21% of White participants. Furthermore, 24% of Black participants cited 
mistrust of drug companies as an inhibitor of WTP compared to 16% of White participants. A 
study of 58 participants from the broader area of Los Angeles found that of the nine themes 
elicited from the data, mistrust of HIV vaccine researchers was the fifth most frequently cited 
inhibitor of WTP (Newman et al., 2006).  
 
Comparable findings have been reported by South African researchers. Parker (2005) 
conducted in-depth qualitative interviews with 10 participants between the ages of 19 and 30 
years from a lower socioeconomic, peri-urban settlement in the Western Cape. She found that 
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alongside not wanting injections and fears relating to stigma and discrimination, mistrust of 
researchers was an important barrier to WTP. Comparable findings were reported by Barsdorf 
and Wassenaar (2005) who examined racial differences in public perceptions of voluntariness 
of medical research participants among 111 participants from two commercial South African 
companies. Black respondents were significantly less likely to volunteer as participants in 
medical research than both White and Indian respondents. Furthermore, these racial 
differences were independent of level of knowledge of medical research procedures and 
personal experience of medical research.  
 
Various explanations for the high levels of mistrust of medical researchers, pharmaceutical 
companies, and governmental organisations among Blacks have been put forth. In the US, 
medical researchers continue to conduct experiments in the shadow of the infamous Tuskegee 
syphilis study, in which 399 Black men from Alabama were purposely denied efficacious 
treatment for syphilis (Gamble, 1997; Shavers et al., 2002). Such exploitation of Blacks due 
to their obvious vulnerability has understandably created a general sentiment of mistrust of 
researchers and powerful, White-controlled pharmaceutical companies (Baldwin–Ragaven, de 
Gruchy, & London, 1999). Similar mistrustfulness is seen in post-colonial Africa, where the 
testing and implementation of Western drugs has been met by some with suspicion, 
opposition, and resistance (Boone & Batsell, 2001; Leach & Fairhead, 2007). Mistrust of 
researchers and pharmaceutical companies by Black Africans seems to have its roots firmly 
planted in Africa’s experience of oppression and exploitation by Whites during the years of 
colonialisation (Nichter, 1995). In that period, the area of public health was one of the key 
“vehicles of ideology” (Lindegger, Quayle, & Ndlovu, 2007, p. 110) used to propagate 
Western dominance and White oppression. For example, the bubonic plague in Cape Town at 
the turn of the twentieth century was used to justify the forced removal of Black Africans 
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from their homes (Swanson, 1977). During the apartheid years, disregard for the human 
rights of Blacks created a fertile breeding ground for unethical research; the legacy of which 
still stands today. According to Barsdorf and Wassenaar (2005, p. 2):  
 
Violations of human rights during apartheid no doubt impacted negatively on health 
practice and research in South Africa. Unethical research before South Africa’s 
democracy in 1994, some targeted at previously disadvantaged segments of the 
population, could serve to reinforce an already tainted public perception of the 
voluntariness of medical research participants. 
 
Mistrust of HIV vaccine researchers by Black Africans has steered the belief that HIV 
prevention efforts are a hidden political conspiracy to control the birth rates of Blacks, thereby 
allowing Whites to regain political control (Klonoff & Landrine, 1999; Nichter, 1995; Ross, 
Essien, & Torres, 2006). There is also the belief that HIV vaccine campaigns are a Western 
initiative to undermine African autonomy, traditional values, and cultural practice (Lindegger 
et al., 2007). Proponents of the latter suggest that Africa’s participation in HIV vaccine 
research represents a ‘selling-out’ to pharmaceutical companies at the expense of Black 
Africans who will be exploited by researchers (Nattrass, 2007). This was the sentiment of the 
South African president Thabo Mbeki, who publicly stated in 2000 that he was unconvinced 
that HIV was the sole cause of AIDS. He also expressed concern over the safety of highly-
active antiretroviral therapy (HAART) which resulted in a slow roll-out of these drugs to 
pregnant HIV positive women (Fassin & Schneider, 2003; Nattrass, 2007).  
 
Research also suggests that many individuals believe that an efficacious vaccine has already 
been developed but is being kept from them. For example, Allen et al. (2005) conducted 3509 
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telephonic interviews with Blacks, Hispanics, MSM, and members of the general US 
population to assess HIV vaccine research attitudes, awareness, and knowledge. Compared to 
18.2% of the general population, 47.1% of the Black participants believed that an HIV 
vaccine has already been developed but is being kept secret. Finally, Nyamathi et al. (2004) 
suggest that the failure of HIV vaccine researchers to allow community members an 
opportunity to be actively involved in the planning of HIV vaccine trials has also contributed 
to the high levels of mistrust. Taken together, it seems that mistrust of HIV vaccine 
researchers is a robust inhibitor of WTP.   
 
2.5.1.2 Knowledge of HIV vaccines and HIV vaccine trials  
 
Several studies have shown that potential HIV vaccine trial participants demonstrate a lack of 
knowledge of HIV vaccines and HIV vaccine trials. Furthermore, poor understanding of HIV 
vaccine trial methodology seems to be associated with lower WTP. The association between 
knowledge and WTP has been found in Western and non-Western settings alike, and seems to 
be independent of the effects of education and socioeconomic status. In the US, Strauss et al. 
(2001) examined factors associated with WTP among injecting drug users (IDUs) from 
Philadelphia, MSM from San Francisco, and Black Americans from Durham. Participants 
indicated that they would not be willing to participate in an HIV vaccine trial unless they 
became more knowledgeable in certain areas of vaccine trial methodology. The areas of 
knowledge included: (i) health complications that may be experienced, and assistance offered 
in dealing with complications; (ii) incentives that would be offered to compensate them for 
their participation; (iii) the effectiveness of the vaccine and future availability of the vaccine; 
and (iv) issues surrounding trust and confidentiality.  
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Similar results were reported by a study that examined correlates of WTP in HIV/STD 
prevention intervention activities among 4,208 migrants aged 18-30 years old in Beijing and 
Nanjing (Yang et al., 2004). The researchers found that a large proportion of the participants 
demonstrated a lack of HIV/AIDS awareness and knowledge surrounding the transmission of 
HIV. Furthermore, a lower level of knowledge was associated with a lower level of WTP. A 
limitation of the study was that the outcome variable ‘WTP in an HIV/STD prevention 
intervention program’ was vague and may have been too general for some participants. As 
such, the results might well have been tainted by participants’ perceptions of what constituted 
an HIV/STD prevention intervention programme.  
 
In Italy, a study that examined knowledge and attitudes regarding prophylactic HIV vaccine 
trials among a national sample yielded similar results to Strauss et al. (2001) and Yang et al. 
(2004) (Starace et al., 2006). Results indicated that only 57.1% of the respondents 
demonstrated a level of knowledge that was ‘sufficient’ for informed consent (knowledge 
level was considered ‘sufficient’ if respondents correctly answered at least four of the six 
questions relating to prophylactic HIV vaccine trials). Areas of knowledge assessed included 
an understanding of prophylactic versus therapeutic vaccines, and potential side effects. A 
multivariate analysis showed that participants with insufficient knowledge were significantly 
less likely to express WTP than participants demonstrating sufficient knowledge.  
 
The most common misconception among potential trial participants seems to be the belief that 
the presence of HIV antibodies after receiving a candidate HIV vaccine means that the 
vaccine has inadvertently infected one with HIV. For example, a study that examined WTP 
among 349 Indian participants at high risk of HIV infection found that post-vaccination HIV 
seropositivity was an important inhibitor of WTP (Sahay et al., 2005). Similar results were 
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reported by a study that evaluated specific features of vaccine trial designs that would 
encourage participation among 73 participants at high risk of HIV infection from Denver, 
Chicago, and San Francisco (Hennessy et al., 1996). Moreover, Newman et al. (2007) found 
that lower WTP was associated with the fear of vaccine-induced infection, and testing 
positive for HIV antibodies among 123 participants from Los Angeles.  
 
While the aforementioned studies suggest that a low level of knowledge is associated with a 
low level of WTP, some studies have reported a null relationship between knowledge and 
WTP (Giocos et al., 2007; Halpern, Metzger, Berlin, & Ubel, 2001; Priddy et al., 2006). 
Moreover, a study that examined changes in WTP and knowledge of vaccine trial concepts 
among 4892 participants from several US populations at high risk of HIV infection yielded 
conflicting results (Koblin, Holte, Lenderking, & Heagerty, 2000). The researchers found that 
WTP declined significantly over time despite significant increases in knowledge of concepts 
such as vaccine-induced seropositivity, placebos, and randomization. The conflicting findings 
suggest that the relationship between knowledge of HIV vaccines and HIV vaccine trial 
concepts and WTP may be parabolic, where relatively low and high levels of knowledge are 
associated with lower WTP. However, further research is required to provide evidence for 
such a hypothesis. Notwithstanding the complexity of the relationship, knowledge of HIV 
vaccines and HIV vaccine trials seems to be a robust inhibitor of WTP. 
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2.5.2 Facilitators of WTP in an HIV vaccine trial 
 
2.5.2.1 Altruism 
 
Evidence suggests that altruism may be a robust facilitator of WTP in an HIV vaccine trial in 
both developing and developed country settings alike. A study that assessed WTP among 
2670 Royal Thai army conscripted recruits found that 43.2% cited altruism as primary 
motivation for WTP (Jenkins et al., 2000). A multivariate logistic regression analysis revealed 
that participants who expressed the wish to help Thai society were significantly more likely to 
express WTP than those who did not. Another study that employed a Thai sample yielded 
similar results (MacQueen et al., 1999). The researchers found that out of the 193 IDUs 
attending drug treatment clinics in Bangkok, 78.6% of the participants expressed the altruistic 
desire to help stop the spread of AIDS.  
 
Comparable findings have been reported by studies in the US. Sengupta et al. (2000) found 
that 80% of their sample of 301 Black Americans cited altruistic reasons for WTP. Examples 
of altruistic reasons were: (i) assisting researchers in their attempt to find a cure for 
HIV/AIDS; (ii) helping those who are HIV-infected or have AIDS; and (iii) wanting to 
participate in HIV vaccine research. Multivariate analyses showed that altruism was the only 
factor that was significantly associated with WTP in AIDS surveys and educational 
interventions. Comparable results were reported by Hays and Kegeles (1999) in a study that 
examined factors associated with WTP among 390 US MSM aged 18 to 29 years. The 
researchers found that the most common reasons for WTP were the desires to contribute to 
ending the AIDS epidemic and to helping others. 
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In another US sample, Nyamathi et al. (2004) conducted qualitative focus groups with 40 
homeless and low-income adults from subsidized apartments and homeless shelters in Los 
Angeles. Participants recurrently reported an altruistic desire to help combat the HIV 
pandemic. Not only is altruism reported to be an important correlate of WTP, but some 
studies show that altruism may be a primary motivation. For example, a study by Buchbinder 
et al. (2004) found that 94% of the participants in their study reported altruism as the main 
reason for WTP.  
 
Studies examining WTP in Brazilian and Indian samples have yielded results similar to those 
found in Thai and US samples. A study that examined WTP among 569 MSM from Rio de 
Janeiro found that 499 (87.7%) considered it very important to help the community at large 
(Périssé et al., 2000). In India, Sahay et al. (2005) conducted a study that examined WTP 
among 349 participants attending three sexually transmitted infections clinics and one 
reproductive tract infections clinic. Approximately 34.1% of all participants and 40.7% of 
male participants at high risk of HIV infection indicated an altruistic desire to participate in a 
future HIV vaccine trial. A multivariate logistic regression analysis showed that altruism 
increased the predictive power of the model significantly by 3.9 units (adjusted OR = 3.9; 
95% CI 1.8 – 8.1). In South Africa, qualititative studies by Parker (2005) and Swartz et al. 
(2006) found that altruism was one of the most important themes to be elicited from the data.  
 
It is not yet clear why individuals express an altruistic desire to participate in an HIV vaccine 
trial. Swartz et al. (2006) suggest that altruism as a reason for WTP may be related to a high 
level of exposure to the deleterious effects of HIV. While that may be so, the researchers do 
not speculate on the possible mechanism by which HIV exposure predicts the altruistic desire 
to participate in a trial. For example, social psychologists have been debating for years the 
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question of whether helping behaviour is egoistically motivated, or whether such behaviour 
is motivated by truly selfless reasons (Hogg & Cooper, 2003). According to Batson (1995), 
helping behaviour is egoistically motivated since the helper may experience many possible 
self-benefits from helping. For example, the helper may receive material rewards (e.g. 
reimbursement or financial reward for participating in an HIV vaccine trial), social rewards 
(e.g. praise and approval by community members), or self-rewards (e.g. enhanced self-esteem 
from participating). The helper may also avoid social punishments (e.g. negative community 
reactions), and self-punishments (e.g. guilt and/ or shame associated with not participating). 
Finally, the helper may reduce aversive arousal evoked by seeing others dying from AIDS. In 
converse however, an altruistic behaviour is seen by some as a truly selfless act motivated by 
empathic concern for another (Dovidio, Allen, & Schroeder, 1990; Smith, Keating, & 
Stotland, 1989). According to Sibicky, Schroeder, and Dovidio (1995, p. 436), empathic 
concern is defined as “an other-oriented emotional response characterized by such feelings as 
compassion, tenderness, soft-heartedness, sympathy, warmth, and feeling moved”. As per this 
school of thought, participating in an HIV vaccine trial is the result of empathetic concern for 
the well-being of others, with self-benefits of participating being unintended consequences. 
 
Related to the debate over the motivation behind helping behaviour is the tension between 
Western and non-Western conceptions of self and other. According to Moodley (2005), the 
‘self’ in Western cultures is considered synonymous with the ‘individual’. As such, the self is 
rigidly contained within the defined boundary of the individual’s body. In non-Western 
cultures such as in South Africa however, the definition of ‘self’ is more fluid and transcends 
the boundaries of the individual body. Therefore, when one experiences empathetic concern 
for another and takes the other’s perspective, one vicariously experiences what the other is 
experiencing because one comes to incorporate oneself within the boundaries of the other 
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(Cialdini, Brown, Lewis, Luce, & Neuberg, 1997). As the distinction between ‘self’ and 
‘other’ becomes more obscure, it may be useful to understand altruism within the milieu of 
‘Ubuntu’ (Moodley, 2005). According to Louw (1998) the notion of Ubuntu may be 
conceptualised by the Zulu axiom ‘umuntu ngumuntu ngabantu’, meaning ‘a person is a 
person through (other) persons’. A definition of Ubuntu is offered by Venter (2004, p. 149): 
 
Ubuntu is a philosophy that promotes the common good of society and includes 
humanness as an essential element of human growth. In African culture the 
community always comes first. The individual is born out of and into the community, 
[and] therefore will always be part of the community. Interdependence, communalism, 
sensitivity towards others and caring for others are all aspects of Ubuntu. 
 
To sum up, altruism seems to be a robust predictor of WTP in both Western and non-Western 
setting alike despite a poor understanding of the mechanism by which altruism predicts WTP. 
Against the backdrop of Ubuntu, an altruistic desire to participate in an HIV vaccine trial may 
be a particularly robust facilitator of WTP among eligible Black South Africans.  
  
2.5.2.2 Perceived risk of HIV infection 
 
Several studies have shown that persons who perceive themselves to be at high risk of HIV 
infection are more likely to express WTP in an HIV vaccine trial. In the US, a longitudinal 
study by Bartholow et al. (1997) assessed changing WTP over an 18 month period among 
1267 MSM. A perception of being highly susceptible to HIV infection was robustly 
associated with WTP at each assessment over the 18 month period of the study. In another US 
study mentioned previously, researchers compared hypothetical and actual willingness to 
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enroll in a prophylactic HIV vaccine trial among participants previously enrolled in an HIV 
vaccine preparedness study (Buchbinder et al., 2004). Participants who reported having at 
least five sexual partners in the previous six months expressed greater WTP in a future HIV 
vaccine trial. 
 
In China, Yang et al. (2004) found that among other correlates, perceived severity of risk 
behaviours was a robust predictor of WTP. A high perceived risk of HIV infection has also 
been shown to be significantly correlated with WTP among 401 Chinese IDUs from Urumqi 
City (Yin et al., 2008). A multivariate logistic regression analysis showed that WTP was 
positively associated with having ever had sex with a drug use partner, needle sharing with a 
new drug use partner in the past 3 months, and seven or more injections per week in the past 
three months.  
  
A positive relationship between perceived risk of HIV infection and WTP has also been 
reported by researchers investigating WTP in Canadian, Italian, and Ugandan samples. In 
Canada, O’Connell et al. (2002) examined WTP in a sample of 440 MSM and bisexual men 
in the greater Vancouver region. The researchers found that participants who expressed a high 
level of perceived HIV risk were significantly more likely to express WTP than participants 
who expressed a low level of perceived risk. In another sample from a Vancouver community, 
Strathdee et al. (2000) investigated WTP among 435 IDU and 330 MSM. In both sub-
samples, WTP was significantly associated with a high perceived risk of HIV infection. In 
Uganda, McGrath et al. (2001) assessed knowledge of vaccine trials and WTP among 1182 
military men between the ages of 18 and 30 years stationed near Kampala. Bivariate analyses 
showed that number of sex partners (other than a wife or regular girlfriend) and perceived 
likelihood of contracting HIV were significantly associated with WTP.  
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In Italy, Starace et al. (2006) found that compared with participants who did not consider 
themselves to be at risk of HIV infection, those with high perceived risk were significantly 
more likely to express WTP. While the study was limited insofar as the sample was not 
representative of the general population of Italy, the participants were sampled from a self-
selected population of individuals that are likely to be identified for participation in a future 
HIV vaccine trial.  
   
In South Africa, Smit et al. (2005) examined WTP among 198 individuals from an urban-
informal community directly after their enrolment into an HIV vaccine preparedness study. A 
bivariate analysis showed that WTP was significantly associated with self-perceived HIV risk. 
Qualitative studies employing South African samples have yielded similar results, whereby 
participants with a high self-perceived risk of HIV infection expressed the desire to participate 
in a future HIV vaccine trial (Parker, 2005). Bartholow et al. (1997) and Nyamathi et al. 
(2004) suggest that individuals who perceive themselves to be at high risk of HIV infection 
express greater WTP in order to be protected against HIV infection. Considering that 
candidate HIV vaccines may not necessarily offer protection from HIV infection, an 
assessment of perceived risk may serve as a proxy variable for level of knowledge of HIV 
vaccines and HIV vaccine trials.  
 
2.5.3 Health concerns and WTP in an HIV vaccine trial 
 
Health concerns have been commonly reported to be an issue for potential trial participants. 
These concerns include the fear of possible short and long term vaccine side-effects, 
disability, or death. For example, Celentano et al. (1995) examined barriers and facilitators of 
WTP among a large sample of female commercial sex workers, men attending sexually 
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transmitted disease clinics, conscripts in the Royal Thai Army, and men discharged from 
the army. The researchers found that 37.6% of the sample expressed a fear of short-term side-
effects, and 30.5% feared possible long-term side-effects. Furthermore, 36.5% reported 
fearing disability or death as a result of receiving a candidate HIV vaccine. Similar results 
were reported by McGrath et al. (2001) in a study that assessed WTP among 1182 Ugandan 
military men between the ages of 18 and 30 years stationed near Kampala. With regard to 
reproductive health concerns, Rudy et al. (2005) reported that the women in their sample were 
fearful that receiving a candidate HIV vaccine may result in difficulties conceiving children, 
effects of the HIV vaccine on the foetus, infection of breast milk and the possibility that the 
vaccine may interfere with long-term fertility. 
 
In South Africa, comparable results were reported by Parker (2005) and Swartz et al. (2006). 
In both studies, participants reported being afraid that the vaccine might cause ill health; a 
serious concern in a setting where many families rely on a single bread-winner. Should a 
participant experience vaccine side-effects and die or feel too ill to work, the economic 
repercussions for the dependents of that participant could be severe. As such, several 
participants reported that they would expect to receive health insurance if they participated. 
That way, their dependents would be taken care of in the event of their ill health or death.     
 
2.5.4 Gender and WTP in an HIV vaccine trial 
 
Of the 30.8 million (95% CI: 30.6 million – 36.1 million) infected adults around the world at 
the end of 2007, 15.4 million (95% CI: 13.9 million – 16.6 million) are women (UNAIDS, 
2007). These statistics indicate that men and women demonstrate equal numbers of HIV 
infections globally. In sub-Saharan Africa however, women carry a disproportionately large 
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burden of the disease as almost 61% of infected adults in this region at the end of 2007 
were women (UNAIDS, 2007). Given the high levels of HIV seropositivity among women in 
sub-Saharan Africa, large numbers of these women will be required to participate in a trial if 
they stand to benefit from an HIV vaccine. Nonetheless, women have had little participation 
in HIV vaccine trials to date (Kapoor, 2004). It is therefore important that researchers focus 
on understanding the barriers and facilitators of WTP among women more specifically.    
 
There seem to be both biological and socioeconomic reasons for the higher prevalence of HIV 
infection among women in sub-Saharan Africa. Biologically, the susceptibility of the vaginal 
tract makes women up to seven times more likely than men to contract HIV during 
unprotected sexual intercourse with an HIV-infected partner (Wassenaar, Barsdorf, & Richter, 
2005). Furthermore, STDs are more likely to be asymptomatic in women than in men, 
increasing the risk of HIV infection (Wilkinson, Connolly, & Rotchford, 1999). In addition, 
some African men are reported to favour ‘dry sex’, or sex where vaginal lubrication is 
impeded (Bass & Jefferys, 2001, as cited in Wassenaar et al., 2005). This practice leads to 
increased tearing of the vaginal membranes resulting in an increased risk of HIV infection. 
 
Socioeconomically, women living in developing country regions such as South Africa 
experience high levels of intimate partner violence and gender inequality; both of which have 
been shown to be important determinants of women’s HIV risk (Mills et al., 2006a; Piot et al, 
2001). In a study that examined the relationship between gender-based violence, gender 
inequality, and women’s HIV risk among 1366 women attending four antenatal health centres 
in Soweto, intimate partner violence and high levels of male control were significantly 
associated with HIV infection (Dunkle et al., 2004). These effects remained even after 
controlling for age, current relationship status, and woman’s HIV-risk behaviour. Stemming 
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from gender inequality, women are often unable to negotiate condom use as contraception 
is thought by many men to be a sign of infidelity (Kapoor, 2004; Mills et al., 2006a; 
Wassenaar et al., 2005). Financially, woman’s reliance on men for economic subsistence 
often results in what Fassin and Schneider (2003) term ‘survival sex’, where women have no 
choice but to agree to unprotected intercourse. Even when women are able to negotiate 
condom use, their dire economic circumstances may prevent them from doing so. For 
example, studies of female sex workers have shown that many do not use condoms as some 
clients are willing to pay more for unprotected sex (e.g.: Basuki et al., 2002). Taken together, 
studies of WTP should focus on understanding the barriers and facilitators of WTP among 
women more specifically if they are to benefit from the development of an HIV vaccine. 
   
2.5.5 Age and WTP in an HIV vaccine trial 
 
Age was reported to be unrelated to WTP in an HIV vaccine trial among a sample of Italians 
(Starace et al., 2006); a sample of populations at high risk of HIV infection in the US (Koblin 
et al., 2000); and a sample of Chinese migrants (Yang et al., 2004). However, a study of gay 
and bisexual men in the greater Vancouver region found that participants aged 24 to 31 years 
were significantly more likely to express WTP than participants aged 26 to 31 years 
(O’Connell et al., 2002). A divergent finding was reported by Buchbinder et al. (2004), who 
found that refusal to participate was lower in participants over the age of 40 years. These 
findings suggest that the relationship between age and WTP may vary from population to 
population. To date, few studies have examined the relationship between age and WTP in 
South African samples. 
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2.5.6 Educational level and WTP in an HIV vaccine trial 
 
A low educational level has been shown to be associated with WTP. A study that assessed 
WTP in Phase I HIV vaccine trials among Royal Thai army conscripted recruits found that 
participants with primary school education or less were significantly more likely to express 
WTP than participants with secondary or vocational schooling (Jenkins et al., 2000). A study 
that examined changes in WTP and knowledge of vaccine trial concepts among high risk 
populations in the US yielded similar results (Koblin et al., 2000). The researchers found that 
participants with college education were significantly less likely to express WTP than 
participants with less than high school education.  
 
2.6 Part I of this study 
 
As mentioned in Chapter 1, this study constituted the second part of a two-part mixed-method 
investigation that aimed to determine the factors associated with WTP in a South African 
sample. Part I was a qualitative study that aimed to elicit thick descriptions of the 
psychological, behavioural, and social concerns of individuals who will be eligible to 
participate in a future HIV vaccine trial (Swartz et al., 2006). To obtain rich narratives from 
such individuals, Swartz et al. conducted 37 semi-structured interviews and 2 focus groups 
with trial site community members who had attended HIV vaccine education workshops 
conducted by Masikhulisane, the community involvement wing of SAAVI. These sites were 
located in Cape Town, Durban, and the Klerksdorp, Orkney, Stilfontein and Hartbeesfontein 
(KOSH) district (the methodology employed is discussed in more detail in Chapter 3). The 
themes related to whether a sub-theme was an inhibitor or enabler, whether a sub-theme was 
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abstract or concrete, and whether a sub-theme concerned only the individual, the 
individual’s family, the individual’s community, or society at large (see Figure 1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AII =Abstract Inhibitor at the Individual Level AEI =Abstract Enabler at the Individual Level 
AIF =Abstract Inhibitor at the Family Level AEF =Abstract Enabler at the Family Level 
AIC =Abstract Inhibitor at the Community Level AEC =Abstract Enabler at the Community Level 
AIS =Abstract Inhibitor at the Societal Level AES =Abstract Enabler at the Societal Level 
CII =Concrete Inhibitor at the Individual Level CEI =Concrete Enabler at the Individual Level 
CIF =Concrete Inhibitor at the Family Level CEF =Concrete Enabler at the Family Level 
CIC =Concrete Inhibitor at the Community Level CEC =Concrete Enabler at the Community Level 
CIS =Concrete Inhibitor at the Societal Level CES =Concrete Enabler at the Societal Level 
___________________________________________________________________________ 
Figure 1. Enabler-Inhibitor quadrant model (Swartz et al., 2006). 
 
Abstract inhibitors were identified at the individual, community, and societal levels and 
included: (i) a negative association between an HIV vaccine trial and HIV/AIDS; (ii) fear of 
illness or death as a result of participating in an HIV vaccine trial; and (iii) a lack of 
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knowledge of HIV vaccines and HIV vaccine trials. Abstract enablers were only identified 
at the individual level and included participant’s reported sense of altruism. Concrete 
inhibitors were identified at the individual, family, and community levels and included: (i) 
monetary costs associated with participation; (ii) fear of being tested for HIV and receiving 
test results; (iii) negative reactions from family and community members; (iv) time delays 
between receiving trial participation information and actual enrolment; and (v) a general 
mistrust of researchers. Concrete enablers were identified at the individual, family, 
community, and societal levels and included (i) practicalities and convenience; (ii) financial 
rewards; (iii) a safe testing environment; (iv) positive family reactions to trial participation; 
(v) the different levels of participation available to different members of the community; (vi) 
the salience of HIV in the community; (vii) positive community reactions to vaccine trials; 
(vii) the need for protection from HIV infection; and (ix) the presence of role models.  
 
These findings are largely in keeping with those of the studies discussed above. This suggests 
that despite the unique socioepidemiological factors associated with the spread of HIV in 
South Africa, eligible participants may to some extent experience similar psychosocial 
concerns about participating in an HIV vaccine trial.  
 
2.7 Measuring WTP in an HIV vaccine trial 
 
A review of the literature revealed that a psychometric measure of WTP in an HIV vaccine 
trial has not been developed. Researchers have relied on visual analogue scales (e.g.: Giocos 
et al., 2007) and single-item scales asking participants to indicate their WTP according to 
response options such as:  
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 “yes” or “no” (Bartholow et al., 1997; Yang et al., 2004);  
 “yes”, “no”, “it depends”, or “do not know” (Vieira de Souza et al., 2003); 
 “definitely join”, “very likely join”, “might join”, “very likely not join”, or “definitely 
not join” (Jenkins et al., 2000); 
 “absolutely”, “probably”, “don’t know”, “probably not”, “no”, or “not eligible” 
(O’Connell et al., 2002); 
 “definitely”, “probably”, “probably not”, or “definitely not willing” (Koblin et al., 
2000). 
 “I am definitely willing to participate”, “I want to participate but let me think about 
it”, “I do not want to participate but would think about it”, “I am not at all willing to 
participate” (Ying et al., 2008). 
 
There are several shortcomings to such an approach. Firstly, an assortment of response 
options makes comparisons between studies problematic as different criteria are used to 
establish WTP. In addition, different response formats yield different levels of measurement. 
For example, whereas scales with response options such as “yes” or “no” produce nominal 
data, scales with response options such as “definitely”, “probably”, “probably not”, or 
“definitely not willing” produce ordinal data. As a result, comparisons between data from 
different studies become complicated.  
 
A second shortcoming is the use of a single item to measure a potentially multidimensional 
construct such as WTP in an HIV vaccine trial. According to Sullivan and Feldman (1979), it 
is doubtful whether a scale with one item can comprehensively assess a wide conception 
domain indicative of a multidimensional construct. A single item is therefore likely to yield a 
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shallow, one-dimensional measurement leading to high levels of systematic error (Neuman, 
2000).  
 
Reliability of single-item scales has also been reported to be problematic. For example, Loo 
(2002, p. 68) states that “while a single-item measure allows for the estimation of test-retest 
reliability, such a measure does not allow for the estimation of the more psychometrically 
important internal consistency reliability of the measure”. One advantage of being able to 
determine internal consistency, usually indexed by Cronbach’s alpha (), is that poorly-
performing items can be identified and deleted to improve the consistency and accuracy of a 
measure. With a single-item measure, however, no such improvements are possible.  
 
With regard to validity, Herting and Costner (1985) argue that content validity and construct 
validity of scales with one item are rarely upheld, since a single item produces a one-
dimensional measurement. Therefore, the extent to which a single-item measures what it 
purports to measure is questionable. In sum then, valid and reliable measurements of WTP 
require the development of a multi-item, multidimensional measure.  
 
2.8 A theoretical framework for studying WTP in an HIV vaccine trial 
 
As mentioned in Chapter 1, WTP in an HIV vaccine trial can be considered to be a health-
promoting behaviour from the perspective of trial participants (Kafaar et al., 2007). Thus, 
three theories of health-promoting behaviour were reviewed in the search for one that may be 
suitable in the context of WTP. These were the Health Belief Model (HBM) (Rosenstock, 
1966), the Protection Motivation Theory (PMT) (Rogers, 1975, 1983, 1985), and the Theory 
of Planned Behavior (TPB) (Ajzen, 1985, 1988, 1991). The HBM and the PMT are briefly 
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described and the reasons for their exclusion will be reiterated. Thereafter, TPB will be 
described in detail and the extension of the theory by the inclusion of additional predictor 
variables will be motivated and discussed.   
 
2.8.1 The Health Belief Model 
 
According to the Rosenstock’s (1966) HBM, the likelihood of an individual performing a 
health behaviour is determined by a consideration of four cognitive factors. These are, using 
condom use as a means of preventing HIV infection as an example:  
 
1. Perceived susceptibility (an individual's assessment of their risk of contracting HIV); 
2. Perceived severity (an individual's assessment of the seriousness of HIV, and its 
potential consequences);  
3. Perceived costs (an individual's assessment of the costs and barriers to using 
condoms); and  
4. Perceived benefits (an individual's assessment of the positive consequences of using 
condom).  
 
Since 1966 when Rosenstock first developed the HBM, several additional factors were added 
to the model. These include: 
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1. Cues to action (external influences promoting condom use, such as media 
campaigns and personal experiences); 
2. Health motivation (the extent to which an individual is motivated to use condoms); 
and 
3. Perceived control (the extent to which an individual perceives to have control over 
using condoms). 
 
The HBM has been successful at predicting some health behaviours such as condom use 
(Mahoney, Thumbs, & Ford, 1995); compliance and attrition in cardiac rehabilitation 
(Oldridge & Streiner, 1990), and the early detection of breast cancer (Calnan, 1984). 
However, meta-analyses of studies that used the HBM (Harrison et al., 1992; Janz & Becker, 
1984) showed that the HBM has only partially successful in predicting health behaviours. 
Ogden (2004) argues that a major reason for the limited success of the HBM has been its 
failure to incorporate social and environmental factors. There is also no provision for the role 
of past behaviour or for fear appeals. A further problem with the HBM in the context of WTP 
in an HIV vaccine trial is that the theory examines the relationship between cognitive 
predictors and the likelihood of actual behaviour. As no Phase III HIV vaccine trials were yet 
underway in South Africa at the time of this study, actual enrolment could not be measured. 
For these reasons, the HBM was ruled out as a theory that may be appropriate within the 
context of WTP in HIV vaccine trials.  
 
2.8.2 The Protection Motivation Theory 
 
The PMT expanded the HBM to include a role for fear appeals (Ogden, 2004). The PMT 
postulates that the likelihood of an individual performing a health behaviour is determined by 
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a consideration of five cognitive factors. These are, again using condom use as a means of 
preventing HIV infection as an example:    
 
1. Perceived susceptibility (an individual's assessment of their risk of contracting HIV); 
2. Perceived severity (an individual's assessment of the seriousness of HIV, and its 
potential consequences);  
3. Response effectiveness (an individual's assessment of the effect that using condoms 
would have on lowering their risk of HIV infection);  
4. Self-efficacy (an individual’s appraisal of their ability to use condoms); and 
5. Fear (the emotional response to the threat of contracting HIV should condoms not be 
used).  
 
The PMT has been less widely criticized than the HBM (Ogden, 2004). Nevertheless, many 
of the criticisms of the HBM also relate to the PMT. For example, the PMT also fails to 
incorporate social and environmental factors that may impact on an individuals’ performing a 
health behaviour. In the context of HIV vaccines trials, socioeconomic factors have been 
frequently shown to be associated with WTP (Smit et al., 2005). As such, the exclusion of 
social and environmental factors by the PMT and HBM poses a serious problem. In addition, 
meta-analyses of studies that used the PMT (e.g. Floyd et al., 2000) have shown that the PMT 
has also been sub-optimal in predicting health behaviours. Taken together, the PMT might 
also be inappropriate for the context of WTP in South African HIV vaccine trials and was 
therefore ruled out. 
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2.8.3 The Theory of Planned behavior  
 
The TPB (Ajzen, 1985, 1988, 1991) is an extension of an earlier theory, the Theory of 
Reasoned Action (TRA) (Ajzen & Fishbein, 1980). The TRA posits that an individual’s 
intention to perform a behaviour is a robust predictor of the individual actually performing the 
behaviour. A behavioural intention is the outcome of a combination of two variables:  
 
1. An individual’s attitude towards the behaviour; and  
2. An individual’s perception of existing subjective norms concerning the behaviour. 
 
An individual’s attitude towards a behaviour is informed by the individual’s beliefs about the 
outcomes of the behaviour, and the individual’s evaluation of these outcomes. An individual’s 
perceived subjective norms is informed by the individual’s perception of the attitude of others 
towards the behaviour, and the individual’s motivation to comply with others. Taken together, 
the TRA predicts that that a positive attitude toward the behaviour and strong normative 
pressure to perform (or not perform) the behaviour will accurately predict an intention to 
perform the behaviour. Furthermore, a strong intention to perform the behaviour will robustly 
predict actual behaviour (Ajzen, 1985, 1988, 1991). The TRA is displayed in Figure 2.   
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Figure 2. The Theory of Reasoned Action.  
 
The TRA can be expressed as the following mathematical function: Behavioural intention = 
β0 + (β1) Attitudes [(beliefs about the outcomes of the behaviour) + (the individual’s 
evaluation of these outcomes)] + (β2) Subjective norms [(the individual’s perception of the 
attitude of others towards the behaviour) + (the individual’s motivation to comply with 
others)]. 
 
The TPB is an extension of the TRA by the inclusion of an additional variable, the 
individual’s perceived behavioural control. An individual’s perception of control over a 
behaviour is informed by the individual’s evaluation of internal factors such prior experience, 
and external factors such as social learning. The TPB also states that perceived behavioural 
control can predict behaviour without the mediating effect of attitudes towards the behaviour 
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and subjective norms. Taken together, the TPB predicts that that a positive attitude toward 
the behaviour, strong normative pressure to perform (or not perform) the behaviour, and a 
strong perception of control over the behaviour will accurately predict an intention to perform 
the behaviour. A strong intention to perform the behaviour will in turn robustly predict actual 
behaviour. Finally, a strong perception of control over the behaviour may predict actual 
behaviour despite one’s attitude towards the behaviour or one’s perception of normative 
pressure. The TPB is displayed in Figure 3.  
 
  
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
________________________________________________________________ 
 
Figure 3. The Theory of Planned Behavior.  
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The TPB can be expressed as the following mathematical function: Behavioural intention = 
β0 + (β1) Attitudes [(beliefs about the outcomes of the behaviour) + (the individual’s 
evaluation of these outcomes)] + (β2) Subjective norms [(the individual’s perception of the 
attitude of others towards the behaviour) + (the individual’s motivation to comply with 
others)] + (β3) Perceived behavioural control [(the individual’s evaluation of internal factors) 
+ (the individual’s evaluation of external factors)]. 
 
Unlike the PMT and the HBM, meta-analyses of studies that have employed the TPB 
recurrently show that the theory has successfully predicted a wide range of health-promoting 
behaviours (Armitage & Conner, 1999b; Armitage & Conner, 2001; Albarracín et al., 2001). 
Behaviours predicted include medication adherence (Conner, Black, & Stratton, 1998), 
condom use (Albarracín et al., 2001; Bryan, Kagee, & Broaddus, 2006; Sheeran & Orbell, 
1998), exercise (Hagger, Chatzisarantis, & Biddle, 2002b), clinical glove use (Watson & 
Myers, 2001); and dietary and fluid adherence in haemodialysis (Fincham et al., 2008). In 
addition, the theory makes provision for the role of social and environmental factors. Given 
the important role that social factors play in the transmission of HIV, an assessment of these 
factors is paramount. Another benefit to using the TPB in this context is the theory’s inclusion 
of behavioural intention, a reliable proxy for actual behaviour (Armitage & Conner, 2001; 
Ajzen, 1985, 1988, 1991; Francis et al., 2004). It follows that in the absence of actual 
enrolling behaviour, measuring an individual’s intention or willingness to participate may be 
the most appropriate proxy for future participation in an HIV vaccine trial.  
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2.8.4 The Theory of Planned Behavior and WTP in an HIV vaccine trial 
 
Regarding WTP in future HIV vaccine trials, only two studies (to my knowledge) have used 
the TPB as a predictive model. The first study evaluated the acceptability of a hypothetical 
future HIV vaccine among 136 Canadian adolescents (Gagnon & Godin, 2000). The second 
study evaluated the extent to which the TPB predicted variance in WTP among 224 South 
African adolescents (Giocos et al., 2007). Multivariate analyses showed that the TPB 
variables were significant predictors of WTP in both samples. These early findings provide 
support for the hypothesis that the TPB may be a useful theoretical framework for 
understanding and predicting WTP in an HIV vaccine trial.  
 
While behavioural intentions are strong predictors of actual behaviour (Ajzen, 1988), they do 
not however account for all of the variance in actual behaviour. Similarly, attitude, subjective 
norms, and perceived behavioural control do not account for all of the variance in behavioural 
intention. The residual variance may therefore be explained by variables beyond the scope of 
the TPB. To account for unexplained variance, researchers have expanded the TPB by 
including additional predictor variables. For example, Bozionelos and Bennett (1999) 
investigated the predictive strength of the TPB in relation to exercise behaviour among 114 
British students. Past behaviour, personal normative beliefs, role beliefs, level of self-
monitoring, and sex role identity were added as additional predictor variables. Results 
indicated that the added variables significantly improved the predictive power of the TPB.  
 
In another sample of British students, McMillan and Conner (2003) used the TPB to predict 
the use of lysergic acid diethylamide (LSD), amphetamine, cannabis, and ecstasy over 6 
months in a sample of 461 British students. Descriptive and moral norms were additional 
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predictor variables. The extended version of the TPB significantly accounted for 49% of 
the variance in intentions, and 45% of the variance in actual behaviour. Furthermore, 
descriptive norms explained additional variance in intentions for all the drugs, and moral 
norms explained additional variance in the intension to use cannabis. 
 
While these research findings are limited to British student samples, they nonetheless 
illustrate that the inclusion of theoretically-driven predictor variables may increase the amount 
of variance explained. To this end, this study included mistrust of researchers, knowledge of 
HIV vaccines and HIV vaccine trials, altruism, and perceived risk of HIV infection (see 
Figure 4). As no Phase III HIV vaccine trials were yet underway in South Africa at the time of 
this writing, we only measured participants’ intention, or willingness, to participate in a future 
Phase III HIV vaccine trial. 
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Figure 4. Application and extension of the Theory of Planned Behavior in this study.  
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2.9 Overview of the chapter 
 
This chapter provided a critical review of both international and South African literature 
surrounding factors that may inhibit or facilitate WTP in an HIV vaccine trial. The literature 
review identified variables that may be robust predictors of WTP in the South African 
context. These include mistrust of researchers, knowledge of HIV vaccines and HIV vaccine 
trials, altruism, and perceived risk of HIV infection. This chapter also outlined the application 
and extension of the TPB to the prediction of WTP in this study, and underscored the need for 
the construction of a reliable and valid measure of WTP. The next chapter describes the 
methodology that was used in this study, and includes a description of the research design, the 
selection of the sample, the construction of a psychometric measure of WTP, and the 
statistical procedures used to analyse the data. 
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CHAPTER 3 
RESEARCH METHODOLOGY 
 
3.1 Introduction 
 
As mentioned previously, this study constituted the second part of a two-part mixed-method 
investigation that aimed to determine the factors associated with WTP in a South African 
sample. Part I was a qualitative study that aimed to elicit thick descriptions of the 
psychological, behavioural, and social concerns of South Africans who will be eligible to 
participate in a future HIV vaccine trial (Swartz et al., 2006). The researchers conducted 37 
semi-structured interviews and 2 focus groups with trial site community members who had 
attended HIV vaccine education workshops conducted by Masikhulisane, the community 
involvement wing of SAAVI. The interviews were recorded verbatim using a dictaphone and 
later transcribed. The transcriptions were entered into the Atlas.ti. software program to assist 
in the identification of themes within the tradition of Grounded Theory (Strauss & Corbin, 
1998). After the interviewers had completed an initial analysis of the transcriptions, the 
research team met to discuss common themes that had emerged from the data. The themes 
related to whether a sub-theme was an inhibitor or enabler, whether a sub-theme was abstract 
or concrete, and whether a sub-theme concerned only the individual, the individual’s family, 
the individual’s community, or society at large. The results of the study were reported in 
Chapter 2.  
 
The objectives for this study (Part II of the investigation) were: 1) to construct a psychometric 
measure of WTP in an HIV vaccine trial; 2) to derive, in an exploratory fashion, the factor 
structure of the new instrument; 3) to examine the extent to which the TPB predicts variance 
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in WTP in an HIV vaccine trial; and 4) to determine whether the TPB is strengthened by 
the inclusion of mistrust of researchers, knowledge of HIV vaccines and HIV vaccine trials, 
altruism, and perceived risk of HIV infection as additional predictor variables. This study 
built on the results of Part I in two ways. Firstly, Part I facilitated the development of an item 
pool for the construction of a WTP measure. Secondly, Part I contributed towards the 
identification of important variables that were included as additional predictor variables in the 
TPB model.   
 
3.2 Participants 
 
A convenience sample of 399 participants was drawn from Masiphumelele, an urban-informal 
settlement near Cape Town. A great concern was whether participants would be sufficiently 
literate to complete the self-report questionnaires, given the high rates of illiteracy in the area 
(Masiphumelele Annual Report, 2008). Careful analysis of the completed questionnaires 
revealed that 79 of the 399 questionnaires (19.8%) were poorly completed, leaving a sample 
size of 320. The large proportion of discarded questionnaires was understandable considering 
that only 60.6% of the participants reported at least a high school level of education. The bias 
introduced by the under-representation of less literate individuals, coupled with the non-
randomness of the sample, indicates that the results of this study are not representative of the 
population at large. Therefore, the results reported in Chapter 4 need to be interpreted against 
the backdrop of the sample limitations. 
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3.3 Research design 
 
This study was a research survey with a cross-sectional design. Participants were asked to 
complete a battery of psychometric instruments on a single occasion during the period of 1 
April 2007 to 14 April 2007.  
 
3.4 Measuring instruments 
 
3.4.1 The Willingness to Participate Scale (WTPS) (Appendix A) 
 
3.4.1.1 Item development 
 
According to Clark and Watson (1995), the first priority in scale construction is to formulate a 
clear conceptualisation of the target construct. The process of conceptualising, articulating, 
and circumscribing the construct of WTP was aided by examining the results of Part I of this 
investigation, and by conducting a comprehensive literature review of both South African and 
international literature on WTP. Once the scope and content domain of the construct was 
identified, the process of developing an item pool began. The primary goal of creating an item 
pool is to derive as many potentially relevant scale items as is necessary to achieve saturation 
of the all facets of the target construct (Comrey, 1988; Comrey & Lee, 1992). Items were 
developed so that they directly reflected inhibitors and facilitators of WTP.  
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3.4.1.2 Item refinement 
   
Once enough items were developed to sufficiently cover all aspects and domains of the 
construct WTP, items were closely examined for ambiguity and redundancy. The process of 
item-refinement continued in an iterative fashion until no further improvements could be 
made. Thereafter, a panel of social scientists working in the area of HIV vaccines that had 
been trained in scale development were asked to review the items for clarity, conciseness, 
relevance, and possible omissions. Once the recommendations made by the panel were 
integrated, focus groups were held with two separate groups of postgraduate psychology 
students undergoing training in psychometric scale construction. The participants were invited 
to comment on the items and made suggestions which improved the readability and 
interpretability of the items. The revised items were once again reviewed by the panel of 
social scientists. 
  
The final scale consisted of 35 items and was named the Willingness to Participate Scale 
(WTPS). The WTPS used a five-point Likert scale response format ranging from “very 
unwilling” to “very willing”. “Very unwilling” was coded 1 and “very willing” was coded 5, 
yielding total scores that ranged between 35 and 175. Higher scores indicated greater WTP. 
Item-by-item descriptive analyses, Cronbach alpha (α) internal reliability coefficients, and 
item-total correlation coefficients were computed and are presented in Chapter 4. 
 
3.4.2 Measuring the TPB variables 
 
A comprehensive review of the literature showed that, at the time of this study, there were no 
standard measures for the TPB constructs in the context of WTP in an HIV vaccine trial. The 
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constructs were attitudes towards participating in an HIV vaccine trial, subjective norms 
about participating in an HIV vaccine trial, and perceived behavioural control of participating 
in an HIV vaccine trial. In the absence of appropriate instruments, scales for the variables 
were constructed according to a scale development manual developed by Francis et al. (2004). 
The manual provides procedural guidelines for the construction of scales to measure TPB 
variables specifically, and integrates literature ranging from the original TPB manuscripts 
(Ajzen, 1985, 1988, 1991) to meta-analyses of studies that have employed the TPB (Armitage 
& Conner, 1999b, 2001; Godin & Kok, 1996). The result is a guide to scale development that 
is not only theoretically accurate, but is based on current practice among TPB researchers. 
Scales were constructed according to the construction guidelines used to develop the WTPS. 
Psychometric properties of the resulting scales are reported in Chapter 4. 
 
3.4.2.1 Attitudes (Appendix B) 
 
To measure attitudes, Francis et al. (2004) suggest the use of several evaluative bipolar 
adjectives which are anchored by a single stem. The bipolar adjectives should be arranged in a 
manner that may yield a mix of positive and negative endpoints. Negatively-worded items 
need to be recoded such that higher numbers reflect a positive attitude towards the target 
behaviour. The item scores are then added to give a total attitude score. 
 
Following these guidelines, a scale with 9 items was developed. Each item was anchored by 
the phrase “participating in an HIV vaccine would be” followed by the use of evaluative 
bipolar adjectives on a seven point scale. Items with positive endpoints, such as “participating 
in an HIV vaccine trial would be worthless/worthwhile”, were scored from 1 to 7 while items 
with negative endpoints, such as “participating in an HIV vaccine trial would be 
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pleasant/unpleasant” were scored from 7 to 1. As such, total scores ranged from 9 to 63 
where higher scores reflected a more positive attitude toward participating in an HIV vaccine 
trial.  
 
3.4.2.2 Subjective norms (Appendix C) 
 
Francis et al. (2004) suggest that to measure subjective norms, three standard items should be 
used and adapted to the context of the study (additional items may be included). The standard 
items are: 1) “most people who are important to me think that…”; 2) “it is expected of me…”; 
and 3) “I feel under social pressure to…” The items should be followed by a Likert scale 
response format ranging from “strongly agree” to “strongly disagree”, and should be arranged 
so that there is a so that there is a mix of positive and negative endpoints. Negatively-worded 
items need to be recoded such that higher numbers reflect a greater social pressure to perform 
the target behaviour. The item scores are then added to give a total score for subjective norms.  
 
Following these guidelines, a measure consisting of 6 items was developed. The scale 
consisted of items such as “I feel pressured by people around me to participate in an HIV 
vaccine trial” and “most people who are important to me think that I should participate in an 
HIV vaccine trial”. The items were scored according to a four-point Likert scale where 
responses ranged from “strongly disagree” to “strongly agree”. “Strongly disagree” was coded 
1 and “strongly agree” was coded 4 yielding total scores that ranged from 6 to 24. Higher 
scores indicated a stronger perception of participation in an HIV vaccine trial being the norm.  
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3.4.2.3 Perceived behavioural control (Appendix D). 
 
According to Francis et al. (2004), items in a scale measuring perceived behavioural control 
should assess two factors: 1) self-efficacy performing the target behaviour; and (2) 
controllability over performing the target behaviour. Self-efficacy is assessed by asking 
participants to report the perceived difficulty of performing the behaviour and their 
confidence in performing the behaviour. Controllability is assessed by asking participants to 
report whether performing the behaviour is up to them, and whether factors beyond their 
control determine their behaviour. As with scales measuring subjective norms, items should 
be followed by a Likert scale response format ranging from “strongly agree” to “strongly 
disagree”. The items should be arranged so that there is a so that there is a mix of positive and 
negative endpoints. Negatively-worded items need to be recoded such that higher numbers 
reflect a greater perception of control of the target behaviour. Item scores are added to give a 
total score for perceived behavioural control.  
 
According to these guidelines, a scale consisting of 6 items was constructed. A four-point 
Likert response format ranging from “strongly disagree” to “strongly agree” was used. For 
items such as “I am confident that I could participate in an HIV vaccine trial if I wanted to”, 
“strongly disagree” was coded 1 and “strongly agree” was coded 4. For reversed items such as 
“the decision to participate in an HIV vaccine trial is beyond my control”, “strongly disagree” 
was coded 4 and “strongly agree” was coded 1. As such, total scores ranged from 6 to 24 
where higher scores indicated a stronger perception of behavioural control over participating 
in an HIV vaccine trial.  
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3.4.3 Scales for the additional variables 
 
There were no standard instruments available for measuring mistrust of researchers, 
knowledge of HIV vaccines and HIV vaccine trials, or altruism in the context of WTP in an 
HIV vaccine trial. As such, brief self-report scales were constructed according to the scale 
construction guidelines used to construct the WTPS. Psychometric properties of the scales are 
reported in Chapter 4.  
 
3.4.3.1 Mistrust of researchers (Appendix E) 
 
A measure consisting of 9 items was developed to measure mistrust of researchers. The scale 
used a four-point Likert response format ranging from “strongly disagree” to “strongly agree”. 
For items such as “the public should be wary of researchers”, “strongly disagree” was coded 1 
and “strongly agree” was coded 4. For reversed items such as “when a researcher gives me 
information I would accept it as true”, “strongly disagree” was coded 4 and “strongly agree” 
was coded 1. As such, total scores ranged from 9 to 36 where higher scores indicated higher 
levels of mistrust of researchers.  
 
3.4.3.2 Knowledge of HIV vaccines and HIV vaccine trials (Appendix F) 
 
To measure knowledge of HIV vaccine s and HIV vaccine trials, a scale consisting of 23 
items was developed. The instrument utilised a two-option response format consisting of 
“true” and “false”. Items included “a placebo is a fake treatment that is similar to the real 
vaccine or drug”, and “HIV vaccines are given to help prevent someone from becoming 
infected with HIV”. Correct responses were coded 2 and incorrect responses were coded 1. As 
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such, total scores ranged from 23 to 46 where higher scores indicated higher levels of 
knowledge of HIV vaccines and HIV vaccine trials.  
 
3.4.3.3 Altruism (Appendix G) 
 
A measure consisting of 11 items was constructed to measure altruism in the context of WTP 
in an HIV vaccine trial. The scale used a four-point Likert response format ranging from 
“strongly disagree” to “strongly agree”. For items such as “I try to help those in need”, 
“strongly disagree” was coded 1 and “strongly agree” was coded 4. For reversed items such as 
“if I cared for others I would be wasting my time”, “strongly disagree” was coded 4 and 
“strongly agree” was coded 1. As such, total scores ranged from 11 to 44 where higher scores 
indicated higher levels of altruism.  
 
3.4.3.4 Perceived risk of HIV infection 
 
To measure perceived risk of HIV infection, participants were requested to indicate their 
perception of self-risk on a ten point scale ranging from “very low risk” to “very high risk”. 
Total scores ranged from 1 to 10 where higher scores indicated a higher perceived risk of HIV 
infection. 
 
3.4.3.5 Demographic variables (Appendix H) 
 
Gender, age, marital status, ethnicity, first language, educational level, and annual family 
income before taxes were assessed using a standard demographic questionnaire. 
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3.5 Translation of measuring instruments 
 
As Xhosa is the predominant language spoken in Masiphumelele (Masiphumelele Annual 
Report, 2008), the scales needed to be translated. The cross-cultural translation and adaptation 
of psychometric instruments is fraught with methodological, conceptual, and linguistic 
difficulties (Beaton, Bombardier, Guillemin, & Ferraz, 2000; Kulich et al., 2008; Van de 
Vijver & Hambleton, 1996). For example, there may be differences in the level of literacy, 
taboo subjects, and social desirability between cultures (Ren, Amick, Zhou, & Gandek, 1998). 
There may also be a lack of appropriate terms or idioms in the target language, preventing 
literal translation. In addition to linguistic differences, there may be contrasting cultural 
beliefs and practices about the body, illness, and health behaviours (Ren et al., 1998). The 
translation of a psychometric instrument therefore involves more than just linguistic 
adaptation of the original language into the target language; it is an iterative process that aims 
to achieve conceptual equivalence within the cultural context of the target language (Beaton 
et al., 2000; Kulich et al., 2008). As such, we aimed to replicate the English measures as 
closely as possible while being sensitive to cultural and linguistic differences between English 
and Xhosa.  
 
A Xhosa-speaking clinical psychologist with training in psychometric scale construction was 
employed to translate the measures from English into Xhosa. The Xhosa instruments were 
then back-translated into English by a Xhosa-speaking post-graduate psychology student with 
training in psychometric scale construction. The student was very experienced in translating 
questionnaires and did not have access to the original English versions of the instruments. A 
panel of five social scientists with training in psychometric scale construction then assessed 
the conceptual equivalence of the items from the two English versions of the measures. The 
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panel concluded that the two sets of English measures demonstrated very good 
correspondence, providing confidence in the Xhosa version of the measures. While significant 
correlations between original and translated items provide support for the validity of the 
translated items (Ren et al., 1998), such analyses could not be performed in this study as there 
were too few completed English questionnaire packets. 
  
3.6 Procedure 
 
A partnership was established with the Desmond Tutu HIV Centre (DTHC) in Cape Town, as 
the centre has a good rapport with Community Advisory Board (CAB) members at 
Masiphumelele. A meeting was held with the CAB members and other interested parties of 
the Masiphumelele community where details of the study were presented and permission to 
conduct the study was requested. After obtaining permission from the CAB and ethical 
clearance was granted by the Internal Review Boards (IRB) of both Stellenbosch University 
and the University of Cape Town, the administration of questionnaires ensued. Community 
educators and recruiters carefully explained the details of the study to potential participants 
who were required to read, understand, and sign consent forms prior to participating in the 
study (Appendix I). A hall was rented at the Masiphumelele clinic to provide a location for 
participants to complete their questionnaires. After completing the questionnaires, participants 
were thanked for their time and each received a R50 gift voucher for a local supermarket as a 
show of gratitude for their participation.  
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3.7 Data analysis 
 
All statistical procedures were performed using the SPSS 15.0 software package. Analyses 
were two-tailed and alpha (α) was set at 0.05. 
 
3.7.1 Data screening 
 
Firstly, case summaries for all variables were requested in order to identify data-capturing 
errors. Secondly, a missing value analysis (MVA) was performed for each variable to identify 
systematic trends in missing data. While listwise deletion of cases with missing data is the 
procedure most likely to produce unbiased parameter estimates (Howell, 2008), doing so 
would have substantially reduced the sample size and power of the study. According to Little 
(1998), the use of least squares has also been shown to be a very good approach to missing 
data. Therefore, missing data were imputed via regression estimation. Variable means and 
percentages before and after missing data imputation were compared to assess the validity of 
the imputed data. Frequencies, percentages, means, and standard deviations were computed to 
describe the sample. Cronbach alpha (α) reliability coefficients were computed to assess the 
internal consistency of the scales. A Pearson product-moment correlation matrix was 
computed to examine bivariate associations between continuous variables. Independent 
samples t-tests and one-way ANOVA tests were performed to examine differences between 
groups. 
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3.7.2 Exploratory factor analysis  
 
A principal component Kaiser normalised exploratory factor analysis (EFA) was conducted 
on the items that constituted the WTPS. This procedure was performed to identify latent 
factors which were informed by the items of the scale. Firstly, the Kaiser-Meyer-Olkin 
statistic (which represents the ratio of the squared correlation between items to the squared 
partial correlation between items) was computed to determine whether or not the data were 
likely to factor well. Thereafter, inter-item Pearson product-moment correlation coefficients 
(r) were derived to examine associations between the items. Items that were not significantly 
correlated with other items were removed from the analysis. Bartlett’s test of sphericity was 
computed to ensure that the inter-item correlation matrix did not approach an identity matrix. 
The converse problem of multicollinearity was assessed by analyzing the determinant of the 
inter-item correlation matrix. Items that correlated very highly with other items (r > 0.8) were 
removed from the analysis. Finally, item-by-item descriptive analyses, Cronbach’s alpha 
internal reliability coefficients, and item-total Pearson product-moment correlation 
coefficients were computed. Factors with eigenvalues greater than 1 were retained (Kaiser, 
1960, 1974). A scree plot was computed to graphically display the number of factors to be 
extracted. A factor loading of 0.40 or greater was used to identify the primary factor on which 
the items loaded. A factor correlation matrix revealed that the factors were significantly 
correlated. As such, oblique rotation (direct oblimin) was performed instead of orthogonal 
rotation (factor score coefficients were computed according to the regression method, where 
scores have a mean of 0 and a variance equal to the squared multiple correlation between the 
estimated factor scores and the true factor values).   
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3.7.2.1 Sample size for exploratory factor analysis  
 
Various and conflicting suggestions have been put forth regarding appropriate sample size for 
EFA. While some recommend having at least 10 observations per variable (Nunnally & 
Bernstein, 1994), others suggest that as few as 5 observations per variable would be sufficient 
(Bryant & Yarnold, 1995; Kass & Tinsley, 1979). Despite the contradictory guidelines 
provided in the literature, a sample size of 300 or more tends to produce stable factor 
solutions regardless of the observation to variable ratio (Comrey & Lee, 1992; Norušis, 2005; 
Tabachnick & Fidell, 2001). For this reason, this study’s sample size of 320 was considered to 
be large enough to ensure stable and reliable parameter estimates.   
 
3.7.3 Two-step linear hierarchical multiple regression analysis 
 
A two-step linear hierarchical multiple regression analysis was performed to: (i) determine the 
amount of variance in WTP explained by the linear combination of TPB variables; and (ii) to 
determine whether or not the inclusion of mistrust of researchers, knowledge of HIV vaccines 
and HIV vaccine trials, altruism, and perceived risk of HIV infection as additional predictor 
variables significant improved the amount of variance explained in WTP. Multicollinearity 
between predictor variables was assessed using the Variance Inflation Factor (VIF) statistic. 
According to Myers (1990), values exceeding 10 are cause for concern. The assumption of 
independence of standardised residuals was assessed using the Durbin-Watson statistic. 
According to Field (2000, 2005), values should be greater than or equal to 1 and less than or 
equal to 3 (1 ≤ x ≤ 3). Boxplots were computed to reveal the presence of outliers. Cook’s 
distances were calculated for each outlier to determine whether or not the outlier exerted a 
significant influence on the regression model as a whole. Cook and Weisberg (1982) suggest 
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that values greater than 1 may be a cause for concern. The assumptions of homoscedasticity 
and linearity were assessed by analysing the standardised residuals/ standardised predicted 
values graph. Finally, the assumption of normally distributed standardised residuals was 
assessed using the Kolmogorov-Smirnov test. 
 
3.7.3.1 Model specification 
 
At step 1, attitude, subjective norms, and perceived behavioural control were entered 
simultaneously to determine the amount of variance in WTP that could be explained by the 
TPB. At step 2, the additional predictor variables were entered simultaneously with TPB 
variables to determine whether or not the additional predictor variables could account for 
additional variance in WTP.  
 
3.7.3.2 Sample size for multiple linear regression analysis 
 
Tabachnick and Fidell (2001) suggest that n ≥ 104 + k (where n refers to sample size and k 
refers to the number of predictor variables) should yield sufficient power to test individual 
predictors. Furthermore, n ≥ 50 + 8(k) should yield enough power to test the squared multiple 
correlation coefficient. According to these guidelines, this study’s sample size of 320 was able 
to yield enough power.  
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CHAPTER 4 
RESULTS 
 
4.1 Demographic characteristics of the sample (Table 1) 
 
The sample consisted exclusively of Black participants who were mostly unemployed 
(76.3%). The large majority were female (89.7%) and the mean age was 30.29 years (SD = 
10.57). Almost all spoke Xhosa as a first language (98.1%) and most were single (71.6%). 
While most indicated that they were unsure of their annual household income before taxes 
(72.8%), a large proportion indicated that their annual household income before taxes was less 
than R10 000 (21.9%). A third of the participants (33.1%) had completed primary school and 
42.2% had attended high school, but had not completed matric. 
 
Table 1 
 
Demographic Characteristics of the Sample 
                                                                         
  
n 
 
 
ƒ 
 
(%) 
 
M 
 
SD 
 
Range 
 
Age (years) 
 
 
320 
  
(100) 
 
30.29 
 
10.57 
 
16-49 
Race 
      Black 
 
320  
320 
(100) 
(100) 
   
Sex 
      Male 
      Female 
 
320  
33 
287 
(100) 
(10.3) 
(89.7) 
   
(Table continues) 
Stellenbosch University http://scholar.sun.ac.za
 67 
(Continued) 
  
n 
 
 
ƒ 
 
(%) 
 
M 
 
SD 
 
Range 
 
Annual household income before taxes 
     Less than R10 000 
     R10 001-R40 000 
     R40 001-R80 000 
     R80 001-R110 000 
     R110 001-R170 000 
     R170 001-R240 000 
     R240 001 and above 
     Unsure 
 
 
320 
 
 
70 
7 
2 
3 
2 
1 
2 
233 
 
(100) 
(21.9) 
(2.2) 
(0.6) 
(0.9) 
(0.6) 
(0.3) 
(0.6) 
(72.8) 
   
Educational status 
     No formal education 
     Completed primary school 
     Attended high school but did  
     not complete matric 
     Completed matric 
     Attended college, university,  
     or technikon but did graduate 
     Graduated from college,  
     university, or technikon 
 
320  
20 
106 
135 
 
52 
5 
 
2 
(100) 
(6.3) 
(33.1) 
(42.2) 
 
(16.3) 
(1.6) 
 
(0.6) 
   
Employment status 
     Employed full time 
     Employed part time 
     Student 
     Unemployed 
     Retired 
320  
18 
34 
21 
244 
3 
 
(100) 
(5.6) 
(10.6) 
(6.6) 
(76.3) 
(0.9) 
   
First language 
      Xhosa 
      Southern Sotho 
      Zulu 
      English 
      Venda 
 
320  
314 
2 
1 
2 
1 
(100) 
(98.1) 
(0.6) 
(0.3) 
(0.6) 
(0.3) 
   
Marital status 
      Single 
      Co-habiting 
      Married 
      Divorced 
      Other 
 
320  
229 
22 
66 
1 
2 
(100) 
(71.6) 
(6.9) 
(20.6) 
(0.3) 
(0.6) 
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4.2 Internal reliability of the measures (Table 2) 
 
4.2.1 Attitudes 
 
The first version of the measure demonstrated poor to modest internal consistency (α = 0.59). 
However, after deleting item 1 (“participating in an HIV vaccine trial would be 
harmful/beneficial”); item 4 (“participating in an HIV vaccine trial would be 
worthless/worthwhile”); and item 9 (“participating in an HIV vaccine trial would be 
silly/clever”), the internal consistency of the scale demonstrated excellent internal consistency 
(α = 0.87). The refined instrument consisted of 6 items. 
 
4.2.2 Subjective norms 
 
The measure demonstrated excellent internal consistency (α = 0.84).  
 
4.2.3 Perceived behavioural control  
 
The measure demonstrated modest internal consistency (α = 0.65). As no items performed 
particularly poorly, the internal consistency of the measure could not be improved.   
 
4.2.4 Mistrust of researchers 
 
The first version of the scale demonstrated modest internal consistency (α = 0.63). However, 
when item 1 (“if I were asked to participate in a research study and the study procedures were 
explained to me by the researcher, I would believe what he or she told me”) was removed 
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from the analysis, the scale demonstrated excellent internal consistency (α = 0.79). The 
refined instrument consisted of 8 items. 
 
4.2.5 Knowledge of HIV vaccines and HIV vaccine trials 
 
The first version of the measure demonstrated modest internal consistency (α = 0.64). 
However, when item 3 (“it is important that the individuals placed in each group in a clinical 
trial are different to each other in as many ways as possible”); item 4 (“in a clinical trial, the 
participants know whether they have received the real vaccine or drug or whether they have 
received the fake vaccine or drug”); item 8 (“a vaccine is given to children, never to adults”); 
item 18 (“if you enroll in an HIV vaccine trial, you will not be asked questions about your 
health and sexual behaviour”); and item 19 (“people who take part in an HIV vaccine trial 
will not be allowed to stop their involvement in the trial”) were deleted, the scale yielded 
good internal consistency (α = 0.71). The refined instrument consisted of 18 items. 
 
4.2.6 Altruism 
 
The original scale demonstrated good internal consistency (α = 0.71). Nonetheless, when item 
1 (“if I help others too much, they may take advantage of me”); item 3 (“I must take care of 
myself before taking care of others”); item 6 (“if I cared for others I would be wasting my 
time”); item 8 (“I will lose out if I worry about other people’s problems or needs”); and item 
10 (“I think the most important thing in life is to look after my own interests first”) were 
deleted, the scale displayed excellent internal consistency (α = 0.87). The refined instrument 
consisted of 6 items.  
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Table 2 
 
Internal Consistency of Measures Before and After Deleting Poorly Performing Items 
 
 
Scale 
 
 
α-bid† 
 
No. of items 
before deletion 
 
 
Items deleted 
 
No. of items 
after deletion 
 
α-aid‡ 
 
Attitude 
 
 
0.59 
 
9 
 
1, 4, 9 
 
6 
 
0.87 
Subjective norms 
 
0.84 6 None 6 0.84 
PBC 
 
0.65 6 None 6 0.65 
Mistrust 
 
0.63 9 1 8 0.79 
Knowledge 0.64 23 3, 4, 8, 18, 19 
 
18 0.71 
Altruism 
 
0.71 11 1, 3, 6, 8, 10 6 0.87 
† Cronbach’s alpha (α) before item deletion; ‡ Cronbach’s alpha (α) after item deletion 
 
4.3 Bivariate correlations between variables (Table 3) 
 
Results indicated that a high level of WTP was associated with a low level of normative 
pressure (r = -0.24, p < 0.01), a high level of altruism (r = 0.24, p < 0.01), a low level of 
mistrust of researchers (r = -0.21, p < 0.05), and a high level of perceived risk of HIV 
infection (r = 0.12, p < 0.05) (Table 3 is presented on the next page).
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Table 3 
 
Bivariate Pearson Product-moment Correlations between Variables 
 
 
 
 
 
WTP 
 
Age 
 
Attitude 
 
Subjective norms 
 
PBC† 
 
 
Mistrust 
 
Knowledge 
 
Altruism 
 
Perceived risk 
 
WTP 
 
1.00 
        
 
Age 
 
0.01 
 
1.00 
       
 
Attitude 
 
0.00 
 
-0.12* 
 
1.00 
      
 
Subjective norms 
 
-0.24** 
 
-0.00 
 
0.11* 
 
1.00 
     
 
PBC† 
 
-0.08 
 
0.09 
 
0.04 
 
0.13* 
 
1.00 
    
 
Mistrust 
 
-0.21* 
 
-0.00 
 
0.09 
 
0.46** 
 
-0.12* 
 
1.00 
   
 
Knowledge 
 
0.10 
 
0.08 
 
0.07 
 
-0.00 
 
-0.02 
 
0.08 
 
1.00 
  
 
Altruism 
 
0.24** 
 
-0.01 
 
0.19** 
 
-0.56** 
 
-0.27** 
 
-0.41** 
 
0.06 
 
1.00 
 
 
Perceived risk 
 
 
0.12* 
 
0.05 
 
0.20** 
 
0.03 
 
-0.12* 
 
-0.02 
 
0.12* 
 
0.11* 
 
1.00 
† Perceived behavioural control; *p < 0.05; **p < 0.01
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4.4 Between-groups effects (Table 4) 
 
Owing to the homogeneity of the sample, the majority of independent variable cell 
frequencies were very low (see Table 1). To permit tests of between-groups effects, the 
independent variables were dichotomised so that each category had enough observations to 
make meaningful comparisons possible. Categories that could not be collapsed were removed 
from the analyses. Annual household income before taxes was dichotomised as ‘less than R10 
000 versus R10 000 or more’. There were 87 cases that could be analysed after dichotomising 
the variable. Educational status was dichotomised into ‘have not completed matric versus 
completed matric or higher education’. All the cases (320) could be analysed after 
dichotomising the variable. Employment status was categorised into ‘unemployed versus 
employed full or part time’. There were 296 cases that could be analysed after dichotomising 
the variable. Finally, marital status was categorised into ‘single versus married’. There were 
295 cases that could be analysed after dichotomising the variable. Comparisons could not be 
made between males and females as there were too few males in the sample. Results indicated 
that participants who had completed matric or higher education demonstrated a higher level of 
altruism [t(319) = 8.23, p < 0.05], and more positive attitudes towards trial participation 
[t(319) = 6.36, p < 0.05] than participants who had not completed matric. (Table 4 begins on 
the next page). 
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Table 4 
 
Tests of Between-groups Effects 
 
 
Variable 
 
 
t 
 
df 
 
p 
 
Annual household income 
       WTP 
       Attitude 
       Subjective norms 
       PBC 
       Mistrust 
       Knowledge 
       Altruism 
       Perceived risk 
 
 
 
0.68 
0.73 
0.84 
1.92 
0.06 
3.45 
0.51 
0.17 
 
86 
 
 
 
0.41 
0.39 
0.36 
0.16 
0.80 
0.06 
0.47 
0.67 
Educational status 
       WTP 
       Attitude 
       Subjective norms 
       PBC 
       Mistrust 
       Knowledge 
       Altruism 
       Perceived risk 
 
 
0.33 
6.36 
0.02 
2.65 
2.36 
0.55 
8.23 
0.58 
319  
0.56 
0.01* 
0.88 
0.10 
0.12 
0.45 
0.01* 
0.58 
Employment status 
       WTP 
       Attitude 
       Subjective norms 
       PBC 
       Mistrust 
       Knowledge 
       Altruism 
       Perceived risk 
 
 
2.33 
0.13 
2.12 
0.09 
0.07 
1.56 
0.35 
0.45 
295  
0.12 
0.71 
0.14 
0.23 
0.78 
0.21 
0.55 
0.50 
(Table continues); *p < 0.05
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(Continued) 
 
Variable 
 
 
t 
 
df 
 
p 
 
Marital status 
       WTP 
       Attitude 
       Subjective norms 
       PBC 
       Mistrust 
       Knowledge 
       Altruism 
       Perceived risk 
 
 
 
0.08 
1.95 
0.11 
1.63 
0.37 
0.01 
1.04 
2.47 
 
294 
 
 
0.77 
0.16 
0.70 
0.20 
0.54 
0.92 
0.30 
0.11 
 
 
4.5 The Willingness to Participate Scale (WTPS) (Table 5)  
 
The WTPS demonstrated excellent internal reliability (α = 0.90). Item-by-item descriptive 
analyses and item-total correlation coefficients provided additional evidence for the internal 
consistency of the measure (Table 5 begins on the next page). 
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Table 5 
 
Item-by-item Descriptive Analyses for the WTPS 
 
 
Item 
 
Item-
total r 
 
 
α-iid† 
 
M 
 
SD 
 
1. Knowing more about the possible benefits of an HIV 
vaccine would make me… 
 
 
0.43** 
 
0.90 
 
4.30 
 
1.23 
2. Having more information about how to cope with 
possible side effects of an HIV vaccine would make 
me… 
 
0.47** 0.90 4.20 1.25 
3. Knowing that participating in an HIV vaccine trial 
would help stop the AIDS pandemic would make me… 
 
0.43** 0.90 4.10 1.22 
4. Receiving free medical care for trial-related illnesses 
would make me… 
 
0.43** 0.90 4.27 1.16 
5. The fact that participating in an HIV vaccine trial would 
be a new experience for me would make me… 
 
0.49** 0.90 4.25 1.14 
6. If I were regarded as a role model because of my 
participation in an HIV vaccine trial would be… 
 
0.56** 0.89 4.12 1.29 
7. Receiving money in return for enrolling in an HIV 
vaccine trial would make me… 
 
0.51** 0.90 3.97 1.39 
8. The possibility of falsely testing HIV positive would 
make me…    
 
0.46** 0.90 3.38 1.48 
9. If my friends approved of my participation in an HIV 
vaccine trial I would be… 
 
0.46** 0.90 3.72 1.35 
10. If I were certain that HIV vaccine researchers have my 
best interests at heart I would be… 
 
0.48** 0.90 4.18 1.26 
11. Knowing more about the possible shortcomings of HIV 
vaccines would make me…  
 
0.55** 0.90 3.91 1.39 
(Table continues); † Cronbach’s alpha (α) if item deleted; **p < 0.01 
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(Continued) 
 
Item 
 
Item-
total r 
 
 
α-iid† 
 
M 
 
SD 
 
12. If there was a risk of being infected with HIV from the 
HIV vaccine being tested I would be…  
 
 
0.41** 
 
0.90 
 
4.02 
 
1.62 
 
13. If participating in an HIV vaccine trial were to take up a 
lot of my time I would be… 
 
 
0.58** 
 
0.89 
 
4.26 
 
1.39 
14. The possibility that I would receive injections in an HIV 
vaccine trial would make me… 
 
0.53** 0.90 3.35 1.40 
15. If my partner were to refuse to have sex with me 
because of my participation in an HIV vaccine trial I 
would be… 
 
0.39** 0.90 3.80 1.48 
16. The possibility of being discriminated against by others 
because of my participation in an HIV vaccine trial 
would make me… 
 
0.54** 0.90 4.24 1.37 
17. The possibility of experiencing mild side effects from 
the HIV vaccine being tested would make me… 
 
0.47** 0.90 4.11 1.43 
18. If transportation to and from the HIV vaccine trial site is 
expensive I would be… 
 
0.49** 0.90 3.45 1.47 
19. HIV vaccine researchers who are clearly trustworthy 
would make me… 
 
0.36** 0.90 3.85 1.33 
20. If I were to lose my job as a result of participating in an 
HIV vaccine trial I would be…  
 
0.49** 0.90 3.17 1.39 
21. Being tested for HIV by medically trained HIV vaccine 
researchers would make me… 
 
0.47** 0.90 3.54 1.03 
22. The possibility that my partner might leave me because 
of my participation in an HIV vaccine trial would make 
me… 
 
0.58** 0.89 3.51 1.33 
(Table continues); † Cronbach’s alpha (α) if item deleted; **p < 0.01 
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(Continued) 
 
Item 
 
Item-
total r 
 
 
α-iid† 
 
M 
 
SD 
 
23. The possibility that members of my church might react 
negatively to my participation in an HIV vaccine trial 
would make me… 
 
 
0.54** 
 
0.90 
 
4.02 
 
1.36 
24. If other people thought I was HIV positive because of 
my participation in an HIV vaccine trial I would be… 
 
0.59** 0.89 3.07 1.28 
25. If my partner approved of my participation in an HIV 
vaccine trial I would be… 
 
0.48** 0.90 3.79 1.34 
26. Free transportation to and from the HIV vaccine trial 
site would make me… 
 
0.39** 0.90 3.85 1.20 
27. The possibility of becoming slightly ill from the HIV 
vaccine being tested would make me… 
 
0.45** 0.90 3.37 1.48 
28. If participating in an HIV vaccine trial fitted into my 
daily routine I would be…  
 
0.46** 0.90 4.43 1.36 
29. If HIV vaccine researchers participated in HIV vaccine 
trials themselves I would be… 
 
0.50** 0.90 3.40 1.19 
30. If I had a guarantee from HIV vaccine researchers that 
the HIV vaccine being tested is safe I would be… 
 
0.51** 0.90 3.62 1.23 
31. If my family reacted negatively to me because of my 
participation in an HIV vaccine trial I would be… 
 
0.42** 0.90 4.08 1.32 
32. Being questioned by HIV vaccine researchers about my 
sexual behaviour would make me… 
 
0.43** 0.90 3.19 1.30 
33. The possibility of receiving a placebo and not the HIV 
vaccine being tested makes me…  
 
0.50** 0.90 4.43 1.57 
34. If my community reacted negatively to me because of 
my participation in an HIV vaccine trial I would be… 
 
0.51** 0.90 3.43 1.27 
(Table continues); † Cronbach’s alpha (α) if item deleted; **p < 0.01 
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(Continued) 
 
Item 
 
Item-
total r 
 
 
α-iid† 
 
M 
 
SD 
 
35. The possibility that I may not benefit personally from 
participating in an HIV vaccine trial would make me… 
 
 
0.45** 
 
0.90 
 
3.48 
 
1.35 
† Cronbach’s alpha (α) if item deleted; **p < 0.01 
 
4.5.1 Factor structure of the WTPS (Figure 5 and Table 6) 
 
Based on an analysis of the scree plot (Figure 5 is presented on the next page) and Kaiser’s 
(1960, 1974) criteria of eigenvalues greater than 1, seven factors were extracted accounting 
for 53.15% of the variance. The first factor, Social approval and trust, included four items and 
accounted for 23.87% of the variance in the model (eigenvalue = 8.35). The second factor, 
Stigmatisation, included five items and accounted for 10.21% of the variance in the model 
(eigenvalue = 3.57). The third factor, Personal costs, included four items and accounted for 
4.80% of the variance in the model (eigenvalue = 1.68). The fourth factor, Personal gains, 
included five items and accounted for 4.08% of the variance in the model (eigenvalue = 1.42). 
The fifth factor, Personal risks, included four items and accounted for 3.51% of the variance 
in the model (eigenvalue = 1.23). The sixth factor, Convenience, included three items and 
accounted for 3.39% of the variance in the model (eigenvalue = 1.18). The seventh factor, 
Safety, included four items and accounted for 3.09% of the variance in the model (eigenvalue 
= 1.08) (Table 6 is presented on page 80). 
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Figure 5. Scree plot of factors to be extracted (Eigenvalue ≥ 1) 
________________________________________________________________________ 
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Table 6 
 
Principal Components Exploratory Factor Analysis of the WTPS 
 
 
 
Item 
 
 
Description 
 
F1 
 
F2 
 
F3 
 
F4 
 
F5 
 
F6 
 
F7 
 
9 
 
Friends approval 
 
0.79 
 
0.04 
 
-0.08 
 
-0.00 
 
0.01 
 
0.08 
 
-0.14 
6 Seen as role model 0.58 -0.00 0.00 0.26 -0.08 0.02 0.08 
10 My interests at heart 0.56 -0.08 0.07 0.07 -0.12 -0.02 0.25 
11 Knowledge of vaccine shortcomings 0.48 -0.02 0.11 0.26 0.09 -0.05 0.06 
13 Having time to participate 0.32 0.08 0.27 -0.07 0.20 0.16 0.23 
34 Negative community reactions 0.18 0.76 -0.11 0.05 0.03 -0.10 -0.01 
31 Negative family reactions -0.05 0.73 -0.00 0.11 0.04 0.12 -0.28 
23 Negative church reactions -0.08 0.68 0.08 -0.02 0.03 0.05 0.16 
24 Perception of being HIV positive -0.00 0.67 0.10 0.07 -0.10 0.03 0.12 
27 Becoming slightly ill  -0.11 0.51 0.20 -0.02 0.09 0.24 0.12 
18 Transportation expenses -0.09 -0.00 0.75 0.08 -0.06 0.12 -0.06 
20 Lose job 0.01 0.13 0.71 -0.03 0.00 -0.04 -0.09 
17 Mild side effects 0.07 0.00 0.63 0.10 0.12 -0.08 0.12 
22 Partner might leave 0.09 0.38 0.48 -0.06 -0.16 -0.05 0.08 
2 Side effects information -0.00 0.11 0.04 0.78 -0.08 -0.11 0.00 
3 Help stop AIDS 0.09 0.11 -0.06 0.73 0.01 0.12 -0.11 
4 Free medical care 0.13 0.00 0.03 0.68 -0.04 0.02 -0.08 
1 Knowing the benefits of vaccine -0.01 -0.07 -0.12 0.64 0.07 -0.06 0.22 
5 New experience -0.05 -0.04 0.19 0.55 0.03 0.13 0.02 
19 Trustworthy researchers 0.22 -0.00 0.21 0.16 -0.60 -0.03 0.16 
12 Risk of HIV infection 0.15 0.10 0.25 0.08 0.58 -0.13 0.13 
32 Questions about sexual behaviour 0.27 0.07 0.14 -0.03 -0.44 0.01 0.10 
8 Falsely testing HIV positive 0.33 -0.01 0.35 -0.01 0.40 0.18 -0.07 
15 Partner refuses sex 0.04 0.22 0.07 -0.13 0.39 -0.13 0.35 
28 Fit into daily routine -0.03 -0.00 0.15 -0.01 -0.01 0.72 0.05 
26 Free transportation 0.08 0.10 -0.25 0.21 0.09 0.64 0.14 
25 Partner approval 0.35 0.09 0.01 -0.07 -0.17 0.49 -0.02 
35 May not benefit personally -0.02 0.25 0.04 0.05 -0.01 0.03 0.00 
33 Receiving a placebo 0.09 0.29 0.21 0.03 0.13 0.13 -0.16 
7 Receiving monetary compensation 0.28 0.10 -0.10 0.16 -0.11 0.09 0.17 
29 Participation by researchers 0.12 0.13 -0.14 0.01 -0.05 0.24 0.59 
30 Vaccine guaranteed to be safe 0.11 0.11 -0.00 0.15 -0.23 0.20 0.51 
21 Medically trained researchers -0.15 -0.12 0.18 0.22 -0.13 0.23 0.46 
16 Discrimination by others 0.08 0.39 0.15 -0.00 0.12 -0.26 0.45 
14 Receiving injections 0.16 -0.19 0.12 0.13 0.14 0.13 0.35 
Eigenvalue  8.35 3.57 1.68 1.42 1.23 1.18 1.14 
Cumulative % 
 
 23.8 7 34.08 38.89 42.97 46.48 49.88 53.15 
F1 = Social approval and trust; F2 = Stigmatisation; F3 = Personal costs; F4 = Personal gains; F5 = Personal risks;  
F6 = Convenience; F7 = Safety. 
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4.5.2 Exploratory factor analysis diagnostics 
 
The Kaiser-Meyer-Olkin statistic, which provides an indication of the appropriateness of 
factor analysis, yielded a value of 0.86. According to Kaiser (1974), values greater than 0.5 
are acceptable, values between 0.7 and 0.8 are good, and values exceeding 0.8 are excellent. 
As such, factor analysis was deemed to be appropriate. An examination of the inter-item 
correlation matrix showed that all the items were significantly correlated with one another 
indicating that no items were required to be deleted. Bartlett’s test of sphericity was 
significant (p < 0.001) indicating that the inter-item correlation matrix was significantly 
different from an identity matrix. Regarding multicollinearity, an analysis of the determinant 
of the inter-item correlation matrix revealed that none of the items correlated excessively with 
one another (r > 0.8), again indicating that no items were required to be deleted. 
 
4.6 Application and extension of the Theory of Planned Behavior  
 
4.6.1 Two-step linear hierarchical multiple regression analysis (Table 7) 
 
At step 1 of the analysis, attitudes, subjective norms, and perceived behavioural control, were 
entered simultaneously and significantly accounted for 6.4% (R² = 0.06, 95% CI 0.01-0.10) of 
the variance in WTP [F(3, 316) = 7.16, p < 0.001]. According to guidelines by Cohen (1988), 
the squared multiple correlation coefficient yielded a small effect size (ƒ2 = 0.06)3. At step 2 
of the analysis, attitudes, subjective norms, perceived behavioural control, mistrust, 
                                                 
3 f2 values of 0.02, 0.18, and 0.40 are considered small, medium, and large, respectively (Cohen, 1988). 
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knowledge, altruism, and perceived risk of HIV infection were entered simultaneously and 
significantly accounted for 10.2% (R² = 0.10, 95% CI: 0.06-0.13) of the variance in WTP 
[F(7, 312) = 5.06, p < 0.001]. According to guidelines by Cohen (1988), the squared multiple 
correlation coefficient yielded a small to medium effect size (ƒ2 = 0.11). At step one, 
subjective norms was the only significant predictor ( = -0.23, t = -4.32, p < 0.01). At step 2, 
significant predictors were subjective norms ( = -0.19, t = -2.88, p < 0.01), mistrust of 
researchers ( = -0.14, t = 2.07, p < 0.05), altruism ( = 0.15, t = 2.14, p < 0.05), and 
perceived risk of HIV infection ( = 0.12, t = 2.17, p < 0.05) (Table 7 is presented on the next 
page). 
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Table 7 
 
Summary of Two-step Linear Hierarchical Multiple Regression Analysis for Variables 
Predicting WTP  
 
 
Step and predictor variable 
 
 
R²  
 
 
ΔR² 
 
B 
 
SE 
 
 
 
p 
 
ƒ2 
 
Step 1 
 
0.06 
     
0.00** 
 
0.06 
 
       Attitude 
 
  0.09 0.13 0.04 0.45  
      Subjective norms 
 
  -1.19 0.27 -0.23 0.00**  
      Perceived behavioural control 
 
  -0.53 0.50 -0.05 0.28  
Step 2 
 
0.10 0.03    0.00** 0.11 
      Attitude  
 
  0.18 0.13 0.07 0.16  
      Subjective norms 
 
  -0.99 0.34 -0.19 0.00**  
      Perceived behavioural control 
 
  -0.02 0.53 0.00 0.99  
      Mistrust 
  
  -0.38 0.38 -0.14 0.04*  
      Knowledge 
 
  0.45 0.38 0.06 0.24  
      Altruism 
 
  0.61 0.42 0.15 0.03*  
      Perceived risk 
 
  0.78 0.36 0.12 0.03*  
*p < 0.05; **p < 0.01; R² = Variance explained; ΔR² = Change in variance explained; B = 
Unstandardised beta coefficient; SE = Standard error for unstandardised beta coefficient;  = 
Standardised beta coefficient; ƒ2 = Cohen’s effect size measure for the squared multiple 
correlation coefficient.
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4.6.2 Regression diagnostics (Figure 6 and Figure 7) 
 
The Kolmogorov-Smirnov test of normality revealed that the distribution of standardised 
residuals was normally distributed [D(319) = 0.47, p = 0.07] (Figure 6 is presented below). 
The Durbin-Watson statistic yielded a value of 2.05. The standardised residuals were 
therefore considered to be independent. Although boxplots revealed the presence of several 
outliers, no Cook’s distances exceeded 1. As such, none of the outliers exerted undue 
influence over the regression model. Examination of the standardised residuals/ standardised 
predicted values plot showed that the assumptions of homoscedasticity and linearity were met 
(Figure 7 is presented on the next page). Finally, the VIF statistic yielded values well below 
10 indicating that no significant multicollinearity between predictor variables was present. 
 
 
 
Figure 6. Histogram and normal probability plot of the standardised residuals. 
_____________________________________________________________________ 
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Figure 7. Standardised residuals/standardised predicted values plot  
___________________________________________________________________________ 
 
 
4.7 Summary of findings 
 
The sample consisted mainly of disadvantaged Black females between the ages of 16 to 49 
years. Independent samples t-tests revealed that participants who were more educated 
demonstrated a higher level of altruism and more positive attitudes towards trial participation 
than less educated participants. The WTPS demonstrated excellent internal consistency and an 
EFA revealed the presence of seven latent factors. The factors accounted for 53.15% of the 
variance in WTP and were: (i) Social approval and trust; (ii) Stigmatisation; (iii) Personal 
costs; (iv) Personal gains; (v) Personal risks; (vi) Convenience; and (vii) Safety. A two-step 
linear hierarchical multiple regression analysis showed that the linear combination of 
attitudes, subjective norms, and perceived behavioural control significantly accounted for 
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6.4% of the variance in WTP, yielding a small effect size. Moreover, the linear combination 
of attitudes, subjective norms, perceived behavioural control, mistrust, knowledge, altruism, 
and perceived risk of HIV infection significantly accounted for 10.2% of the variance in 
WTP, yielding a small to medium effect size. Subjective norms, mistrust of researchers, 
altruism, and perceived risk of HIV infection were significant independent predictors of WTP. 
A reduction in normative pressure and mistrust of researchers, and an increase in altruism and 
perceived risk of HIV infection were significantly associated with an increase in WTP.    
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CHAPTER 5 
DISCUSSION AND CONCLUSION 
 
5.1 Introduction 
 
According to the most recent data available on the prevalence and incidence of HIV 
(UNAIDS, 2007), South Africa continues to be the country with the largest number of HIV 
infections in the world. While various behaviour change initiatives have been implemented 
with the goal of reducing the spread of HIV/AIDS, these initiatives have been suboptimal as 
the pandemic shows no sign of abating (Sahay et al., 2005). As such, an HIV vaccine is likely 
to be an important development as a biological agent may circumvent some of the challenges 
of initiating widespread behaviour change. A challenge to the development of an efficacious 
vaccine, however, is the recruitment of several thousands of participants who need to be HIV 
negative but at high risk of HIV infection (Slack et al., 2005). There are therefore important 
ethical (Kerns, 1997; Lindegger & Richter, 2000; Lindegger et al., 2000) and 
sociobehavioural (Smit et al., 2005) issues need to be considered before large scale HIV 
vaccine trials can commence.  
 
One of the key sociobehavioural issues concerns the willingness of individuals at high risk of 
HIV infection to participate in HIV vaccine trials. A review of the WTP literature revealed 
two important research needs. Firstly, a reliable and valid psychometric measure of WTP has 
not yet been developed. Secondly, there is a paucity of theory to guide studies of WTP. 
Accordingly, the first objective of this thesis was to construct a psychometric measure of 
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WTP, and to derive the exploratory factor structure of the measure. The second objective was 
to examine the extent to which the Theory of Planned Behavior (TPB) could predict variance 
in WTP, and to determine whether the TPB was strengthened by the inclusion of mistrust of 
researchers, knowledge of HIV vaccines and HIV vaccine trials, altruism, and perceived risk 
of HIV infection as additional predictor variables. 
 
Results indicated that the Willingness to Participate Scale (WTPS) is a reliable measure of 
WTP among the most eligible Black individuals in the Western Cape of South Africa. The 
WTPS also displayed initial construct validity, as evidenced by the presence of seven latent 
factors that reflected various inhibitors and facilitators of WTP that have been identified in the 
literature. The factors accounted for 53.15% of the variance in WTP, and were: (i) Social 
approval and trust; (ii) Stigmatisation; (iii) Personal costs; (iv) Personal gains; (v) Personal 
risks; (vi) Convenience; and (vii) Safety.  
 
Regarding the second objective, the linear combination of the TPB variables (attitudes, 
subjective norms, and perceived behavioural control) significantly accounted for 6.4% of the 
variance in WTP, yielding a small effect size. Furthermore, the linear combination of the TPB 
variables, together with mistrust of researchers, knowledge, altruism, and perceived risk of 
HIV infection significantly accounted for 10.2% of the variance in WTP, yielding a small to 
medium effect size. A reduction in normative pressure and mistrust of researchers, and an 
increase in altruism and perceived risk of HIV infection were significantly associated with an 
increase in WTP.  
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This chapter begins with a discussion of the study limitations, and an evaluation of the extent 
to which the sample represented the population of Masiphumelele residents. Thereafter, the 
factor structure of the WTPS is discussed and the applicability of the TPB in this context is 
examined. Finally, the conclusions drawn from this study are presented and implications for 
further research are considered. 
 
5.2 Limitations of the study 
 
The results of this study should be interpreted against the backdrop of several limitations. 
Firstly, the level of literacy among the participants was low. As such, there is doubt as to 
whether the participants completed the measures accurately. Low levels of literacy in 
developing country setting such as South Africa is a common hurdle for quantitative research 
projects which employ psychometric instruments (Foxcroft, 1997). Furthermore, cross-
cultural translation and adaptation of psychometric instruments is fraught with 
methodological, conceptual, and linguistic difficulties (Beaton et al., 2000; Kulich et al., 
2008; Van de Vijver & Hambleton, 1996). While every effort was made to ensure the validity 
of the translated questionnaires, it is possible that there may have been conceptual 
incongruence between some items.  
 
In addition to issues of literacy and cross-cultural adaptation, the use of Western techniques of 
psychological testing is also politically-laden. According to Stead (2002, p. 87), 
“psychometric issues have figured prominently in debates on transformation in psychology as 
they were firmly embedded in western psychology and its related cultural assumptions”. The 
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problems with psychometric measures notwithstanding, anti-psychometric test lobbyists have 
yet to provide alternative methods of assessment (Stead, 2002). So while the use of 
questionnaires in developing country settings is admittedly problematic, there are no suitable 
alternatives as yet to assess relationships between variables in large samples of individuals.  
 
Another limitation of the study is the possibility of systematic differences between those who 
made their way into the sample and those who did not. For example, it is possible that 
individuals who were unaware of the study, individuals who refused to participate, and 
individuals who were away at the time of questionnaire administration may have been 
systematically different to those who did participate. Similarly, there may also have been 
systematic differences between those who successfully completed the questionnaire packet (n 
= 320) and those that did not (n = 79). Participants who did not complete the questionnaire 
successfully may have had time constraints or lower levels of literacy than those who did 
successfully complete the questionnaire. A possible cause of the large number of poorly 
completed questionnaire packets is the fact that it was protracted, owing to the many variables 
that were measured. Questionnaire fatigue may also have prevented participants from 
completing the final items in the questionnaire accurately. Finally, it is possible that the 
results may have been confounded by social desirability bias and demand characteristics, 
given that the study was about the willingness of individuals to help others. 
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5.3 The representativeness of the sample    
 
As this study employed a convenience sampling procedure, there is doubt as to whether the 
sample is representative of the population of Masiphumelele residents. To gauge the 
generalisability of the results of this study, I compared the demographic characteristics of the 
sample to the demographic make-up of Masiphumelele according to the most recent South 
African census data (Statistics South Africa [SSA], 2001). In some ways the sample 
adequately represented the population of Masiphumelele. For example, census data showed 
that 97.1% of the Masiphumelele residents in 2001 were Black individuals and 91.5% spoke 
Xhosa as a first language. In the sample, 100% were Black individuals and 98.1% spoke 
Xhosa as a first language. Regarding the educational level of the population according to the 
census data, 5.4% reported no formal education, 27.1% had attended and completed primary 
school, 45.1% had attended high school but did not complete matric, 18.9% had completed 
matric, and 0.7% had received higher education. Similar proportions were observed in the 
sample, as 6.3% reported no formal education, 33.1% had completed primary school, 42.2% 
had attended high school but did not complete matric, 16.3% had completed matric, and 0.6% 
had received higher education.  
 
Nonetheless, there was divergence between the sample and the population in terms of age, 
gender proportions, and unemployment levels. Regarding age, census data show that 64.5% of 
the population were between the ages of 18 and 54 in 2001. In the sample however, a much 
larger proportion of individuals were from a similar age cohort (92.2% were between the ages 
of 16 and 49 years). The larger proportion of individuals between late teens and middle-age 
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suggests that the sample may not be representative of the population in terms of age. 
However, there is a major benefit to having over-sampled this age cohort: South Africans 
between the ages of 15 and 49 years are at highest risk of HIV infection (Shisana et al., 2005; 
UNAIDS, 2007). This cohort will therefore be most eligible to participate in an HIV vaccine 
trial. It might therefore be more of a strength than a weakness that the results of this study 
apply more acutely to individuals between late teens and middle age.  
 
Regarding gender, half of the population (50.4%) were male according to the census data but 
only 10.3% were male in the sample. The under-representation of males in this study means 
that differences between men and women on the dependent variables could not be established. 
Also, the results of this study may not be generalisable to the population of men in 
Masiphumelele. Even so, there are some benefits to having over-sampled women. For 
example, women in sub-Saharan Africa carry a disproportionately large burden of the disease 
(UNAIDS, 2007). Various factors, both biological and socioeconomic, have contributed to 
this skew. Biologically, the susceptibility of the vaginal tract makes women more likely than 
men to contract HIV during unprotected sexual intercourse (Wassenaar et al., 2005). 
Additionally, STDs are more likely to be asymptomatic in women than in men, which 
increases women’s risk of HIV infection (Wilkinson et al., 1999). Finally, the practice of ‘dry 
sex’, or sex where vaginal lubrication is impeded, can lead to increased tearing of the vaginal 
membranes resulting in an increased risk of HIV infection (Bass & Jefferys, 2001). 
Socioeconomically, South Africa women experience high levels of gender inequality and 
intimate partner violence (Mills et al., 2006a). These factors in turn have both been shown to 
be important determinants of women’s HIV risk after controlling for age, current relationship 
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status, and woman’s HIV-risk behaviour (Dunkle et al., 2004). In addition to gender 
inequality, many women are reliant on men for economic subsistence (Basuki et al., 2002). 
These factors together make it very difficult for women to negotiate condom use with their 
partners (Fassin & Schneider, 2003). For these reasons, it is important to understand the 
barriers and facilitators of WTP among women more specifically if they are to benefit from 
the development of an HIV vaccine. The over-representation of women in this study may 
therefore be a positive aspect of the study rather than a limitation. 
 
Regarding levels of unemployment, census data suggest that 58.9% of the population of 
Masiphumelele residents in 2001 were unemployed. In the sample however, 76.3% reported 
being unemployed. The difference may indicate an increase in unemployment in the period 
between 2001 and 2006 when the data for this study were collected. Alternatively, residents 
who were employed may have been under-represented. This possibility is likely as I collected 
data during office hours when employed individuals were at work. Considering that the poor 
bear the brunt of the HIV pandemic (Gilbert & Walker, 2002), it may be beneficial that the 
unemployed be more acutely represented in this study. 
 
In sum then, the sample seemed to represent the population of Masiphumelele in terms of 
ethnicity, predominant language spoken, and educational level. However, the sample over-
represented women, the unemployed, and those between late teens and middle age. 
Considering that Black women between the ages of 15 and 49 years who reside in urban 
informal settlements are at highest risk of HIV infection in South Africa, the skew in the 
sample may actually be beneficial rather than problematic. The results of this study are 
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thought to be generalisable to the most eligible Black HIV vaccine trial participants in the 
Western Cape of South Africa. 
 
5.4 Factor structure of the WTPS 
 
The factor structure of the WTPS was very difficult to interpret. The latent constructs that the 
factors represented were somewhat tricky to identify and name, and several factors seemed to 
overlap substantially. It is therefore paramount that future research be done to confirm the 
factor structure of the WTPS in a similar sample. Each of the factors is discussed in turn. 
 
5.4.1 Social approval and trust 
 
This factor was complex, as items measuring two seemingly independent dimensions of WTP 
loaded onto the same factor. The first dimension of the factor reflected participants’ desire to 
receive social rewards for participating in an HIV vaccine trial, such as approval from friends 
and being considered a role model to others. The second dimension reflected participants’ 
concerns over the trustworthiness of HIV vaccine researchers. Areas of concern were the 
extent to which vaccine researchers have trial participants’ interests at heart, and being made 
aware of the possible shortcomings of a candidate HIV vaccine.  
 
In the first Phase of this study, participants indicated that they would be more likely to 
participate if their families and community reacted positively towards their decision to 
participate (Swartz et al., 2006). Similarly, Jenkins et al. (2000) found that recognition from 
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family and friends was an important facilitator of WTP among Royal Thai army conscripted 
recruits. With regard to participation in clinical trials generally, the desire for approval from 
others has been shown to be a facilitator of enrolment. For example, Ross et al. (1999) 
conducted a systematic review of peer-reviewed research articles reporting barriers to 
participation in randomised controlled trials. They found that five peer-reviewed research 
papers reported that a lack of social rewards and recognition was a significant inhibitor of 
clinical trial enrolment.  
 
Regarding the second dimension of this factor, participants expressed concern over the 
trustworthiness of HIV vaccine researchers. Areas of concern included the extent to which 
vaccine researchers have trial participants’ interests at heart, and the degree to which 
researchers will communicate possible shortcomings of a candidate HIV vaccine. Mistrust of 
medical researchers, drug companies, and governmental organisations has been frequently 
reported to be an inhibitor of WTP in an HIV vaccine trial among both Whites and Blacks 
from developing and developed countries alike (Braunstein et al., 2008; Sengupta et al., 
2000). This issue will be discussed at greater length later on in the chapter.   
 
As mentioned previously, the factor ‘Social approval and trust’ seems to be factorially 
complex as two seemingly independent dimensions of WTP loaded together. It is conceivable 
that the participants in this study considered participating in an HIV vaccine trial an 
opportunity to show bravery by assisting potentially untrustworthy researchers. In return for 
their bravery, family members and members of the community may praise the individual who 
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in turn may be considered to be a role model to others. This hypothesis is purely speculative, 
however, and requires further research.  
 
5.4.2 Stigmatisation 
 
This factor reflected participants’ concern regarding the possibility of being stigmatised and 
discriminated against by others as a result of participating in an HIV vaccine trial. The fear of 
negative social consequences as a consequence of participating in an HIV vaccine trial has 
been reported to be a significant inhibitor of WTP in both Western and non-Western contexts. 
In a study that assessed reports of trial-related discrimination among 1516 US trial 
participants, 57.8% reported negative reactions from friends, family and co-workers following 
self-disclosure of trial participation (Allen et al., 2001). The researchers reported that a 
common reason for the negative social reactions was concern that the candidate vaccine may 
have deleterious health outcomes for trial participants. Participants also reported experiencing 
negative social reactions due to the assumption that participants in HIV vaccine trials are 
infected with HIV, or are at risk of becoming infected with HIV. Additionally, participants 
reported experiencing stigma as a result of vaccine-induced seropositivity. Problems 
experienced in this regard may to relate difficulty obtaining health or life insurance, 
restrictions on trial participants’ ability to travel abroad, being unable to donate blood, being 
overlooked by potential employers, and being disallowed to serve in the military (McCluskey 
et al., 2005). 
 
Stellenbosch University http://scholar.sun.ac.za
  
 
 
97 
 
Similar findings were reported by Sheon, Wagner, McElrath, Keefer, and Zimmerman (1998), 
who examined self-reported discrimination among 266 vaccine trial participants enrolled in an 
HIV vaccine trial in the US. Almost all of the participants (99%) reported some form of 
discrimination related to their participation in an HIV vaccine trial. The most common cause 
of negative social reactions was reported to be assumption that participants in HIV vaccine 
trials are infected with HIV. Some participants also reported experiencing employment 
problems and having applications for health and life insurance declined. While comparable 
results have been found in the South African context (Lesch et al., 2006; Giocos et al., 2007; 
Parker, 2005; Swartz et al., 2006), there is the possibility that social harms associated with 
participation in South African HIV vaccine trials could also manifest in domestic violence 
(Milford et al., 2007). As such, stigmatisation in the South African context could pose a 
unique problem to HIV vaccine researchers.  
 
5.4.3 Personal costs 
 
This factor reflected the participants’ concerns over health, financial, and interpersonal costs 
associated with participation in an HIV vaccine trial. With regard to health costs, participants 
expressed concern over possible HIV vaccine physical side-effects. Fear of vaccine side 
effects was also found in Part I of this study, and is concern that has been frequently voiced 
by potential trial participants all over the world (Mills et al., 2004, 2006b). For example, a 
study of gay and bisexual men in the US found that 28% of the participants cited fear of 
physical side-effects as an inhibitor of WTP (Hays & Kegeles, 1999). Fear of possible vaccine 
side-effects was also reported to be an inhibitor of WTP among a large sample of IDUs and 
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MSM in the US (Strauss et al., 2001). A study that examined reasons for declining to enrol 
among persons eligible for a Phase II prophylactic HIV vaccine trial yielded similar results 
(Newman, Daley, Halpenny, & Loutfy, 2008). The researchers found that behind the fear of 
vaccine-induced seropositivity, fear of potential long-term side-effects was the most important 
reason for declining to participate. In another US study, researchers found that the fear of 
physical side-effects was a salient concern among their sample of Latinos and Blacks 
(Newman et al., 2006).  
 
With regard to financial costs associated with participation in an HIV vaccine trial, 
participants indicated that transport costs associated with regular clinic visits would be a 
significant financial burden. In addition, participants were concerned about the perceived 
possibility that participating in an HIV vaccine trial may result in their losing their jobs. These 
findings have been widely reported among poor individuals in both developing and developed 
country contexts (Nyamathi et al., 2004; Sengupta et al., 2000; Swartz et al., 2006). As such, 
remuneration for transport costs has been a long-standing ethical guideline for HIV vaccine 
trial researchers. 
 
Regarding interpersonal costs, participants expressed concern that their sexual relationship(s) 
might be strained as their sexual partner(s) might refuse to engage in sex should they 
participate in an HIV vaccine trial. A further concern for the participants in this study was the 
possibility that their sexual partner(s) may leave for fear of being at increased risk of HIV 
infection. The fear of possible strained sexual relationships has commonly been reported to be 
a robust inhibitor of WTP (Mills et al. 2004; 2006b). Celentano et al. (1995) examined WTP, 
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perceived benefits, and perceived barriers to enrolment in HIV vaccine trials among 
participants at high risk of HIV infection in northern Thailand. The researchers found that 
approximately 36.5% of the participants were fearful that their sexual partner(s) might refuse 
sexual intercourse should they participate in an HIV vaccine trial. A similar finding was 
reported by Sahay et al. (2005) in their study of 349 Indian respondents of lower socio-
economic status at low and high risk for HIV infection. These findings are also congruent 
with those of Part I of this study (Swartz et al., 2006).  
 
5.4.4 Personal gains 
 
Personal gains reflected the participants’ desire to benefit personally from participating in an 
HIV vaccine trial. Perceived benefits included receiving free medical care, and the attainment 
of information regarding the development of candidate HIV vaccines. The provision of free 
medical care has been widely reported to be a significant facilitator of WTP (Kerns, 1997; 
McGrath et al., 2001; Parker, 2005). However, cost-free treatment is a controversial ethical 
issue. In developing countries such as South Africa, free medical care might be a gross 
incentive for impoverished individuals who do not understand that treatment will be provided 
for trial-related ill health only (Moodley et al., 2002; Slack et al., 2000, 2005). Therefore, a 
central issue relating to the recruitment of HIV vaccine trial volunteers is that of informed 
consent. According to Lindegger and Richter (2000), it is essential that vaccine trial 
volunteers fully comprehend several aspects of HIV vaccine trials, including the fact that they 
will only receive medication for trial-related illnesses.  
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Participants also expressed the desire to learn more about HIV vaccines. This finding has been 
widely reported in previous research. In a study that examined specific features of vaccine 
trial designs that might encourage participation among 73 MSM in the US, participants who 
expressed WTP indicated that they would like to learn more about HIV vaccines (McGrath et 
al., 2001). The desire to become more knowledgeable of HIV vaccines has also been reported 
by studies of lower-socioeconomic Black South Africans (Parker, 2005; Swartz et al., 2006). 
From the perspective of trial participants, it is possible that they wish to be informed of the 
workings of a candidate HIV vaccine in order to understand the potential health risks 
associated with participating in an HIV vaccine trial. From the perspective of HIV vaccine 
researchers, such knowledge is also a requirement for informed consent (Kerns, 1997; 
Lindegger & Richter, 2000; Lindegger, Slack, & Vardas, 2000).  
 
5.4.5 Personal risks 
 
This factor reflected participants’ perceived personal risks associated with participating in an 
HIV vaccine trial. Perceived risks included possibly contracting HIV from a candidate 
vaccine, and testing positive for HIV antibodies after receiving a candidate HIV vaccine. 
Participants were also concerned that providing intimate details of their sexual behaviour may 
be risky, as such information might be disclosed to others. The finding that eligible 
participants fear vaccine-induced HIV infection has been frequently reported by researchers in 
the US (Bartholow et al., 1997; Nyamathi et al., 2004), Thailand (Celentano et al., 1995), and 
South Africa (Parker, 2005; Swartz et al., 2006). The fear of contracting HIV from a vaccine 
has been reported to inhibit WTP among potential trial participants after even after they have 
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undergone educational workshops which deal with the issue of vaccine-induced infection 
(e.g.: Koblin et al., 2000). It is possible that potential participants simply do not understand 
the science behind how a vaccine operates, and therefore become fearful upon hearing that 
actual HI viruses are used in the making of an HIV vaccine (Leach & Fairhead, 2007). 
Alternatively, individuals might feel that there is a possibility that scientists are downright 
wrong, and that an HIV vaccine can in fact cause HIV infection. Researchers should aim to 
tests these hypotheses in future research.  
 
The finding that eligible participants fear the possibility of testing positive for HIV antibodies 
has also been well documented in both developing and developed contexts (Buchbinder et al., 
2004; Hays & Kegeles, 1999; Jenkins et al., 2000). As mentioned previously, testing positive 
for HIV antibodies after receiving a candidate vaccine is a result of the body’s response to the 
vaccine and not to HIV (Slack et al., 2000, 2005). As such, the participants’ perceived risk of 
vaccine-induced seropositivity and infection may be a function of low levels of knowledge of 
HIV vaccines. In the US, Newman et al. (2007) found that participants who reported to be 
fearful of vaccine-induced infection or seroconversion demonstrated poor knowledge of HIV 
vaccines and HIV vaccine trials. Similar results were reported by Yang et al. (2004) in a study 
that examined correlates of WTP in HIV/STD prevention intervention activities among 4,208 
migrants in China.  
 
The participants in this study stated that providing details of their sexual behaviour might 
entail a degree of risk, as intimate details may be disclosed to others. McCluskey et al. (2005) 
and Swartz et al. (2006) reported similar results. According to Mills et al. (2006b), 
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dissemination of intimate details may have deleterious effects on participants’ lives, as 
employment opportunities, family relations, and social acceptance may be compromised. HIV 
vaccine researchers should therefore take great measures to protect confidentiality and 
develop trusting relationships with potential trial participants. 
 
5.4.6 Convenience 
 
This factor highlighted the participants’ need for participating in an HIV trial to be 
convenient. Participants indicated that they would be less willing to enroll if a vaccine trial if 
participating will be time-consuming. Participants also reported the need for participating in 
an HIV vaccine trial to fit into their daily routines. These needs have been commonly reported 
in literature. According to Buchbinder et al. (2004), pragmatic obstacles are the most 
underestimated factor limiting potential participation in an HIV vaccine trial. In their study, 
which compared hypothetical and actual willingness to enroll in an HIV vaccine trial, 21% of 
the participants declined to participate based on competing time demands. Similar results 
were reported by Sahay et al. (2005) in their Indian sample. In addition to time constraints, 
conflicting familial constraints (Parker, 2005; Sahay et al., 2005) have also been reported to 
be significant inconveniences that may inhibit WTP. It is therefore important that HIV 
vaccine trials be organised in such a manner that participating be as convenience as possible 
for participants. Participants in Part I of this study reported that they would be less 
inconvenienced if vaccine trial sites were near to their homes or places of work (Swartz et al., 
2006). 
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5.4.7 Safety 
 
This factor reflected the participants’ concerns regarding possible dangers of a candidate 
vaccine, and social harms that may be incurred as a result of participating in an HIV vaccine 
trial. With regard to vaccine dangers, participants reported that they would feel safer if 
researchers guaranteed the safety of the candidate vaccine. This finding was also reported by 
Hays and Kegeles (1999) who found that participants in their sample of MSM expressed a 
lower level of WTP in the absence of assured vaccine safety by researchers. Participants in 
this study also reported that they would feel safer if medically-trained researchers 
administered the candidate vaccine, and if researchers were themselves participants. It is 
likely that participants would regard the participation of HIV vaccine researchers as evidence 
for the health safety of the candidate HIV vaccine (Swartz et al., 2006). Health concerns that 
have been reported previously include the fear of possible short and long term vaccine side-
effects, disability, or death (Celentano et al., 1995). With regard to reproductive health 
concerns, Rudy et al. (2005) reported that the women in their sample were fearful that 
receiving a candidate HIV vaccine may result in difficulties conceiving children, and that the 
a candidate vaccine may have negative effects on a foetus.  
 
Regarding social harms, participants expressed concern over possible stigma and 
discrimination from friends, family members, and the community at large as a result of their 
participation. This finding was also reported by Allen et al. (2001). Lesch et al. (2006) 
suggest that a major source of negative social reactions stems from the perception that HIV 
vaccine trial participants are infected with HIV, or may at least be at high risk of HIV 
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infection. Additionally, many people are unaware that testing positive for HIV antibodies 
during an HIV vaccine trial is a result of the body’s response to the candidate HIV vaccine 
and not necessarily to HIV (Jenkins et al., 2000; Sahay et al., 2005; Sheon et al., 1998). In 
contexts such as South Africa where there are high levels of gender inequality, social harms 
may even manifest in domestic violence (Milford et al., 2007). Possible social harms 
associated with participation in South African HIV vaccine trials should therefore be a key 
concern among vaccine researchers. 
 
5.5 Application of the Theory of Planned Behavior  
  
Results indicated that the theory performed sub-optimally, as little variance in WTP could be 
accounted for by the TPB variables. The performance of each TPB variable is discussed in 
turn. 
 
5.5.1 Attitudes 
 
The finding that attitudes towards participating in an HIV vaccine trial did not predict WTP is 
congruent with a study that examined the ability of the TPB to predict variance in WTP 
among 224 lower socioeconomic adolescents in South Africa (Giocos et al., 2007). As 
mentioned in Chapter 2, attitudes are thought to be influenced by behavioural beliefs 
regarding the behaviour. Research to date has provided empirical evidence for this assertion. 
For example, Armitage and Conner (1999b), who assessed the predictive validity and causal 
ordering of TPB constructs over a 3-month period, found that behavioural beliefs accounted 
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for up to 41% of the variance in attitudes. Considering that this study dealt with hypothetical 
WTP, it is conceivable that the participants may not yet have formulated behavioural beliefs 
regarding actual HIV vaccine trial participation. Furthermore, the potential lack of 
behavioural beliefs may be compounded by poor knowledge of HIV vaccine trials (Newman 
et al., 2007; Strauss et al., 2001; Yang et al., 2004).  
 
Despite the possibility that the participants in this study may not yet have formulated 
behavioural beliefs regarding participating in an HIV vaccine trial, Eiser (1994) argues that 
behavioural beliefs change over time according to the salience of the behaviour. Therefore, as 
HIV vaccine trials become more salient, and knowledge regarding HIV vaccines and HIV 
vaccine trials improves, it is possible that beliefs concerning participating may be developed. 
Consequently, attitudes towards participating may in future become crystallised among 
eligible participants. Future researchers should therefore re-evaluate the utility of the attitudes 
construct once HIV vaccine trials become more salient in South Africa. 
 
5.5.2 Subjective norms  
 
Subjective norms was the only independent TPB variable that significantly predicted WTP. 
This finding was also reported by Giocos et al. (2007) in their study of WTP among South 
African adolescents. A number of meta-analyses that have examined the efficacy of the TPB 
have concluded that subjective norms may be the weakest predictor of behavioural intentions 
(Godin & Kok, 1996; Sheppard, Hartwick, & Warshaw, 1988; Van den Putte; 1991). Some 
researchers have even advocated the exclusion of subjective norms altogether (Armitage & 
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Conner, 2001). The finding that perceived normative pressure was not only a robust predictor 
of WTP, but was the only significant predictor of WTP in this study and another South 
African study (Giocos et al., 2007) contradicts the results of the meta-analyses. Considering 
that the studies that were evaluated in the meta-analyses assessed the utility of the TPB in 
Western samples, the divergent findings may be a function of social and economic well-being. 
Alternatively, the divergent findings may be accounted for by different conceptions of selves 
and others between the West and the non-West.  
 
As mentioned previously, individuality is a primary objective in Western cultures where the 
‘self’ is separate from the ‘other’ (Cialdini et al., 1997; Moodley, 2005). The result is 
decision-making that is largely independent of the beliefs, values, and desires of others. In 
non-Western settings like South Africa however, the definition of ‘self’ is more fluid and 
transcends the boundaries of the individual body. Therefore, the decision to engage in a 
particular behaviour is principally influenced by the beliefs and attitudes of others towards 
that behaviour. Future research should aim to replicate this finding so as to evidence this 
argument. 
 
5.5.3 Perceived behavioural control  
 
Results indicated that perceived behavioural control did not predict WTP. Similar results were 
found by Giocos et al. (2007). As no large scale HIV vaccine trials were yet underway in 
South Africa at the time of this study, the participants would not have had prior experience 
with HIV vaccine trials. Given that prior experience is an important component of perceived 
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behavioural control, it is conceivable that the lack of experience may have contributed to the 
variable’s failure to predict WTP. Another important component of perceived behavioural 
control is an evaluation of one’s capacity to engage in a behaviour based on observing the 
experiences of salient others (Ajzen, 1988). As this study focused on hypothetical WTP only, 
the participants may not have explored issues of self-efficacy and control over trial 
participation. In addition to a lack of prior experience and social learning, it likely that the 
participants may not have been knowledgeable enough regarding the requirements of HIV 
vaccine trials to have considered issues of control over participating (Giocos et al., 2007). 
When HIV vaccine trials become more salient, and eligible participants become more 
knowledgeable of HIV vaccines and HIV vaccine trials, perceived behavioural control may in 
future predict WTP.  
 
5.6 Extension of the Theory of Planned Behavior   
  
Results indicated that the linear combination of TPB variables (attitudes, subjective norms, 
and perceived behavioural control), together with the additional predictor variables 
significantly increased the amount of variance explained from 6.4% to 10.2%. However, the 
squared multiple correlation coefficient yielded a small to medium effect size. As with the 
first model that tested the linear combination of TPB variables exclusively, subjective norms 
was the only TPB variable that significantly predicted WTP. Regarding the additional 
predictor variables, mistrust of researchers, altruism, and perceived risk of HIV infection were 
significant independent predictors. Each variable is discussed in turn. 
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5.6.1 Mistrust of researchers 
 
Results indicated that mistrust of researchers was a significant inhibitor of WTP in an HIV 
vaccine trial. This finding is congruent with those of previous studies in developed countries 
(Braunstein et al., 2008; Hays & Kegeles, 1999; Newman et al., 2006; Sengupta et al., 2000; 
Shavers et al., 2002) and in South Africa (Parker, 2005; Swartz et al., 2006). In the South 
African context, it is likely that high levels of mistrust of researchers may stem from 
memories of human rights violations during the colonial and apartheid years (Boone & 
Batsell, 2001; Nichter, 1995). In those periods, Blacks were exploited by white researchers as 
a result of their obvious vulnerability (Barsdorf & Wassenaar, 2005). It therefore follows that 
eligible Black HIV vaccine trial participants may be mistrustful of HIV vaccine researchers 
and powerful, White-controlled pharmaceutical companies (Baldwin–Ragaven et al., 1999). 
According to Nichter (1995), many Black Africans feel that Africa has been used as a 
laboratory for testing Western medicines; to the detriment of Blacks who do not benefit from 
the fruits of the clinical trials in which they participated.  
 
There is also scepticism and opposition to Western medicines such as vaccines (Leach & 
Fairhead, 2007). According to Ross et al. (2006), many Black Africans continue to believe 
Western HIV ‘medicines’ are merely a hidden political conspiracy to control the birth rates of 
Blacks, thereby allowing Whites to regain political control. Concerns over Western medicines 
have not been confined to the general public. Political leaders such as South African president 
Thabo Mbeki and Zimbabwean president Robert Mugabe have publicly stated that AIDS is 
not as big a problem as the West makes it out to be, and that HIV antiretroviral drugs are a 
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Western initiative to undermine African autonomy, traditional values, and cultural practices 
(Fassin & Schneider, 2003). Research also suggests that many Blacks, from both the US and 
Africa, believe that an efficacious vaccine has already been developed but is being kept from 
them (Allen et al., 2005). To ameliorate the high levels of mistrust among Black individuals, 
it is imperative that researchers develop trusting relationships with eligible Black participants. 
A failure to do so may result in lower WTP among eligible trial participants in South Africa.    
 
5.6.2 Knowledge of HIV vaccines and HIV vaccine trials  
 
Previous research findings suggest that a low level of knowledge of HIV vaccines and HIV 
vaccine trials may be an important inhibitor of WTP (e.g.: Strauss et al., 2001; Starace et al., 
2006). In contrast with these findings, this study found that knowledge was not a significant 
predictor of WTP. Similar results were found by Halpern et al. (2001) in their study of 610 
Philadelphia residents at high risk for HIV infection. It is possible that other concerns and 
issues relating to HIV vaccine trial participation may have been salient for the participants in 
this study. For example, latent factors that emerged from the WTPS included concerns over 
possible negative social consequences, potential personal costs and risks, and issues of 
convenience. Another possible reason for the null finding may be that the distribution of 
knowledge scores was significantly negatively skewed. The negative skewness indicated a 
ceiling effect, whereby most participants scored on the upper end of the spectrum of overall 
knowledge scores. The grouping of scores at the positive end of the continuum suggests that 
variance may have been artificially constrained, limiting power to detect significant effects.  
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5.6.3 Altruism 
 
Results indicated that altruism was a significant predictor of WTP in an HIV vaccine trial. 
This finding is congruent with previous research findings from the US (Buchbinder et al., 
2004; Nyamathi et al. (2004), Thailand (Jenkins et al., 2000; MacQueen et al., 1999), Brazil 
(Périssé et al., 2000), India (Sahay et al., 2005) and South Africa (Parker, 2005; Swartz et al., 
2006). Swartz et al. (2006) suggest that an altruistic desire to participate may be related to a 
high level of exposure to the deleterious effects of HIV. Considering that the prevalence of 
HIV is higher in South African informal settlements than anywhere else in the world 
(UNAIDS, 2007), exposure to HIV is potentially a useful variable to examine in future 
research involving South African samples. However, the question arises as to whether 
exposure to HIV results in a truly selfless desire to help those afflicted by the disease, or an 
egoistic desire to reduce aversive arousal evoked by seeing others dying from AIDS. One 
possible way of understanding altruism in African contexts is in terms of Ubuntu. As 
discussed previously, Ubuntu is an African philosophy whereby the common good of society 
comes before the good of any one individual (Venter, 2004). In such a case, an appeal to 
Ubuntu may increase the level of WTP among eligible South African participants (Moodley, 
2005). This is a tentative statement however, as it goes beyond the data of this study.  
 
5.6.4 Perceived risk of HIV infection  
 
Participants who perceived themselves to be at high risk of HIV infection expressed a higher 
level of WTP in an HIV vaccine trial. This finding supports those of previous studies in both 
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US and South Africa. A longitudinal study by Bartholow et al. (1997) assessed changing 
WTP over an 18 month period among 1267 MSM in the US. A perception of being highly 
susceptible to HIV infection was significantly associated with WTP at each assessment over 
the period of the study. In another US study mentioned previously, researchers compared 
hypothetical and actual willingness to enrol in a prophylactic HIV vaccine trial among 
participants previously enrolled in an HIV vaccine preparedness study (Buchbinder et al., 
2004). Participants who reported having at least five sexual partners in the previous six 
months expressed greater WTP in a future HIV vaccine trial. In South Africa, Smit et al. 
(2005) examined WTP among 198 individuals from an urban-informal community directly 
after their enrolment into an HIV vaccine preparedness study. Results indicated that WTP was 
significantly associated with self-perceived HIV risk.  
 
According to Swartz et al. (2006), many potential trial participants consider participating in an 
HIV vaccine trial an opportunity to become protected from HIV infection. Participants 
expressed the belief that a candidate HIV vaccine will certainly demonstrate efficacy and, as 
such, will guard against HIV infection. Participants in this study who considered themselves 
to be at high risk for HIV infection may have expressed WTP for this reason. Also, 
participants who perceived themselves to be at high risk of HIV infection may have expressed 
WTP so as to protect their sexual partner(s) from HIV infection (McGrath et al., 2001). As a 
candidate HIV vaccine may not necessarily provide protection from HIV infection, it is 
important that willing participants demonstrate adequate knowledge of HIV vaccines and HIV 
vaccine trials before they may be enrolled. 
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5.7 Conclusions 
 
Against the backdrop of the study limitations, this study yielded the first multidimensional 
measure of WTP in an HIV vaccine trial: the Willingness to Participate Scale (WTPS). 
Results suggest that the WTPS is a reliable measure of WTP among Black individuals in the 
Western Cape of South Africa who will be most eligible to participate in future HIV vaccine 
trials. The WTPS also displayed initial construct validity, as evidenced by the presence of 
seven latent factors that reflected inhibitors and facilitators of WTP that have been identified 
in the literature. This study also showed that the Theory of Planned Behavior (TPB) may not 
be a suitable theoretical framework for studying WTP in an HIV vaccine trial at this point in 
time. Finally, mistrust of researchers, altruism, and perceived risk of HIV infection were 
shown to be significant independent predictors of WTP among the population of interest. As 
these variables have also been shown to predict WTP in other contexts around the world, it 
seems that they may be universal predictors. While further research is required to evidence 
this statement, the identification of robust predictors may enable researchers to develop 
effective recruitment strategies that lead to sufficient numbers of trial participants, and ensure 
that trials are conducted in an ethical manner. 
 
The results of this study point to several areas that require further investigation. Future 
research should aim to validate the factor structure of the WTPS in both this and other 
samples. The large amount of unexplained variance in WTP after accounting for the effect of 
the TPB suggests that unmeasured variables are explaining much of the residual variance. 
These variables need to be identified and incorporated into a suitable theoretical 
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underpinning. A better understanding of complex variables such as knowledge of HIV 
vaccines and HIV vaccine trials may be achieved by examining their relationships with WTP 
over time. Longitudinal studies may also allow for an assessment of causal relationships if 
appropriate controls are in place. Finally, researchers should examine the relationship between 
witnessing the deleterious effects of HIV and WTP in an HIV vaccine trial. 
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APPENDIX A 
Below are some reasons people have given that would make them more or less likely to participate 
in a future HIV vaccine trial.  In each case please indicate how much this item would affect your 
decision to participate. For each statement, please indicate how much it would affect your decision to 
participate. 
 
The response options are as follows: 
 
1 = Would make me very willing to participate in a future HIV vaccine trial 
2 = Would make me somewhat willing to participate in a future HIV vaccine trial 
3 = Would not affect my decision either way  
4 = Would make me somewhat unwilling to participate in a future HIV vaccine trial 
5 = Would make me very unwilling to participate in a future HIV vaccine trial 
 
 1. Very 
willing 
2. 
Somewhat 
willing 
3. Would 
not affect 
my 
decision 
4. 
Somewhat 
unwilling 
5. Very 
unwilling 
1. Knowing more about the possible 
benefits of an HIV vaccine would 
make me… 
     
2. Having more information about how 
to cope with possible side effects of 
an HIV vaccine would make me… 
     
3. Knowing that participating in an HIV 
vaccine trial would help stop the 
AIDS pandemic would make me… 
     
4. Receiving free medical care for trial-
related illnesses would make me… 
     
5. The fact that participating in an HIV 
vaccine trial would be a new 
experience for me would make me… 
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 1. Very 
willing 
2. 
Somewhat 
willing 
3. Would 
not affect 
my 
decision 
4. 
Somewhat 
unwilling 
5. Very 
unwilling 
6. If I were regarded as a role model 
because of my participation in an 
HIV vaccine trial would be… 
     
7. Receiving money in return for 
enrolling in an HIV vaccine trial 
would make me… 
     
8. The possibility of falsely testing HIV 
positive would make me…    
     
9. If my friends approved of my 
participation in an HIV vaccine trial I 
would be… 
     
10. If I were certain that HIV vaccine 
researchers have my best interests 
at heart I would be… 
     
11. Knowing more about the possible 
shortcomings of HIV vaccines would 
make me…  
     
12. If there was a risk of being infected 
with HIV from the HIV vaccine being 
tested I would be…  
     
13. If participating in an HIV vaccine trial 
were to take up a lot of my time I 
would be… 
     
14. The possibility that I would receive 
injections in an HIV vaccine trial 
would make me… 
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 1. Very 
willing 
2. 
Somewhat 
willing 
3. Would 
not affect 
my 
decision 
4. 
Somewhat 
unwilling 
5. Very 
unwilling 
15. If my partner were to refuse to have 
sex with me because of my 
participation in an HIV vaccine trial I 
would be… 
     
16. The possibility of being discriminated 
against by others because of my 
participation in an HIV vaccine trial 
would make me… 
     
17. The possibility of experiencing mild 
side-effects from the HIV vaccine 
being tested would make me… 
     
18. If transportation to and from the HIV 
vaccine trial site is expensive I would 
be… 
     
19. HIV vaccine researchers who are 
clearly trustworthy would make me… 
     
20. If I were to lose my job as a result of 
participating in an HIV vaccine trial I 
would be…  
     
21. Being tested for HIV by medically 
trained HIV vaccine researchers 
would make me… 
     
22. The possibility that my partner might 
leave me because of my 
participation in an HIV vaccine trial 
would make me… 
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 1. Very 
willing 
2. 
Somewhat 
willing 
3. Would 
not affect 
my 
decision 
4. 
Somewhat 
unwilling 
5. Very 
unwilling 
23. The possibility that members of my 
church might react negatively to my 
participation in an HIV vaccine trial 
would make me… 
     
24. If other people thought I was HIV 
positive because of my participation 
in an HIV vaccine trial I would be… 
     
25. If my partner approved of my 
participation in an HIV vaccine trial I 
would be… 
     
26. Free transportation to and from the 
HIV vaccine trial site would make 
me… 
     
27. The possibility of becoming slightly ill 
from the HIV vaccine being tested 
would make me… 
     
28. If participating in an HIV vaccine trial 
fitted into my daily routine I would 
be…  
     
29. If HIV vaccine researchers 
participated in HIV vaccine trials 
themselves I would be… 
     
30. If I had a guarantee from HIV 
vaccine researchers that the HIV 
vaccine being tested is safe I would 
be… 
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 1. Very 
willing 
2. 
Somewhat 
willing 
3. Would 
not affect 
my 
decision 
4. 
Somewhat 
unwilling 
5. Very 
unwilling 
31. If my family reacted negatively to me 
because of my participation in an 
HIV vaccine trial I would be… 
     
32. Being questioned by HIV vaccine 
researchers about my sexual 
behaviour would make me… 
     
33. The possibility of receiving a placebo 
and not the HIV vaccine being tested 
makes me…  
     
34. If my community reacted negatively 
to me because of my participation in 
an HIV vaccine trial I would be… 
     
35. The possibility that I may not benefit 
personally from participating in an 
HIV vaccine trial would make me… 
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Ngezantsi kukho izizathu ezithi zinikwe ngabantu ezinokubenza babenomdla kakhulu okanye 
kancinci ekuthabatheni inxaxheba kwimizamo yogonyo olukhusela ukosulelwa yintsholongwane 
kaGawulayo kwilixa elizayo. Kwisivakalisi ngasinye bonisa ukuba olo luvo lungasichaphazela 
kangakanani na isigqibo sakho sokuthabatha inxaxheba. Kwintetho nganye, nceda ubonise ukuba 
ingasichaphazela kangakanani na isigqibo sakho sokuthabatha inxaxheba. 
 
Limpendulo onokukhetha kuzo zezi zilandelayo: 
 
1 = Izakundenza ndifune kakhulu ekuthabatheni inxaxheba kwimizamo yogonyo olukhusela 
ukosulelwa yintsholongwane kaGawulayo (HIV) kwilixa elizayo 
2 = Izakundenza ndifune njee ekuthabatheni inxaxheba kwimizamo yogonyo olukhusela ukosulelwa 
yintsholongwane kaGawulayo kwilixa elizayo  
3 = Ayiyi kusichaphazela isigqibo sam nangayiphi na indlela 
4 = Izakundenza ndingafuni njee ukuthabatha inxaxheba kwimizamo yogonyo olukhusela ukusulelwa 
yintsholongwane kaGawulayo kwilixa elizayo 
5 = Izakundenza ndingafuni kakhulu/konke konke ukuthabatha inxaxheba kwimizamo yogonyo 
olukhusela ukosulelwa yintsholongwane kaGawulayo kwilixa elizayo 
 
 1. 
Ndingafuna 
kakhulu 
2. 
Ndingafuna 
njee 
3. 
Ayiyikusichaphazela 
isigqibo sam 
4. 
Ndingangafuni 
njee 
5. 
Ndingangafuni 
kakhulu/konke 
konke 
1. Ukuba nolwazi oluninzi 
mayela neengeniso 
ezingafumaneka kugonyo 
olukhusela ukosulelwa 
yintsholongwane 
kaGawulayo (HIV) 
lungandenza ndi… 
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 1. 
Ndingafuna 
kakhulu 
2. 
Ndingafuna 
njee 
3. 
Ayiyikusichaphazela 
isigqibo sam 
4. 
Ndingangafuni 
njee 
5. 
Ndingangafuni 
kakhulu/konke 
konke 
2. Ukuba nolwazi oluninzi 
mayela nendlela 
zokumelana 
neenkcahpazelo 
empilweni yam 
ezingathizenziwe lugonyo 
olukhusela ukosulelwa 
yintsholongwane 
kaGawulayo (HIV) 
zingenza ndi… 
     
3. Ukwazi ukuba 
ukuthabatha inxaxheba 
kumzamo wogonyo 
olukhusela ukosulelwa 
yintsholongwane 
kaGawulayo (HIV) 
kuzakunceda ukuphelisa 
ubhubhane wesifo 
sikaGawulayo (AIDS) 
kungandenza ndi…  
     
4. Ukufumana unyango 
simahla kwisigulo 
eimayela nomzamo 
wogonyo kungenza ndi…  
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 1. 
Ndingafuna 
kakhulu 
2. 
Ndingafuna 
njee 
3. 
Ayiyikusichaphazela 
isigqibo sam 
4. 
Ndingangafuni 
njee 
5. 
Ndingangafuni 
kakhulu/konke 
konke 
5. Into yokuba ukuthabatha 
inxaxheba kumzamo 
wogonyo olukhusela 
ukosulelwa 
yintsholongwane 
kaGawulayo (HIV) iyinto 
entsha endingazange 
ndakhe ndayenza 
ingandenza ndi… 
     
6. Ukuba bendiza kubonwa 
njengomzekelo omhle 
ekuhlaleni ngokuthabatha 
inxaxheba kumzamo 
wogonyo olukhusela 
ukosulelwa 
yintsholongwane 
kaGawulayo (HIV) 
bendinga…  
     
7. Ukubhatalelwa 
ukuthabatha inxaxheba 
kumzamo wogonyo 
olukhusela ukosulelwa 
yintsholongwane 
kaGawulayo (HIV) 
kungandenza ndi… 
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 1. 
Ngafuna 
kakhulu 
2. 
Ndingafuna 
njee 
3. 
Ayiyikusichaphazela 
isigqibo sam 
4. 
Ndingangafuni 
njee 
5. 
Ndingangafuni 
kakhulu/ 
konke konke 
8. Ukwenzeka kwento 
yokuba ndifunyaniswe 
ndinesifo sikaGawulayo 
ngempazamo kungenza 
ndi…    
     
9. Ukuba iitshomi zam 
bezingavuma ukuba 
ndithabathe inxaxheba 
kumzamo wogonyo 
oloukhusela ukosulelwa 
yintsholongwane 
kaGawulayo (HIV) 
ndinga… 
     
10. Ukuba bendikholelwa 
ukuba abaphandi 
bomzamo wogonyo 
olukhusela ukosulelwa 
yintsholongwane 
kaGawulayo (HIV) 
bendinga… 
     
11. Ukuba nolwazi oluninzi 
mayela neengxaki 
neempazamo zemigonyo 
ekhusela ukosulelwa 
yintsholongwane 
kaGawulayo (HIV) 
ingandenza ndi…  
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 1. 
Ngafuna 
kakhulu 
2. 
Ndingafuna 
njee 
3. 
Ayiyikusichaphazela 
isigqibo sam 
4. 
Ndingangafuni 
njee 
5. 
Ndingangafuni 
kakhulu/ 
konke konke 
12. Ukuba bekukho ubungozi 
bokosulelwa 
yintsholongwane 
kaGawulayo (HIV) obuvela 
kologonyo lukhusela 
ukosulelwa 
yintsholongwne 
kaGawulayo 
luvavanywayo bendinga…  
     
13. Ukuba ukuthabatha 
inxaxheba kumzamo 
wogonyo olukhusela 
ukosulelwa 
yintsholongwane 
kaGawulayo (HIV) bekuza 
kuthabatha ixesha lam 
elininzi bendinga… 
     
14. Ithuba lokuba 
ndisenokuncuntswa 
ngeenaliti kumzamo 
wogonyo okhusela 
ukosulelwa 
yintsholongwane 
kaGawulayo (HIV) 
lingandenza ndi… 
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 1. 
Ndingafuna 
kakhulu 
2. 
Ndingafuna 
njee 
3. 
Ayiyikusichaphazela 
isigqibo sam 
4. 
Ndingangafuni 
njee 
5. 
Ndingangafuni 
kakhulu/ 
konke konke 
15. Ukuba iTsheri yam 
ibingala ukulalana nam 
ngenxa yokuthabatha 
kwam inxaxheba 
kumzamo wogomyo 
olukhusela ukosulelwa 
yintsholongwane 
kaGawulayo (HIV) 
bendinga…   
     
16. Ithuba lokuba ndicalu-
calulwe ngabanye 
ngenxa yokuthabatha 
inxaxheba kumzamo 
wogonyo olukhusela 
ukosulelwa 
yintsholongwane 
kaGawulayo  lingenza 
ndi… 
     
17. Ithuba lokuba ndifumane 
ukugulana okuncinci 
olwenziwa lologonyo 
olukhusela ukosulelwa 
yintsholongwane 
kaGawulayo (HIV) 
luvavanywayo lungenza 
ndi…  
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 1. Ngafuna 
kakhulu 
2. 
Ndingafuna 
njee 
3. 
Ayiyikusichaphazela 
isigqibo sam 
4. 
Ndingangafuni 
njee 
5. 
Ndingangafuni 
kakhulu/ 
konke konke 
18. Ukuba indlela 
yokuthuthwa ukuya 
nokubuya kwindawo apho 
wenzelwa umzamo 
wogonyo olukhusela 
ukosulelwa 
yintsholongwane 
kaGawulayo (HIV) 
kuxabisa kakhulu 
ndinga… 
     
19. Abaphandi bomzamo 
wogonyo olukhusela 
ukosulelwa 
yintsholongwane 
kagawulayo 
abathembekileyo 
ngenene bangenza ndi… 
     
20. Ukuba 
bendinokuphelelwa 
ngumsebenzi ngenxa 
yokuthabatha inxaxheba 
kumzamo wogonyo 
olukhusela ukosulelwa 
yintsholongwane 
kaGawulayo (HIV) 
bendinga…  
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 1. 
Ngafuna 
kakhulu 
2. 
Ndingafuna 
njee 
3. 
Ayiyikusichaphazela 
isigqibo sam 
4. 
Ndingangafuni 
njee 
5. 
Ndingangafuni 
kakhulu/ 
konke konke 
21. Ukuvavanyelwa 
intsholongwane 
kaGawulayo (HIV) 
ngabaphandi bogonyo 
olukhusela ukosulelwa 
yintsholongwane 
kaGawulayo 
abaqeqeshiweyo 
kwezonyango  kungenza 
ndi… 
     
22. Ithuba lokuba iTsheri yam 
ingandishiya ngenxa 
yokuthabatha inxaxheba 
kumzamo wogonyo 
olukhusela ukosulelwa 
yintsholongwane 
kaGawulayo (HIV) 
lingandenza ndi… 
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 1. 
Ndifune 
kakhulu 
2. Ndifune 
njee 
3. 
Ayiyikusichaphazela 
isigqibo sam 
4. Ndingafuni 
njee 
5. Ndingafuni 
kakhulu/konke 
konke 
23. Ithuba lokuba abantu 
baseCaweni yam 
bangayithandi into 
yokuthabathabatha kwam 
inxaxheba kumzamo 
wogonyo olukhusela 
ukosulelwa 
yintsholongwane 
kaGawulayo (HIV) 
ingandenza ndi… 
     
24. Ukuba abanye abantu 
bangacinga ukuba 
ndinentsholongwane 
kaGawulayo (HIV) 
ngenxa yokuba 
ndithabatha inxaxheba 
kumzomo wogonyo 
olukhusela ukosulelwa 
yintsholongane 
kaGawulayo (HIV) 
ndinga… 
     
25. Ukuba isithandwa sam 
besingavuma ukuba 
ndithabathe inxaxheba 
kumzamo wogonyo 
olukhusela ukosulelwa 
yintsholongwane 
kaGawulayo ndinga… 
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 1. 
Ndifune 
kakhulu 
2. Ndifune 
njee 
3. 
Ayiyikusichaphazela 
isigqibo sam 
4. Ndingafuni 
njee 
5. Ndingafuni 
kakhulu/konke 
konke 
26. Ukufumana isithuthi 
simahla sokuya nokubuya 
kwindawo yomzamo 
wogonyo olukhusela 
ukosulelwa 
yintsholongwane 
kaGawulayo 
kungandenza ndi… 
     
27. Ithuba lokuba ndingagula 
kancinci ngenxa yaloo 
mzamo wogonyo 
olukhusela ukosulelwa 
yintsholongwane 
kaGawulayo 
oluvavanywayo 
lingandenza ndi… 
     
28. Ukuba ukuthabatha 
kwam inxaxheba 
kumzamo wogonyo 
olukhusela ukosulelwa 
yintsholongwane 
kaGawulayo (HIV) 
lungahambelana nezinto 
endizenza imihla 
ngemihla lingandenza 
ndi…  
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 1. 
Ndifune 
kakhulu 
2. Ndifune 
njee 
3. 
Ayiyikusichaphazela 
isigqibo sam 
4. Ndingafuni 
njee 
5. Ndingafuni 
kakhulu/konke 
konke 
29. Ukuba abaphandi 
bogonyo olukhusela 
ukosulelwa 
yintsholongwane 
kaGawulayo 
bangathabatha inxaxheba 
buqu kumzomo wogonyo 
olukhusela ukosulelwa 
yintsholongwane 
kaGawulayo (HIV) 
ndinga… 
     
30. Ukuba bendinokuba 
nesiqinisekiso esivela 
kubaphandi bogonyo 
olukhusela ukosulelwa 
yintsholongwane 
kaGawulayo (HIV) 
sokuba ologonyo 
olukhusela ukosulelwa 
yintsholongwane 
kaGawulayo (HIV) 
luvavanywayo 
lukhuselekile... 
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 1. 
Ndingafuna 
kakhulu 
2. 
Ndingafuna 
njee 
3. 
Ayiyikusichaphazela 
isigqibo sam 
4. 
Ndingangafuni 
njee 
5. 
Ndingangafuni 
kakhulu/konke 
konke 
31. Ukuba abantu basekhaya 
abayithandi into 
yokuthabatha inxaxheba 
kwam kumzamo wogonyo 
olukhusela ukosulelwa 
yintsholongwane 
kaGawulayo ndinga… 
     
32. Ukubuzwa ngabaphandi 
bogonyo olukhusela 
ukosulelwa 
yintsholongwaen 
kaGawulayo (HIV) 
mayela nokuziphatha 
kwam kwezokulalana 
kungandenza ndi… 
     
33. Ithuba lokuba 
ndingafumana ugonyo 
olungelilo nqo (olufana 
nelo lenyani kodwa lube 
lungelilo linikelwa njee 
ukukholisa) endaweni 
yogonyo olukhusela 
ukosulelwa 
yintsholongwane 
kaGawulayo (HIV) 
oluyinyani kungandenza 
ndi… 
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 1. Ndifune 
kakhulu 
2. Ndifune 
njee 
3. 
Ayiyikusichaphazela 
isigqibo sam 
4. Ndingafuni 
njee 
5. Ndingafuni 
kakhulu/konke 
konke 
34. Ukuba abantu 
basekuhlaleni banga 
ngayithandi into 
yokuthabatha kwam 
inxaxheba kumzamo 
wogonyo olukhusela 
ukosulelwa 
yintsholongwane 
kaGawulayo (HIV) 
ndinga… 
     
35. Ithuba lokuba 
kungenzeka ndingazuzi 
buqu ngokuthabatha 
inxaxheba kumzamo 
wogonyo olukhusela 
ukosulelwa 
yintsholongwane 
kaGawulayo (HIV) 
lingandenza ndi… 
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 APPENDIX B 
 
 
Below are some statements regarding attitudes towards participating in an HIV vaccine trial. 
Please circle the number that best indicates your attitude towards HIV vaccine trials.  
 
Participating in an HIV vaccine trial would be:  
 
1. Harmful 1 2 3 4 5 6 7 Beneficial  
2. Good  1 2 3 4 5 6 7 Bad  
3. Pleasant 1 2 3 4 5 6 7 Unpleasant  
4. Worthless  1 2 3 4 5 6 7 Worthwhile  
5. Important  1 2 3 4 5 6 7 Unimportant  
6. Admirable  1 2 3 4 5 6 7 Non Admirable  
7. Necessary 1 2 3 4 5 6 7 Unnecessary  
8. Beneficial  1 2 3 4 5 6 7 Non beneficial  
9. Silly  1 2 3 4 5 6 7 Clever  
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Ngezantsi kukho iintetho ezimayela neemvakalelo/nezimvo mayelo nokuthabatha inxaxheba 
kumzamo wogonyo olukhusela ukosulelwa yintsholongwane kaGawulayo (HIV). Nceda ubonise 
ngesangqa kwinani elibonisa imvakalelo/uluvo lwakho ngokupheleleyo mayela nokuthabatha 
inxaxheba kwimizamo yogonyo olukhusela ukosulelwa yintsholongwane kaGawulayo (HIV)  
 
Ukuthabatha inxaxheba kumzamo wogonyo olukhusela ukosulelwa yintsholongwane kaGawulayo (HIV) 
kungaba: 
 
1. Nobungozi 1 2 3 4 5 6 7 Kunengeniso  
2. Kokulungileyo  1 2 3 4 5 6 7 Kokubi  
3. Kokumnandi 1 2 3 4 5 6 7 Kokungemnandanga  
4. Kokungento yanto 1 2 3 4 5 6 7 Kululutho  
5. Kokubalulekileyo  1 2 3 4 5 6 7 Akubalulekanga  
6. Kuyathandeka  1 2 3 4 5 6 7 Akuthandeki  
7. Kuyimfuneko 1 2 3 4 5 6 7 Akuyomfuneko 
8. Kunengeniso 1 2 3 4 5 6 7 Akunangeniso 
9. Kulugezo 1 2 3 4 5 6 7 Akuyo nkalipho  
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APPENDIX C 
 
 
Below are some statements regarding participating in an HIV vaccine trial. There are no right 
or wrong answers. Please read each item carefully and indicate with a cross ‘X’ whether you 
strongly disagree, disagree, agree or strongly agree. 
 
 
 Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
1. Most people who are important 
to me think that I should 
participate in an HIV vaccine 
trial.  
    
2. It is expected of me to 
participate in an HIV vaccine 
trial.  
    
3. I feel pressured by people 
around me to participate in an 
HIV vaccine trial.  
    
4. Most people who are important 
to me are willing to participate in 
an HIV vaccine trial.  
    
5. Doing what significant people in 
my life think I should do is 
important to me.  
    
6. Approval by others of my 
participation in an HIV vaccine 
trial is important to me. 
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 Ngezantsi kukho iintetho mayela nokuthabatha inxaxheba kumzamo wogonyo olukhusela 
ukosulelwa yintsholongwane kaGawulayo (HIV). Akukho zimpendulo zifanelekileyo 
nezingafanelekanga. Nceda ubonise ngo ‘X’ ukuba ingaba awuvumi kakhulu, awuvumi, 
uyavuma, okanye uyavuma kakhulu. 
 
 
 Andivumi 
kakhulu/konke 
konke 
Andivumi Ndiyavuma Ndiyavuma 
kakhulu 
1. Uninzi lwabantu ababalulekileyo 
kum bacinga ukuba ndifanele 
ukuthabatha inxaxheba 
kumzamo wogonyo olukhusela 
ukosulelwa yintsholongwane 
kaGawulayo (HIV)  
    
2. Kulindelwe kuba ndithabathe 
inxaxheba kumzamo wogonyo 
olukhusela ukosulelwa 
yintsholongwane kaGawulayo 
(HIV)   
    
3. Ndiziva ndinyanzeliswa 
ngabantu abakufuphi nam 
ukuba ndithabathe inxaxheba 
kumzamo wogonyo olukhusela 
ukosulelwa yintsholongwane 
kaGawulayo  
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 Andivumi 
kakhulu/konke 
konke 
Andivumi Ndiyavuma Ndiyavuma 
kakhulu 
4. Uninzi lwabantu ababalulekileyo 
kum bathabatha inxaxheba 
kumzamo wogonyo olukhusela 
ukosulelwa yintsholongwane 
kaGawulayo (HIV).  
    
5. Ukwenza into abantu 
ababakulekileyo ebomini bam 
abacinga ukuba ndifanele 
ndiyenze kubalulekile kum 
    
6. Ukuvunyelwa ngabanye ukuba 
ndithabathe inxaxheba 
kumzamo wogonyo olukhusela 
ukosulelwa yintsholongwane 
kaGawulayo (HIV) kubalulekile 
kum. 
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APPENDIX D 
 
 
 
 Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
1. I am confident that I could 
participate in an HIV vaccine 
trial if I wanted to  
    
2. It would be very difficult for me 
to participate in an HIV vaccine 
trial  
    
3. The decision to participate in an 
HIV vaccine trial is beyond my 
control  
    
4. Whether or not I decide to 
participate in an HIV vaccine 
trial is entirely up to me  
    
5. I would not be able to participate 
in an HIV vaccine trial even if I 
wanted to  
    
6. It is up to me to decide whether 
or not I would participate in an 
HIV vaccine trial  
    
 
Below are some statements regarding your ability to participate in an HIV vaccine trial. Please 
read each item carefully and indicate with a cross ‘X’ whether you strongly disagree, disagree, 
agree or strongly agree  
Stellenbosch University http://scholar.sun.ac.za
  
 
 
165 
 
 
 
 
 Andivumi 
kakhulu/konke 
konke 
Andivumi Ndiyavuma Ndiyavuma 
kakhulu 
1. Ndizithembile ukuba 
ndingathabatha inxaxheba 
kumzamo wogonyo olukhusela 
ukosulelwa yintsholongwane 
kaGawulayo xa ndifuna. 
    
2. Kuyakubanzima kakhulu ukuba 
ndithabathe inxaxheba 
kumzamo wogonyo olukhusela 
ukosulelwa yintsholongwane 
kaGawulayo  
    
3. Isigqibo sokuba ndithabathe 
inxaxheba kumzamo wogonyo 
olukhusela ukosulelwa 
yintsholongwane kaGawulayo 
singaphaya kwamandla am.  
    
Ngezantsi kukho iintetho mayelana nokukwazi kwakho ukuthabatha inxaxheba kumzamo wogonyo 
olukhusela ukosulelwa yintsholongwane kaGawulayo (HIV). Nceda ufunde enye nenye intetho 
ngocoselelo uze ubonise ngo ‘X’ ukuba awuvumi kakhulu, awuvumi, uyavuma, uyavuma kakhulu.  
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 Andivumi 
kakhulu/konke 
konke 
Andivumi Ndiyavuma Ndiyavuma 
kakhulu 
4. Ukuba ndigqiba ekubeni 
ndithabathe inxaxheba okanye 
ndingathabathi inxaxheba 
kumzamo wogonyo olukhusela 
ukosulelwa yintsholongwane 
kaGawulayo (HIV) 
kuxhomekeke kum qwaba. 
    
5. Bendingena kukwazi 
ukuthabatha inxaxheba 
kumzamo wogonyo olukhusela 
ukosulelwa yintsholongwane 
kaGawulayo nokuba bendifuna.  
    
6. Kuxhomekeke kum ukwenza 
isigqibo sokuthabatha okanye 
ukungathabathi nxaxheba 
kumzamo wogonyo olukhusela 
ukosulelwa yintsholongwane 
kaGawulayo. 
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APPENDIX E 
 
 
Below are some statements regarding your feelings about researchers. Please read each 
item carefully and indicate with a cross ‘X’ whether you strongly disagree, disagree, agree or 
strongly agree. 
 
 
 Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
1. If I were asked to participate in a 
research study and the study 
procedures were explained to 
me by the researcher, I would 
believe what he or she told me. 
    
2. I would not trust a researcher to 
tell me the truth about a study in 
which I was invited to 
participate. 
    
3. Researchers exploit people 
when they test medicines on 
humans. 
    
4. The public should be wary of 
researchers. 
    
5. I am suspicious of researchers.     
6. When a researcher gives me 
information I would accept it as 
true.  
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 Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
7. In research studies that test 
medicines on humans, the 
research subjects are generally 
treated ethically.  
    
8. In research studies that test 
medicines on humans, the 
subjects’ rights are often 
violated.  
    
9. In research studies that test 
medicines on humans, the 
research subjects are often 
harmed. 
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Ngezantsi kukho iintetho ezimayela nezimvo zakho mayela nabaphandi. Nceda ufunde enye 
nenye intetho ngocoselelo uze ubonise ngo ‘X’ ukuba awavumi kakhulu, awuvumi, uyavuma, 
uyavuma kakhulu 
 
 
 Andivumi 
kakhulu 
Andivumi Ndiyavuma Ndiyavuma 
kakhulu 
1. Ukuba bendinokucelwa ukuba 
ndithabathe inxaxheba 
kuphando/kwisifundo, zize 
iinkcukacha zolo phando/zeso 
sifundo zicaciswe kum 
ngumphandi, bendinoyi 
kukholelwa loonto umphandi 
andixelele yona. 
    
2. Andinakuthemba ukuba 
umphandi undixelela inyaniso 
mayela nolo phando/sifundo 
endicelwe ukuba ndithabathe 
inxaxheba kuso. 
    
3. Abaphandi bayabasebenzisa 
babahlukumeze abantu xa 
bevavanya amayeza ebantwini. 
    
4. Abantu bafanele ukuba 
babalumkele abaphandi. 
    
5. Ndiya bakrokrela abaphandi.     
6. Xa umphandi endinika ulwazi, 
ndizakulamkela olo lwazi 
njengoluyinyaniso.  
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 Andivumi 
kakhulu 
Andivumi Ndiyavuma Ndiyavuma 
kakhulu 
7. Kuphando/kwizifundo apho 
amayeza avavanywa ebantwini, 
abathathi nxaxheba kolophando 
baphathwa 
ngokusesikweni/ngokusemtheth
weni 
    
8. Kuphando/kwizifundo ezivavanya 
amayeza ebantwini, abathathi 
nxaxheba 
bayakhohlakalelwa/bayahlukuny
ezwa 
    
9. Kuphando/kwizifundo ezivavany 
amayeza ebantwini, abathathi 
nxaxheba bayonzakaliswa. 
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APPENDIX F 
 
 
Below you will find statements relating to your knowledge of clinical trials, HIV vaccines and HIV 
vaccine trials. Please read each item carefully and indicate with a cross ‘X’ whether you think the 
statement is true or false. If you do not know whether the statement is true or false, please take 
your best guess. 
   
 
 True False 
1. A placebo is a fake treatment that is similar to a real vaccine or drug. 
  
2. In a clinical trial there are usually two groups of people: one group that receives 
the real vaccine or drug and the other group that receives a fake vaccine or drug 
(placebo).  
  
3. It is important that the individuals placed in each group in a clinical trial are 
different to each other in as many ways as possible.  
  
4. In a clinical trial, the participants know whether they have received the real 
vaccine or drug or whether they have received the fake vaccine or drug 
(placebo).  
  
5. Sometimes some participants in a clinical trial may recover from an illness even 
though they only receive the fake vaccine or drug (placebo).  
  
6. When testing a new medication or vaccine it is necessary to have a group that 
receives only a placebo. This will help researchers to determine whether the new 
medication works better than the fake medication (placebo).  
  
7. A vaccine is given to help prevent someone from becoming infected with a 
disease. 
  
8. A vaccine is given only to children, never to adults.    
9. If a person receives a new vaccine that does not work properly, he or she may 
not be protected from becoming infected with the disease.  
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 True 
 
False 
10. An HIV vaccine (when it becomes available) can never give you HIV or AIDS.    
11. New vaccines are tested on human beings only once they have been shown to 
be safe in animals.   
  
12. If you decide to participate in an HIV vaccine trial, you will receive information 
about the trial before you are included in the study.  
  
13. People who want to enroll in an HIV vaccine trial will be asked to sign a form 
saying that they agree to participate before they are included in the trial. 
  
14. If you receive an HIV vaccine it is possible that you may test HIV positive even 
though you are not really infected with HIV.  
  
15. If people have unsafe sex, the HIV vaccine being tested might not protect them 
from becoming infected with HIV.  
  
16. People who take part in HIV vaccine trials will receive free health care at the 
study clinic only for trial-related medical problems.  
  
17. If you enroll in an HIV vaccine trial you will receive medical and HIV tests 
regularly all the way through the trial.  
  
18. If you enroll in an HIV vaccine trial, you will not be asked questions about your 
health and sexual behaviour.  
  
19. People who take part in an HIV vaccine trial will not be allowed to stop their 
involvement in the trial.  
  
20. An HIV vaccine trial is a study in which a new HIV vaccine is tested to see if it 
prevents people from contracting HIV. 
  
21. In an HIV vaccine trial, scientists want to know whether there are fewer HIV 
infections in the group that receives the new HIV vaccine than in the group that 
receives the fake HIV vaccine (placebo).  
  
22. If fewer people in the group that receives the real vaccine develop HIV than 
those who are given the fake HIV vaccine (placebo), we may conclude that the 
vaccine is working effectively.  
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 True 
 
False 
23. In an HIV vaccine trial, some participants have a better chance than others of 
being placed in the group that receives the real vaccine. 
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 Ngezantsi uzakufumana iintetho ezimayela nemizamo yonyango, imigonyo ekhusela 
ukosulelwa yintsholongwane kaGawulayo (HIV) kunye nemizamo yemigonyo ekhusela 
ukosulelwa yintsholongwane kaGawulayo (HIV). 
   
 
 Yinyaniso Ngamampunge/bubuxoki 
1. Usinga-nyango/yeza lunyango olufana nogonyo 
okanye isiyobisi/iyeza lenyani. 
  
2. Iqela elinye liye lifumane ugonyo/isiyobisi/iyeza 
lokwenyani lize elinye iqela lifumane usinga-
gonyo/siyobisi/yeza (elifana nqwa nelenyani, libe 
lingelilo, linikelwa nje ukukholisa).  
  
3. Kubalulekile ukuba abantu ababekwe kwiqela ngalinye 
lomzamo wonyango bohluke omnye komnye 
ngeendlela ezininzi kanga ngoko. 
  
4. Kumzamo wonyango, abathathi nxaxheba bayayazi 
into yokuba bafumene ugonyo/isiyobisi/iyeza oluyinyani 
okanye usinga-gonyo/siyobisi/yeza (olufana nqwa 
nelenyani lube lungelilo, lunikelwa njee ukukholisa). 
  
5. Ngamanye amaxesha abanye abathathi nxaxheba 
bayaphila bazive bebhetele ekuguleni kwabo noxa 
bebenikwe usinga-gonyo/siyobisi/yeza elingelilo 
lenyani (elifana nqwa nelenyani libe lingelilo, linikelwa 
njee ukukholisa). 
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 Yinyaniso Ngamampunge/bubuxoki 
6. Xa kuvavanywa iyeza okanye ugonyo olutsha 
kuyimfuneko ukuba kubekho iqela elinikwa usinga-
yeza/gonyo/siyobisi (olufana nqwa nelenyani lube 
lungelilo, linikelwa njee ukukholisa). Loo nto inceda 
ukuba abaphandi bakwazi ukubona ukuba ingaba elo 
yeza litsha lisebenza ngokugqithileyo na kuno singa-
yeza (elifana nqwa nelenyani, libe lingelilo, linikelwa 
njee ukukholisa). 
  
7. Ugonyo lunikelwa ukuba lukhusele umntu ekosulelweni 
sisifo. 
  
8. Ugonyo lunikwa abantwana kuphela, hayi abantu 
abadala.  
  
9. Ukuba umntu unikwe ugonyo olutsha olungasebenzi 
kakuhle, akasayi kukhuseleka ekosulelweni sisifo.  
  
10. Ugonyo olukhusela ukosulelwa yintsholongwane 
kaGawulayo (HIV) (xa selufumaneka,sele lukhona) 
alisoze likunike intsholongwane kaGawulayo (HIV) 
okanye uGawulayo (AIDS).   
  
11. Imigonyo emitsha ivavanywa eluntwini emva kokuba 
kufunyaniswe ukuba ikhuselekile kwizilwanyana. 
  
12. Ukuba ugqiba kwelokuba mawuthabathe inxaxheba 
kumzamo wogonyo olukhusela ukosulelwa 
yintsholongwane kaGawulayo (HIV), uyakufumana 
ulwazi mayela nomzamo lowo phambi kokuba 
ungeniswe kolo phando.  
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 Yinyaniso Ngamampunge/Bubuxoki 
13. Abantu abafuna ukungenela umzamo wogonyo 
olukhusela ukosulelwa yintsholongwane kaGawulayo 
(HIV) bayakucelwa ukuba basayine ixwebhu elichaza 
ukuba bayavuma phambi kokuba bangeniswe kuloo 
mzamo. 
  
14. Xa ufumana ugonyo olukhusela ukosulelwa 
yintsholongwane kaGawulayo (HIV) likhona ithuba lokuba 
ufunyaniswe unentsholongwane kaGawulayo noxa 
ungenayo konke konke.  
  
15. Ukuba abantu balalana ngokungakhuselelekanga 
(abasebenzisi isingxobo) olo gonyo lukhusela ukosulelwa 
yintsholongwane kaGawulayo (HIV) luvavanywayo 
lusenoku ngabakhuseli ekosulelweni yintsholongwane 
kaGawulayo (HIV)  
  
16. Abantu abathabatha inxaxheba kwimizamo yogonyo 
olukhusela ukosulelwa yintsholongwane kaGawulayo 
(HIV) bazakufumana unyango kwindlu yophando mayela 
nezigulo eziphathelene nemizamo kuphela. 
  
17. Ukuba ungenele umzamo wogonyo olukhusela 
ukosulelwa yintsholongwane kaGawulayo (HIV) 
uzakufumana uvavanyo lwezigulo kunye novavanyo 
lwentsholongwane kaGawulayo (HIV) rhoqo ngalo lonke 
ixesha lomzamo.  
  
18. Ukuba ungenele umzamo wogonyo olukhusela 
ukosulelwa yintsholongwane kaGawulayo (HIV) awusayi 
kubuzwa mayela nempilo yakho kunye nokuziphatha 
kwakho kwezokulalana.  
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 Yinyaniso Ngamampunge/Bubuxoki 
19. Abantu abathabatha inxaxheba kumzamo wogonyo 
olukhusela ukosulelwa yintsholongwane kaGawulayo (HIV) 
abasayi kuvunyelwa ukuba barhoxe ekuthabatheni kwabo 
inxaxheba kuloo mzamo.  
  
20. Umzamo wogonyo olukhusela ukusulelwa yintsholongwane 
kaGawulayo (HIV) luphando/sisifundo apho ugonyo olutsha 
olukhusela ukosulelwa yintsholongwane kaGawulayo (HIV) 
luthi luvavanywe ukuze kubonwe ukuba lunakho na 
ukukhusela abantu ekosulelweni yintsholongwane 
kaGawulayo (HIV) kusini na. 
  
21. Kumzamo wogonyo olukhusela ukosulelwa yintsholongwane 
kaGawulayo (HIV), iinzululwazi zifuna ukwazi ukuba ingaba 
kukho abantu abambalwa na abathe bosulelwa 
yintsholongwane kaGawula kutsha nje kweli qela elithe 
lafumana ugonyo olutsha olukhusela ukosulelwa 
yintsholongwane kaGawulayo xa kuqhathaniswa neli qela 
liye lafumana usinga-gonyo (ugonyo olufana nqwa nolululo 
ibe ingelulo, linikelwe ukukholisa njee).   
  
22. Ukuba baye babambalwa abantu abathe bosulelwa 
yintsholongwane kaGawulayo kweli qela lifumene ugonyo 
olukhusela ukosulelwa yintsholongwane kaGawulayo 
oluyinyani kuneqela elifumene usinga-gonyo (ugonyo 
olufana nqwa nolululo ibe ingelulo linikelwe ukukholisa njee), 
singagqiba ukuba ugonyo lusebenza ngokupheleleyo.  
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 Yinyaniso Ngamampunge/Bubuxoki 
23. Kwimizamo yogonyo olukhusela ukosulelwa 
yintsholongwane kaGawulayo (HIV), abanye abathathi 
nxaxheba banethuba elingaphezulu kunabanye lokufumana 
ugonyo lwenyani. 
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APPENDIX G 
 
 
Below are some statements regarding your feelings about helping others. Please read each 
item carefully and indicate with a cross ‘X’ whether you strongly disagree, disagree, agree or 
strongly agree. 
 
 
 Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
1. If I help others too much, they 
may take advantage of me. 
    
2. I try to help those in need.     
3. I must take care of myself 
before taking care of others.  
    
4. I would give up my own comfort 
to help someone else.  
    
5. I usually support community 
projects in any way I can. 
    
6. If I cared for others I would be 
wasting my time. 
    
7. In my own life, I have given up 
rewards for myself so that 
another person would benefit. 
    
8. I will lose out if I worry about 
other people’s problems or 
needs. 
    
9. I try to use my abilities to make 
the world a better place. 
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 Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
10. I think that the most important 
thing in life is to look after my 
own interests first. 
    
11. My life is better when I help 
other people. 
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Nceda ufunde enye nenye intetho ngocoselelo uze ubonise ngo ‘X’ ukuba awuvumi kakhulu, 
awuvumi, uyavuma, uyavuma kakhulu 
 
 
 Andivumi 
kakhulu/konke 
konke 
Andivumi Ndiyavuma Ndiyavuma 
kakhulu 
1. Ukuba ndinceda abanye kakhulu, 
bangandenza isisulu sabo. 
    
2. Ndiyazama ukubanceda abo 
bafuna uncedo. 
    
3. Ndifanele ukuba ndiqale 
ngokuzikhathalela phambi kokuba 
ndikhathalele abanye abantu 
    
4. Ndingancama olwam 
ulonwabo/ufudumalo ukwenzela 
ukuba ndincede omnye umntu. 
    
5. Exesheni elininzi ndiyancedisa 
kwwiiprojekhthi/imisebenzi 
yasekuhlaleni kangangoko 
ndinakho. 
    
6. Ukuba bendinokukhathalela 
abanye abantu bendingazichithela 
ixesha. 
    
7. Ebomini bam, ndiye ndancama 
izipho eyaye izezam ukwenzela 
ukuba kungenele/zifunyanwe 
ngomnye umntu. 
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 Andivumi 
kakhulu/konke 
konke 
Andivumi Ndiyavuma Ndiyavuma 
kakhulu 
8. Ndizakuphulukana 
nezinto/namathuba ukuba 
ndingalibala kukuzikhathaza 
ngeengxaki nezidingo zabanye 
abantu. 
    
9. Ndizama ukusebenzisa izakhono 
zam ukwenza ilizwe ibeyindawo 
ebhetele 
    
10. Ndicinga ukuba eyona nto 
ibalulekileyo ebomini kukujongana 
nemidla/nezidingo zam kuqala. 
    
11. Ubomi bam bubhetele xa ndinceda 
abanye abantu. 
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APPENDIX H 
 
1. What is your gender? 
 
 
 
2. Please write your age here: ___________ 
 
3. What is your current marital status? 
 
Single  
Living together  
Married  
Divorced  
Other 
_________________ 
 
Female  
Male  
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4. What population group do you belong to? 
 
Black  
Coloured  
Indian  
White  
Asian  
Other 
___________ 
 
 
5. What is your first language? 
 
Xhosa  
Northern Sotho   
Southern Sotho  
Zulu  
English  
Afrikaans  
Swazi  
Ndebele  
Tsonga  
Tswana  
Venda  
Other 
___________________ 
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6. What is the highest level of education that you have completed? 
 
No formal education   
Completed primary school   
Attended high school but did not complete matric   
Completed matric   
Attended university, college or technikon but did not graduate   
Graduated from university, college or technikon  
 
7. What is your current work situation? 
 
Employed full time   
Employed part time   
Student  
Unemployed  
Retired  
 
8. Which of the following best describes your approximate annual family income from all sources, 
before taxes?  
 
Less than R10 000  
R10 001-R40 000  
R40 001-R80 000  
R80 001-R110 000   
R110 001-R170 000  
R170 001-R240 000  
R240 001 and above  
Don’t know  
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1. Bong ba gago ke eng? 
 
 
 
2. Tswee tswee, kwala dingwaga tsa gago fa: ___________ 
 
3. Maemo a gago a nyalo ke afe? 
 
Mongwe  
Re nna mmogo   
Nyetswe  
Tlhadile  
Enngwe 
_________________ 
 
Mosadi  
Monna  
Stellenbosch University http://scholar.sun.ac.za
  
 
 
187 
 
4. O wela mo setlhopheng sefe sa morafe? 
 
Montsho  
Mokhalate  
Moindia  
Mosweu  
Moasia  
Enngwe 
___________ 
 
 
5. Puo ya gago ya ntlha ke efe? 
 
Sethosa  
Sepedi   
Sesotho  
SeZulu  
Seesimane  
Seaferikanse  
Seswati  
Setebele  
SeTsonga  
Setswana  
SeVenda  
E nngwe 
___________________ 
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6. Ke maemo a kwa godimo a thuto a o nang le ona? 
 
Ga ke na thuto e e fomale   
Feditse thuto ya sekolo se se potlana   
Tsene sekolo se segolo mme ga ke a wetsa matiriki   
Falotse materiki   
Tsene yunibesiti, kholeje kgotsa thekenikone mme ga ke a aloga   
Alogile kwa yubesiti, kholeje kgotsa thekenikone  
 
7. Maemo a gago a tiro mo nakong ya jaanong ke afe? 
 
Thapilwe nako e e tletseng   
Thapilwe nakwana   
Moithuti  
Ga ke dire  
Ke rotse tiro  
 
8. Ke efe ya tse di latelang e e tlhalosang sentle lotseno lwa ngwaga la `lapa la gago go tswa 
metsweding yotlhe, pele go lekgetho?  
 
Tlase ga R10 000  
R10 001-R40 000  
R40 001-R80 000  
R80 001-R110 000   
R110 001-R170 000  
R170 001-R240 000  
R240 001 le go feta  
Ga ke itse  
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APPENDIX I 
 
STELLENBOSCH UNIVERSITY 
 
Dylan Fincham, Researcher 
Department of Psychology 
Telephone Number: 083 402 2675 
 
CONSENT FORM 
 
Identification of factors affecting willingness to participate in an HIV vaccine trial 
 
INVITATION TO PARTICIPATE 
You are cordially invited to take part in the aforementioned research project. 
 
AIM 
The aim of this research project is to establish the factors that could affect people’s willingness to 
participate in future HIV vaccine trials. 
 
PROCEDURE 
As a participant, you will be asked to complete a questionnaire packet that assesses attitudes towards 
participating in a future HIV vaccine trial, knowledge of HIV vaccines and HIV vaccine trials, mistrust of 
researchers, and altruism. 
 
COSTS AND FINANCIAL RISKS 
There are no financial costs directly associated with taking part in this project.  
 
BENEFITS 
There is no guarantee that you will benefit personally from the study. However, your contribution will add 
greatly to understanding the factors associated with willingness to participate in HIV vaccine trials. 
 
COMPENSATION 
By agreeing to take part in this research study, you will be compensated with R50 for traveling costs. 
 
ALTERNATIVES 
Participation in this research project is entirely voluntary and you may choose not to take part. 
  
CONFIDENTIALITY 
Every attempt will be made to keep all information collected in this study strictly confidential, except as 
may be required by court order or by law. If any publications result from this research, you will not be 
identified by name.  
 
ADDITIONAL INFORMATION 
Your participation in this study is completely voluntary, and you are free to decline to take part.  You 
may stop taking part at any time. If you stop taking part in the project, you may ask that we not use the 
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information already given to us.  You are encouraged to ask questions about the study at any time as 
they occur to you during the programme.  
 
DISCLAIMER/ WITHDRAWAL 
You agree that taking part in this study is completely voluntary and that you may stop at any time. 
 
SUBJECT RIGHTS 
If you have any questions regarding taking part in this research study, you may contact the researcher, 
Mr. Dylan Fincham, by telephoning 083 402 2675. 
 
CONCLUSION 
By signing below you are indicating that you have read and understood the consent form and that you 
agree to take part in this research study.  
 
 
__________________________   ________________________ 
Subject's signature    Date 
 
 
 
__________________________   ________________________ 
Witness's signature     Date 
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 STELLENBOSCH UNIVERSITY 
 
Dylan Fincham, Umphandi 
Icandelo lePsychology 
Inombolo yoqhagamshelwano: 083 402 2675 
 
IFOMU YEMVUMELWANO 
 
Inkqubo yokufumana iimeko ezithomalalisa umdla wokuthabatha inxaxheba kuvavanyo lweyeza 
elikhusela ukosulelwa yi-HIV  
 
 
ISIMEMO SOKUTHABATHA INXAXHEBA 
Uyacelwa ukuba uthabathe inxaxheba kolu phando lukhankanyiweyo ngentla. 
 
INJONGO YOLU PHANDO 
Injongo yolu phando kukufumanisa eyona miba ethi iphembelele okanye iphazamise umdla 
ekuthabatheni inxaxheba  kumalinge acetywayo ovavanyo lweyeza elikhusela ukosulelwa  yi-HIV. 
 
INKQUBO-MGAQO 
Njengothabatha inxaxheba, uyakucelwa ukuba ugcwalise umqulu wephepha lemibuzo ephanda 
ngezimvo malunga nokuthabatha inxaxheba kwixa elizayo kuvavanyo lweyeza elikhusela ukosulelwa  
yi-HIV, ulwazi ngamayeza athintela i-HIV, novavanyo lweyeza elikhusela ukosulelwa yi-HIV, 
ukungathembi abaphandi, nokunikezela ngolwazi ngokukhululekileyo.  
 
INTLAWULO NONGCIPHEKO NGEZEMALI 
Akusayikubakho zintlawulo eziqondene nokuthabatha inxaxheba kolu phando.   
 
INZUZO 
Akukho siqinisekiso sokokuba kungakho inzuzo eqondene nolu phando. Kodwa ke, igalelo lakho 
liyakongeza kakhulu kulwazi ngeemeko ezinxulumene  nomdla wokuthabatha inxaxheba kuvavanyo 
lweyeza elikhusela ukosulelwa  yi-HIV.  
 
IMBUYEKEZO 
Ngokuvuma ukuthabatha inxaxheba kolu phando, uyakubuyekezwa ngesipho se-R50 eyakujongana 
nokukhwela into yokuhamba. 
 
OKUNYE OKUNOKWENZEKA 
Ukuthabatha inxaxheba kolu phando kuse kuzinikezeleni kwakho ngokupheleleyo kwaye ungakhetha 
ukungathabathi nxaxheba.  
  
IMFIHLELO 
Ziyakwenziwa zonke iinzame zokuba ulwazi oluqokelelweyo kolu phando luhlale luyimfihlelo, 
ngaphandle kwaxa lunokufunwa ngokomyalelo wenkundla okanye ngokwasemthethweni. Xa kungakho 
papasho olwenziwayo kolu phando, igama lakho alisayi kukhankanywa.  
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ULWAZI OLONGEZELELWEYO 
Ukuthabatha inxaxheba kolu phando lolokuzinikela ngokupheleleyo,kwaye ukhululekile ukwala 
ukuthabatha inxaxheba. Unganqumama nangaliphina ilixa. Ukuba uyarhoxa ekuthabatheni inxaxheba 
kolu phando, unakho ukucela ukuba ulwazi onikezele ngalo lungasetyenziswa. Uyakhuthazwa ukuba 
ubuze imibuzo ngolu phando nangaliphina ilixa ngendlela evela ngayo kuwe ngexesha lenkqubo. 
 
UKUYEKA 
Uyavuma ukuba ukuthabatha inxaxheba kolu phando lolokuzinikela ngokupheleleyo kwaye ungayeka 
nangaliphina ilixa.  
 
AMALUNGELO ABATHABATHI-NXAXHEBA 
Ukuba unemibuzo malunga nokuthabatha inxaxheba kolu phando, ungaqhagamshelana nomphandi, u- 
Mr. Dylan Fincham, kule nombolo 083 402 2675. 
 
ISIPHELO 
Ngoku sayina ngaphantsi uqondisa ukuba uyifundile wayiqonda ifomu yemvumelwano kwaye uyavuma 
ukuthabatha inxaxheba kulo phando.   
 
 
__________________________   ________________________ 
Igama lomthathi nxaxheba   Umhla 
 
 
 
__________________________   ________________________ 
Igama lengqina        Umhla 
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